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Summary 
 
Heterologous production of large multi domain proteins from higher plants is often 
cumbersome. Barley limit dextrinase (LD), a 98 kDa multi domain starch and α-limit 
dextrin debranching enzyme, plays a major role in starch mobilization during seed 
germination and is possibly involved in starch biosynthesis by trimming of intermediate 
branched α-glucan structures. Highly active barley LD is obtained by secretory 
expression during high cell-density fermentation of Pichia pastoris. The LD encoding 
gene fragment without signal peptide was subcloned in-frame with the Saccharomyces 
cerevisiae α-factor secretion signal of the P. pastoris vector pPIC9K under control of 
the alcohol oxidase 1 promoter. Optimization of a fed-batch fermentation procedure 
enabled efficient production of LD in a 5-L bioreactor, which combined with affinity 
chromatography on β-cyclodextrin-Sepharose followed by Hiload Superdex 200 gel 
filtration yielded 34 mg homogenous LD (84% recovery). The identity of the 
recombinant LD was verified by N-terminal sequencing and by mass spectrometric 
peptide mapping. A molecular mass of 98 kDa was estimated by SDS-PAGE in 
excellent agreement with the theoretical value of 97419 Da. Kinetic constants of LD 
catalysed pullulan hydrolysis were found to Km,app = 0.16 ± 0.02 mg/mL and kcat,app = 79 
± 10 s-1 by fitting the uncompetitive substrate inhibition Michealis-Menten equation, 
which reflects significant substrate inhibition and/or transglycosylation. The resulting 
catalytic coefficient, kcat,app/Km,app= 488 ± 23 mL/(mg·s) is 3.5 fold higher than for 
barley malt LD. Surface plasmon resonance (SPR) analysis showed α-, β-, and γ-
cyclodextrin (CD) binding to LD with Kd of 27.2, 0.70, and 34.7 µM, respectively.  
LD extracted from germinating barley seeds is found in a “bound”, inactive form 
and a free, enzymatically active form. The inactive LD form was proposed to consist of 
a complex with the endogenous limit dextrinase inhibitor (LDI) and extraction under 
reducing conditions resulted in enzymatically fully active LD. The binding kinetics and 
energetics of LD with LDI wild-type and N-terminal extension or truncation variants of 
LDI produced in P. pastoris, were determined using SPR analysis. Fitting a 1:1 binding 
model to SPR data showed a high-affinity binding of KD = 40 ± 3 × 10-12 M with kon ~ 1 
× 106 M-1 s-1 and koff  ~ 5 × 10-5 s-1 at pH 6.0, 150 NaCl and 25 °C. The dissociation rate 
koff increased 10-fold by raising pH from the optimum pH 6.5 to 10, whereas kon was 
maintained resulting in KD being pH dependent. In contrast koff and kon varied only by 
factor of 2 at 75 mM – 1 M NaCl. Electrostatic forces thus did not contribute 
significantly to the LD/LDI stability. Favourable enthalpic and entropic contributions to 
complex formation were indicated by the van’t Hoff parameters ∆H° = −27 kJ/mol and 
T∆S° = 30 kJ/mol resulting in a binding free energy ∆G°= −57 kJ/mol as calculated 
from KD values in the temperature range 10−35 °C. The N-terminally extended or 
truncated LDI mutants changed KD marginally, suggesting the wild-type LDI N-
terminal sequence not to be critical for binding to LD.  
The crystal structures of LD in complex with the competitive inhibitors α- and β-
cyclodextrin  have been refined at 2.5 Å and 2.1 Å, respectively. The enzyme is 
composed of four domains: an eight-stranded N-terminal domain, a putative 
carbohydrate binding module (CBM48), followed by the catalytic domain comprising a 
(β/α)8-like barrel lacking α-helix 5 and finally a C-terminal domain consisting of a two-
sheet β-sandwich motif. The CDs are observed at the expected carbohydrate main-chain 
binding-site occupying the aglycone subsites +1 and +2. One glycerol molecule and 
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three water molecules mimic a glucose residue at subsite –1, thereby identifying 
residues involved in substrate binding. The spaciousness of Met440, a uniquely 
positioned residue amongst α-1,6 acting enzymes, would clash with glucosyl residues at 
subsite –4.This steric hindrance is proposed to affect substrate specificity. A part of an 
extended loop between β5 and β6 of the catalytic (β/α)8-barrel (residues Asp513–Asn520) 
differs from microbial pullulanases in sequence and structure and seems to contribute 
both to the substrate specificity and to the observed higher affinity of LD towards α-CD 
compared to pullulanases. Novel insight onto the specificity determinants and possible 
role in starch biosynthesis is illuminated by this first structure of a plant limit 
dextrinase. 
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Dansk Resumé 
 
Heterolog produktion af store multidomæne proteiner fra højere planter er ofte 
besværlig. Byg limit dextrinase (LD), er et 98 kDa stort multidomain stivelses og 
grænsedextrin afgreningsenzym, som spiller en vigtig rolle i stivelsesmobilisering under 
frøspiring og er muligvis også involveret i stivelse biosyntesen ved trimning af 
intermediære forgrenede α-glucan strukturer. Aktivet byg LD er blevet fremstillet ved 
sekretorisk ekspression i en høj celledensitets fermentering af Pichia pastoris. Det LD 
kodende genfragment uden signal peptid blev subklonet in-frame med Saccharomyces 
cerevisiae α-faktor sekretion signalet ind i P. pastoris ekspression vektoren, pPIC9K 
under kontrol af alkohol oxidase 1 promotoren. Optimering af en fed-batch 
fermentering procedure i en 5-L bioreaktor efterfulgt af affinitetskromatografi på β-
cyclodextrin-Sepharose og gelfiltrering (Hiload Superdex 200) resulterede i 34 mg 
homogent LD (84% udbytte). Identiteten af det rekombinante LD blev påvist med N-
terminal sekvensering og ved peptid massespektrometrisk. En molekylmasse på 98 kDa 
blev anslået ved SDS-PAGE og er i glimrende overensstemmelse med den teoretiske 
værdi på 97,419 kDa. Kinetiske konstanter for LD katalyseret pullulan hydrolyse blev 
bestemt til Km,app = 0,16 ± 0,02 mg/mL og kcat,app = 79 ± 10 s-1 ved anvendelse af 
Michealis-Menten ligningen for ikke-konkurrencedygtige substrat hæmning, hvilket 
afspejler en væsentlig substrat-hæmning og/eller transglycosylation. Den katalytiske 
koefficient, kcat,app/Km,app = 488 ± 23 mL/(mg·s) er 3,5 gange højere end for LD isoleret 
fra byg malt. Surface plasmon resonans (SPR) analyse viste at α-, β-og γ-cyclodextrin 
(CD) bandt til LD med en Kd på hhv. 27,2, 0,70, og 34,7 mM.  
LD isoleret fra spirende byg frø er fundet i en "bundet" inaktiv form, og en fri 
enzymatisk aktiv form. Den inaktive LD form blev foreslået til at bestå af et kompleks 
med den endogene limit dextrinase hæmmer (LDI) og isolering under reducerende 
forhold resulterede i enzymatisk fuldt aktivt LD. Bindings kinetik og energetik af LD 
med LDI vildtype og N-terminal forlængelede eller trunkerede varianter af LDI 
produceret i P. pastoris, blev bestemt ved hjælp af SPR analyse. Anvendelse af en 1:1-
bindingsmodel til de generede SPR data viste en høj bindingsaffinitet med KD = 40 ± 3 
× 10-12 M og kon ~ 1 × 106 M-1 s-1 og koff ~ 5 × 10-5 s-1 ved pH 6,0, 150 mM NaCl og 25 
°C. Ved at hæve pH-værdien fra den optimale pH-værdien, 6,5 til 10 steg dissociation 
hastigheden koff 10 gange, mens kon blev opretholdt, hvilket resulterede i en pH-
afhængig KD. I modsætning varierede koff og kon kun med en faktor 2 ved ændring af 
NaCl indholdet i bufferen fra 75 mM – 1 M. Elektrostatiske kræfter synes derfor ikke at 
bidrage væsentligt til LD/LDI stabiliteten. van't Hoff parametrene blev beregnet ud fra 
KD værdierne i temperaturintervallet 10−35 °C. Favorable enthalpi- og entropi-værdier 
(∆H° = − 27 kJ/mol og T∆S° = 30 kJ/mol) indikerede at begge komponenter bidrog til 
kompleksdannelsen og resulterede i en bindings fri energi, ∆G° = − 57 kJ/mol. N-
terminalt forlængede eller trunkerede LDI mutanter ledte kun til en marginal ændring af 
KD, hvilket indikerer at den N-terminale sekvens af vildtype LDI ikke er afgørende for 
binding til LD.  
Krystalstrukturerne af LD i kompleks med de kompetitive inhibitorer α- og β-CD er 
blevet forfinet til hhv. 2,5 Å og 2,1 Å. Enzymet består af fire domæner: Et otte-strenget 
N-terminale domæne; et formodet kulhydrat bindende modul (CBM48), efterfulgt af et 
katalytisk domæne bestående af en (β/α)8-lignende tønde som mangler α-helix 5 og 
endelig et C-terminal domæne bestående af et to-arket β-sandwich-motiv. 
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Cyclodextrinerne er observeret ved det forventede bindingssted for den primære 
kulhydrat kæde og okkuperer aglycon subsite +1 og +2. Et glycerol molekyle og tre 
vandmolekyler efterlignede en glukose rest ved subsite –1, og dermed identificerede 
aminosyre rester, der er involveret i substrat binding. Positionen af den rummelighed 
aminosyre rest Met440 i LD, som har en unik position blandt α-1,6 
afgreningsenzymerne, vil kollidere med glucosyl rester ved subsite –4. Denne sterisk 
hindring foreslås at påvirke substrat specificiteten. En del af en udvidet loop mellem β5 
og β6 af den katalytiske (β/α)8-tønde (aminosyre rester Asp513–Asn520) adskiller sig fra 
de mikrobielle pullulanaser i både sekvens og struktur og synes at bidrage til både den 
observerede substratspecificitet og den højere α-CD affinitet af LD i forhold til 
pullulanaserne. Ny indsigt i substrat specifikke afgørende faktorer og den mulige rolle i 
stivelse biosyntesen er belyst ved hjælp af denne første struktur af en plante limit 
dextrinase. 
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1 Introduction 
 
1.1 Carbohydrate-Active Enzymes and Clan-H 
 
Carbohydrate-active enzymes are classified according to the CAZy classification 
(1), which divides the enzymes into four main classes based on the type of catalysed 
reaction: glycoside hydrolases (GH) (2), glycosyl transferases (GT) (3), polysaccharide 
lyases (PL) and carbohydrate esterases (CE) (4). In addition to the catalytically active 
classes of enzymes, a special class of non-catalytic carbohydrate binding modules 
(CBM) is defined (5). Within each main class the enzymes are grouped based on 
sequence similarities. Up to this date, 115 different GH families have been classified, 
which again are grouped into 14 clans (GH-A to GH-N) based on a common over-all 
protein fold and catalytic mechanism. GH13, 70 and 77 all belong to clan-H sharing the 
same catalytic domain containing a (β/α)8-barrel. The specificity in GH13 is diverse 
covering more than 20 different activities in three enzyme classes; transferases (EC 
2.x.x.x), hydrolases (EC 3.x.x.x) and isomerases (EC 5.x.x.x) (1). Furthermore, GH13 
has been divided into 35 subfamilies based on clustering, similarity search and 
phylogenetic methods (6). Enzymes belonging to GH13 utilize the retaining mechanism 
with the catalytic nucleophile/base being an aspartate and the catalytic proton donor 
being a glutamate, both identified experimentally (see section 1.21 for detailed 
description of the mechanism).  
 
 
1.2 Limit Dextrinase (LD) 
 
Starch, the most prominent carbohydrate in the human diet, the major carbohydrate 
reserve in cereal seeds and an important industrial raw material, occurs as compact 
supramolecular granules in barley grains and is composed of the polysaccharides 
amylose (Figure 1.1A), a linear α-1,4-glucan, and about 70% amylopectin (Figure 1.1B) 
(reviewed in (7)). In addition to a linear α-1,4-glucan structure, the amylopectin 
contains frequent α-1,6 glucosidic branches connecting shorter linear α-1,4 linked 
chains of varying length to the α-1,4-glucan main-chain (reviewed in (7)).  
In barley, starch granules are stored in the seed endosperm that consists of dead 
tissue and the concerted action of different amylolytic enzymes is required for its 
breakdown to metabolisable oligosaccharides, maltose, and glucose (8) (Figure 1.2A). 
The germination of barley grain (Figure 1.2B) is initiated by an increase in temperature 
and the uptake of water, which induces the synthesis of the phytohormone gibberellic 
acid (GA3) in the embryo. GA3 diffuses to the aleurone layer where it induces de novo 
synthesis of limit dextrinase (LD), α-amylases (isoform 1 and 2) and α-glucosidase (9, 
10). The hydrolytic enzymes are then released to the starchy endosperm where they are 
involved in the mobilisation of storage starch, which provides energy to the growing 
plantlet. LD thus hydrolyses α-1,6-glucosidic bonds in α-limit dextrins derived from 
amylopectin, but has low activity towards amylopectin, present in the mature seed, itself  
(11); α-amylase hydrolyses α-1,4 glucans in an endo-fashion; β-amylase catalyses 
release of maltose from non-reducing ends of the substrates and is unable to pass α-1,6-
 ______________________________________________________________________ 
______________________________________________________________________ 
2 
 
branch points; and the α-glucosidase primarily hydrolyses maltooligosaccharides to 
glucose (8) (Figure 1.2A).  
 
 
 
 
Figure 1.1. Representative structures of linear α-1,4 linked amylose (A), the α-1,4 branched α-1,6 linked 
amylopectin (B) and pullulan composed of α-1,6-linked maltotriose repeats (C). R indicates the reducing 
end of the polymers and R1 indicates the non-reducing end of the polymers, amylose and pullulan, as well 
as the non-reducing end of the sugar side-chain of amylopectin. R2 indicates the non-reducing end of the 
sugar main-chain of amylopectin. n is an integer indicating the number of maltotriose repeats in the 
pullulan. 
LD (EC. 3.2.1.41, pullulanase) is indeed the sole debranching enzyme in seed 
starch mobilization (8, 12). In barley a single gene encodes LD, which is induced in the 
germinating seed by the GA3 (9, 12). Transcripts of the LD gene can be detected in the 
aleurone layer already 12 h after the onset of germination, but LD activity does not 
increase until two days later and reaches a maximum at day 5 after onset of germination 
(9, 13). The level of LD activity in the starchy endosperm is low compared with the α-
amylase activity. Furthermore, the release of LD from the aleurone layer to the 
endosperm appears to be slower than of α-amylase (13) and it was suggested therefore 
to occur as a consequence of cell wall degradation and not via a secretory pathway. The 
secretion of LD, however, has been a matter of debate since a putative leader sequence 
has been identified upstream the mature peptide, but was not predicted to be a signal 
peptide targeting to the ER (9, 12).  
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Figure 1.2. A. The role of α-amylase isoform I and II, β-amylase, limit dextrinase and α-glucosidase in 
degradation of amylase and amylopectin in cereal seed starchy endosperm. B. The germination of barley 
grain is initiated by an increase in temperature and the uptake of water, which induces the synthesis of the 
phytohormone gibberellic acid (GA3) in the embryo.  GA3 diffuses to the aleurone layer where it induces 
de novo synthesis of limit dextrinase, α-amylases and α-glucosidase. The hydrolytic enzymes are then 
released to the starchy endosperm, where they are involved in the catabolism of the storage starch for 
support of the growing plantlet. 
 
In addition to an important role in starch degradation in germinating seeds, LD is 
shown in maize (14) and Arabidopsis (15) to participate in the breakdown of transitory 
starch in leaves. Furthermore, LD is present in developing grains and suggested to play 
a role in starch biosynthesis (9, 13, 16). The hypothesis that the structure of amylopectin 
is the outcome of a balance between debranching and branching enzyme activities (17, 
18) gets support both from maize deficient in pullulanase-type debranching enzyme (i.e. 
LD), having affected starch granule morphology (14) and from a Arabidopsis mutant 
deficient in three isoamylase isozymes and the single LD isozyme with abolished starch 
granule biosynthesis (19). It is therefore believed that successful synthesis of the 
amylopectin starch fraction in plants involves the action of two types of α-1,6 glycoside 
hydrolases, the isoamylases (EC 3.2.1.68) and the limit dextrinase (20, 21). 
Besides the activity towards limit dextrins, LD also shows high activity towards 
pullulan, a linear polysaccharide composed of α-1,6-linked maltotriose repeats (8, 11) 
(Figure 1.1C). LD is thus classified together with pullulanases that are large 
multidomain enzymes that belong to either glycoside hydrolase family 13 subfamily 12 
(GH13_12) (firmicutes), subfamily 13 (GH13_13) (bacteria and eukaryota) or 
subfamily 14 GH13_14) (bacteria), depending on their phylogenetic origin (1, 6). 
Pullulanase encoding genes are identified in plants and their gene products are referred 
to as LDs. The primary structures of plant LDs are highly conserved with sequence 
identities of 80–95% for the cereal homologous enzymes from barley, rice, maize and 
wheat, which are all monocots. The more phylogenic distant homologues from the 
dicots e.g. spinach and Arabidopsis share only 62% over-all sequence identity with 
barley LD (Figure 1.3). Comparison of the barley LD primary structure with that of the 
microbial pullulanases from Bacillus subtilis str. 168 (BsPUL), Bacillus 
acidopullulyticus (BaPUL) and Klebsiella pneumoniae (KpPUL) shows sequence 
identities ranging from 30 to 35% (blastp, default settings, BLOMSUM 62, gap opening 
and extension penalties of 11 and 1, respectively; 
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http://blast.ncbi.nlm.nih.gov/Blast.cgi). So far the vast majority of the characterized 
pullulanases are of microbial origin. The reason for lack of structural information on LD 
primarily stems from its low abundance and lack of efficient purification procedures for 
homogeneous plant proteins and efficient heterologous expression systems for plant LD. 
In the past recombinant production of LD from maize (22),  spinach (23), and wheat 
(24) resulted in very poor yields, which emphasised the challenges of producing some 
plant proteins in E. coli. A similar situation was found for barley α-glucosidase (25), in 
which case, however, a breakthrough was obtained by high cell-density fermentation of 
the host Pichia pastoris resulting in good yields of very pure and five times more 
catalytically efficient α-glucosidase than the enzyme purified from malt (26).  
The α-1,6 acting enzymes including pullulanases of bacterial and LD of plant origin 
(EC 3.2.1.41), isoamylases (EC 3.2.1.68), neopullulanases (EC 3.2.1.135), the latter 
having α-1,4 activity as the main activity, are all composed of similar domain 
organisation, although the number of domains can vary. An N-terminal part, which 
varies in length and can contain several independent structural domains including 
carbohydrate binding modules (CBMs) and is followed by the catalytic (β/α)8-barrel 
domain. A loop protruding from the (β/α)8-barrel between β-strand 2 and α-helix 2 is 
often referred to as Loop 2 (27, 28). Furthermore, a long loop  is connecting β-strand 3 
and α-helix 3 (by convention called B-domain (27, 28), despite the fact that it cannot be 
considered a structurally independent domain). The catalytic domain is followed by a C-
terminal domain, with a two-sheets β-sandwich structural motif which was first 
described in TAKA-amylase A, an α-amylase produced by Aspergillus oryzae (29). LDs 
and isoamylases contain only one annotated CBM namely CBM48 (30), whereas the 3D 
structures of KpPUL and BaPUL (31, 32) reveal two carbohydrate binding modules, 
CBM41 and CBM48, situated N-terminally to the catalytic domain. Based on multiple 
sequence alignment of GH13 family members and the Pfam domain prediction (27, 33), 
LD is proposed to be composed of an N-terminal part including an uncharacterized part 
and a CBM48 module (30). 
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Figure 1.3. Sequence alignment of plant limit dextrinases The alignment rendering was done with the 
program ESPript (34). C, indicates the three catalytic residues Asp473 (nucleophile), Glu510 (general 
acid/base, and Glu644 (third acid in the catalytic triad).  Hv, Hordeum vulgare, acc.# AAD04189 
expressed in Pichia pastoris; Ta, Tritium aestivum, acc.# ABL84490 ; Os, Oryza sativa, acc.#  
H0806H05; Zm, Zea mays, acc.# AAD11599; So, Spinacia oleracea, acc.# CAA58803; At, Arabidopsis 
thaliana, acc.# Q8GTR4. Identical residues in the alignment are marked with red boxes and white 
characters, similar residues are in red characters, while blue frame indicates similarity across groups. 
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1.2.1 Reaction Mechanism and Substrate Specificity of LD 
 
LD catalysed hydrolysis of the α-1,6 glycosidic bond takes place via general acid 
catalysis, which requires a proton donor (Asp473) and a nucleophile/base (Glu510). 
Cleavage of the α-1,6 linkage results in retention of the configuration around the 
anomeric carbon via a double displacement mechanism, which is common for GH13 
family members independent of the linkage being an α-1,4 or α-1,6 bond (35). The two-
step reaction involves a nucleophilic attack from the deprotonated Asp473 forming a 
covalent β-glycosyl-enzyme intermediate and simultaneously a protonation of the 
leaving aglycone by Glu510. The oxocarbonium ion-like transition state is believed to be 
stabilized by side-chains from several conserved amino acids in the active site, 
especially His404 and His641 (12, 35, 36). The deprotonated Glu510 acts as a base by 
activating the acceptor being either a water molecule or a primary hydroxyl group at C6 
in a glucose residue in the intermediate, which results in the retention of the α-
configuration in either a free reducing end (hydrolysis, Figure 1.4A) or a new α-1,6 
glycosidic bond (transglycosylation, Figure 1.4B).   
 
 
Figure 1.4 LD catalysed α-1,6 hydrolysis mechanism with retention of the α-configuration of either the 
reducing end (hydrolysis) (A) or in a new glucosidic bond (transglycosylation) (B). The distance between 
the nucleophile and the acid/base is typically 5.5 Å (35). R and R1 indicate glucose residues at the 
reducing and non-reducing end, respectively, of the substrate. R2 indicates the glucose residues of the 
incoming acceptor.  
 
 
LD is specific for cleavage of α-1,6 bonds in branched dextrins and polymers with α-1,4 
main-chain bonds which can be either linear like pullulan or branched like amylopectin 
and is classified as a starch debranching enzyme. The relative rates of LD and KpPUL 
hydrolysis of a range of starch derived oligosaccharides and polymers as well as 
pullulan is summarised in Table 1.1 and clearly shows a preference for the polymer 
derived oligosaccharides compared with polymeric substrates, in contrast to isoamylase  
(37, 38). The optimum length of the main-chain is four glucose residues for both LD 
and KpPUL and for LD a 2-fold increase in hydrolysis rate is observed when the side-
chain changes from α-maltosyl to α-maltotriosyl, which indicates that the optimum 
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length of side-chain for hydrolysis is three glucose residues (11). LD and KpPUL show 
no hydrolytic activity towards the di- and trisaccharides, isomaltose, panose and 
isopanose and neither are they capable of catalysing the hydrolysis of α-1,6 linkages 
between a single glucose residues attached to either linear or cyclic oligosaccharides 
(11, 39, 40). 
Table 1.1.  Relative rates of hydrolysis of various substrates by LD and KpPUL 
Substrate Relative ratea Relative rateb Relative ratec 
 LD LD KpPUL 
63-α-maltosylmaltotriose - 13 49 
63-α-maltosylmaltotetraose - 123 169 
63-α-maltotriosylmaltotriose - 129 90 
63-α-maltotriosylmaltotetraose 358 243 123 
Nonasaccharide from pullulan - 114 - 
Pullulan 100 100 100 
α-CD - 12 - 
Amylopectin β-limitdextrin - 68 - 
Amylopectin - <<1 - 
Glycogen - 0 - 
a  (37), b (11), c (39). b and c not necessarily determined at saturating conditions. 
 
LD (11, 41-43) as well as other debranching enzymes such as KpPUL and BaPUL 
(44), the debranching enzyme TreX from Sulfolobus solfataricus P2 (45), and 
isoamylase from Pseudomonas amyloderamosa (PaISO) (44) have been shown to 
display transglycosylation activity in addition to their hydrolytic activity. The 
transglycosylation activity of LD can be used in the production of new materials for 
applications in e.g. prebiotics, synthesis of novel inhibitors or potentially drug delivery. 
Chemoenzymatic syntheses of oligosaccharides with specific structures are clearly 
competitive with conventional synthetic approaches, which are often inadequate in 
producing substantial quantities of the product, owing the time consumption and 
complex nature of the synthesis involving selective protection/deprotection and 
manipulation of the reactants. In addition to the clear advantage in producing novel 
compounds an investigation of the LD catalysed transglycosylation reactions using 
different lengths of linear donors and acceptors may also lead to a better understanding 
of the substrate specificity of LD. 
 
 
1.3 Limit Dextrinase Inhibitor (LDI) 
 
LD extracted from germinating barley seeds is found in a “bound”, inactive form 
and a free, enzymatically active form (46). The inactive LD form was proposed to 
consist of a complex with the endogenous limit dextrinase inhibitor (LDI) and 
extraction under reducing conditions resulted in enzymatically fully active LD (46, 47). 
After the onset of germination, the amount of the free LD increased with time 
coinciding with the disappearance of LDI (46, 48). Whether this disappearance is 
caused by reduction by thioredoxin h (49) or degradation by a proteases (46) is not 
known.  
LDI belongs to the CM-protein family of small proteins (110–160 amino acids) 
found in chloroform/methanol extracts of flour, also referred to as the cereal-type 
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inhibitors (50). This group includes α-amylase and protease inhibitors active on 
enzymes from different species, and proposed to be part of the plant defence against 
pest and pathogens (50). Members of this family are monomers, dimers or tetramers 
(51, 52) and share the common fold; bifunctional inhibitor/lipid-transfer protein/seed 
storage 2S albumin (SCOP: Structural Classification of Proteins (53)), which features a 
helical bundle with a simple up-and-down topology. Despite a high sequence identity 
(up 98%) amongst family members, very high specificity was observed (54). The 
variation is mainly in the flexible loop between α-helix 3 and α-helix 4 and at the C-
terminal, which makes the prediction of specific interactions between inhibitor and 
target enzyme very challenging in the absence of a complex structure (54, 55). 
Furthermore, the loop region around the catalytic site of a target enzyme also plays an 
important role in the interaction between the enzyme and inhibitor (54). Cereal-type 
inhibitors and their target enzymes form a 1:1 molar complex (51, 55-60), and the 
inhibition was found to be competitive using p-nitrophenyl α-D-maltoside as substrate, 
with Ki in the range of 11–57 nM, depending on inhibitor and α-amylase (51, 56, 58).  
The N-terminal of RATI, α-amylase/trypsin bifunctional inhibitor from ragi is 
directly involved in the interaction with TMA, α-amylase from the larvae of Tenebrio 
molitor, as observed in the crystal structure of the complex. This interaction is primarily 
mediated by hydrogen bonding between the terminal amino group of Ser1 and the 
carboxyl groups of the catalytic residues in TMA (Asp185 and Asp287), but also by 
hydrophobic interactions between Val2 (RATI) and Trp56, Trp57 and Tyr60 in TMA are 
contributing (59). 
LDI has 114 amino acids and the nine cysteines form 4 disulfide bonds, and leaving 
one free thiol group, possibly Cys59 (61). Two forms of LDI with pI-values of 6.7 and 
7.2, respectively, were extracted and purified from mature barley seeds in very small 
amounts (62). The two forms have identical amino acid sequence and inhibitory 
activity, but differ in the post-translational modification, by either a glutathione or a 
cysteine forming a mixed disulfide bond with the free Cys59 (61, 62). To date only basic 
data on LDI and its interactions with LD have been reported (57, 61, 62). The 
stoichiometry of the complex between LD and LDI was characterized as a 1:1 molar 
ratio by mass spectrometry (57). In addition the binding between LD and LDI was 
reported to be strong although no quantitative data were available (57, 62). The three-
dimensional structure of LDI has been modelled based on the structure of RATI, 
sharing 46% sequence identity with LDI (61). Based on this model, LDI is predicted to 
assume the same fold as other CM-proteins (61). Trypsin inhibitors of this family, share 
a common loop sequence believed to account for their trypsin inhibitory activity. LDI 
does not possess this activity presumably due to a sequence difference in this particular 
loop (57). It has been suggested that LDI binds to the active site of LD in a similar 
manner to RATI and TMA as seen in the crystal structure of the complex (59), and that 
the N-terminus of the LDI is critical in binding to LD (61). Especially Ser4 and Val5 
from LDI were suggested to interact with LD and it has been believed that the three 
amino acids (TLE) preceding Ser4 are important for the specificity of LDI for LD and 
the lack of inhibitory activity towards α-amylases (61). LDI purified from barley seed 
displayed some variations in the length of the C-terminus, precluding an important role 
of the C-terminus of LDI in binding to LD (57, 62). LDI seems to be highly specific for 
LD as two different debranching enzymes of bacterial origin namely KpPUL and PaISO 
were virtually insensitive to LDI (47).  
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1.4 LD and LDI in Malting and Brewing 
 
In addition to the roles in starch biosynthesis in the developing grains (21) and 
degradation in the germinating seed (8), LD is central in beer production by catalyzing 
oligosaccharide debranching during malting and mashing (63). In the brewing and 
distilling industries the degradation of starch into fermentable carbohydrate i.e. glucose, 
maltose, and maltotriose, is specifically important for reaching a high alcohol level (64). 
However, significant amounts of unfermentable branched dextrins present in beer is in 
part attributed to the presence of high levels of LDI in malt, which inhibits the activity 
of LD (48, 65). Thus by increasing the effectiveness of LD in the mashing process, a 
higher alcohol yield would be obtained during the fermentation process which would be 
advantageous for the brewing industry. Based on this one could infer that lowering the 
amount of LDI would lead to a higher alcohol yield, however, other data suggests that 
the presence of the heat stable LDI in the mash stabilizes the heat labile LD and protects 
it against inactivation (66). One could therefore argue that lowering the LDI levels will 
not necessarily lead to an increased LD activity in the mash, due to the heat inactivation 
of LD in the absent of LDI. This is further complicated due to cultivar variations in both 
heat stability and activity of LD (67). 
 
 
1.5 Objectives of the Present Study 
 
Despite the fact that LD has been studied since the fifties (68) insight is lacking 
both on the precise role of LD in the biosynthesis of amylopectin and on the molecular 
basis for substrate specificity in biological and industrial processes. Even though the 
LD/LDI system is of great importance in both academic and industrial contexts, details 
of their interactions remain elusive up to date, perhaps due to the challenges in 
purification of native proteins from their natural source. The general objective was to 
perform structure-function studies of barley limit dextrinase and characterize the 
interaction between LD and its endogenous inhibitor. 
 
 
The specific goals were: 
 
• To establish a system for recombinant expression of barley limit dextrinase, 
which will facilitate future investigation of structure-function relationships 
using site-directed mutagenesis and truncations guided by information of 
family GH13 domain architecture as retrieved from the CAZy-database (1). 
 
 
• To examine the transglycosylation activity of LD using α-maltosyl or α-
maltotriosyl fluorides as donor and a range of linear and cyclic dextrins as 
acceptor. In addition to obtaining novel oligosaccharide products using 
transglycosylation, the transglycosylation pattern of LD will also give 
information of the structure-function relationship of the enzyme with focus 
on the active site area.   
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• To establish a heterologous expression system for barley limit dextrinase 
inhibitor and to discern the kinetics and the energetics of complex formation 
between LD and LDI (LD/LDI), including an evaluation of the role of the 
N-terminal loop of LDI in the inhibitory activity and binding affinity to LD.  
 
 
• To crystallize and determine the 3D structure of LD and the LD/LDI 
complex. 
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2 Experimental Procedures 
 
2.1 Construct, Expression and Purification 
2.1.1 Limit Dextrinase 
2.1.1.1 Construction of E. coli LD Expression Plasmid 
An LD cDNA (GenBank accession No. AF022725) (12) cloned in the pET11a 
expression vector was provided from an in-house collection (41). Sequencing showed 
that the clone contained three mutations compared with the published sequence (12). 
These mutations were corrected using Quikchange Multi site-directed mutagenesis kit 
(Stratagene, La Jolla, CA) and the primers MVC1, MVC3, MVC5 (Table 2.1). The 
corrections were performed as recommended by the manufacturer (Stratagene). E. coli 
XL10-Gold (Stratagene) was transformed with the resulting pET11a/LD plasmid. The 
isolated plasmid was sequenced to confirm the back mutations to the wild-type LD 
sequence. The construct was subsequently transformed into Rosetta(DE3)™ (Novagen, 
Madison, WI) by electroporation for E. coli expression. This strain contains an extra 
plasmid harbouring the genes encoding the tRNA for the seven rare codons (AUA, 
AGG, AGA, CUA, CCC, CGG, and GGA). 
 
Table 2.1. Primers used for construction of E. coli LD expression plasmids 
Primers for correction of pET11/LD clone 
Name Sequence 
MVC1 5´-CCGGAAACCGTGACTCAGAAGTTCCCTTTCATCAGC-3´ 
MVC3 5´-GCTGGTGACCCTTATGCTAGAAGCCTTTCTGC-3´ 
MVC5 5´-GGGTACTATGTTAGAAGGGATACTAATGGCCAGATTGAG-3´ 
The triplet changed are indicated in italic. 
 
2.1.1.2 Pilot Scale Expression in E. coli  
LB medium (100 mL) containing 100 µg/mL ampicillin and 34 µg/mL 
chloramphenicol were inoculated with a culture grown overnight to a starting OD600 of 
0.1. Untransformed Rosetta(DE3) strain served as negative control for expression. The 
cultures were induced at OD600 ~ 0.6 with isopropyl β-D-1-thiogalactopyranoside 
(IPTG) to a final concentration of 1 mM and the temperature was lowered to 20 °C. 
Samples (1 mL) were taken throughout the induction period and were immediately 
centrifuged at 13,000g for 2 min. Supernatants and pellets were stored on ice until SDS-
PAGE and immunoblot analysis. The pellets were dissolved by adding  2 × SDS-
loading buffer (50 µL) and aliquots of the supernatants were mix with the appropriate 
amount of SDS-loading buffer. The SDS-PAGE, Coomassie staining and 
immunoblotting were performed as described in section 2.5.2. 
 
2.1.1.3 Construction of P. pastoris LD Expression Plasmid 
The pET11a/LD plasmid was used as template in PCR with forward primer MVC8 
and reverse primer MVC14 (Table 2.2). The PCR involved preheating at 94 °C (2 min), 
30 cycles at 94 °C (15 s), 55 °C (30 s), and 72 °C (3 min), followed by a final 
elongation (7 min). The resulting PCR product (2678 bp) encoding the mature LD 
lacking the putative leader sequence (amino acid residues 22–905 according to 
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accession No, AAD04189, NCBI Protein database) with flanking NotI restriction sites 
introduced by the primers (in bold) was digested, gel-purified and cloned into the NotI 
site of the pPIC9K vector (Invitrogen, Carlsbad, CA) to obtain in-frame cloning with 
the α-mating factor secretion signal from Saccharomyces cerevisiae (Figure 2.1A).E. 
coli, XL10-Gold (Stratagene) was transformed with the resulting pPICK9/LD (Figure 
2.1B) and isolated plasmids from single colony transformants, selected on LB-agar 
plates containing 100 µg/mL ampicillin, were analyzed for correct orientation of the 
inserted gene using the XbaI restriction site present in both vector and insert. The 
sequence of the final construct was verified by sequencing using forward primers and 
reverse primers covering the LD mature protein encoding region (Table 2.2.). Small 
scale plasmid preparation, restriction enzyme digestion, ligation, and transformation 
followed standard molecular biology protocols (69). 
 
Table 2.2. Primers used for construction of P. pastoris LD expression plasmids and sequencing 
Primers for P. pastoris construct 
Name Sequence 
MVC8 (forw.) 5´-AAGCGGCCGCTGCGTTCATGCCGGA-3´ 
MVC14 (rev.) 5´-AAGCGGCCGCTTAACACCGAGGTTCGACAAAGACT-3´ 
Primers for LD sequencing in pPIC9K 
Name Sequence 
α-factor (forw.) 5´-TACTATTGCCAGCATTGCTGC-3´, 
PLD001 (forw.) 5´-TGCAATTACCCGGCGTGCTG-3´ 
PLD003 (forw.) 5´-GAATATCGTCAGATGGTCCA-3´ 
PLD005 (forw.) 5´-TGATGTTATCAGTGTGAAGA-3´ 
PLD002 (rev.) 5´-CGGTTTTCCCACTCTCTTGG-3 
PLD004 (rev.) 5´-TTAACCTATCAACCATGAAA-3´ 
PLD006 (rev.) 5´-AACACCCCAATTGTTTGTTT-3´ 
3AOX1 (rev.) 5´-GCAAATGGCATTCTGACATCC-3´ 
 
 
 
Figure 2.1. Design of the pPIC9K/LD plasmid. (A) Schematic representation of the construction of LD 
gene cloned in-frame with α-factor secretion signal. The linker between the α-factor and the LD gene is a 
part of the multiple cloning site. (B) The LD encoding expression plasmid used for P. pastoris 
transformation (70). 
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2.1.1.4 Transformation of P. pastoris and Selection for Expression and LD 
Secretion 
Prior to transformation, pPICK9K/LD (20 µg) was linearized with PmeI followed 
by purification (Strataclean; Stratagene ), precipitation, and redissolving in sterile Milli-
Q water. Electrocompetent P. pastoris strain GS115 (Invitrogen) cells were transformed 
with the linearized plasmid by electroporation using a Micropulser (Bio-Rad, Hercules, 
CA). Transformants were isolated by prototrophic growth on minimal medium lacking 
histidine and supplemented with 1% sorbitol (RDB plates: 1 M sorbitol, 2% (w/v) 
dextrose, 1.34% (w/v) yeast nitrogen base without amino acids (YNB), 1.64 µM biotin, 
270 µM L-glutamic acid, 335 µM L-methionine, 342 µM L-lysine, 381 µM L-leucine, 
381 µM L-isoleucine) (71). Plates were incubated at 30 °C for 2−4 days. 
Transformants secreting LD were selected by colony blotting using antibodies 
against LD from barley malt (72). Single colonies of His+ transformants were picked 
from the initial RDB plates, transferred to YPD plates, grown for two days and then 
replicated to nitrocellulose membranes (Hybond ECL, 0.45 µm, Amersham 
Biosciences, Freiburg Germany) placed on minimal medium plates containing 0.5% 
(v/v) methanol (MM plates: 1.34% (w/v) YNB, 1.64 µM biotin, 0.5% (v/v) methanol) 
followed by incubation at 30 °C for two days. Secreted LD was detected by 
immunoblotting using anti-LD primary antibody (72), and goat anti-rabbit alkaline 
phosphatase conjugated secondary antibody (Dako, Glostrup, Denmark). The membrane 
was rinsed with Milli-Q water to remove cells before blocking in Tris-buffered saline 
Tween-20 (TBST) with BSA (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.2% (v/v) 
Tween 20, 1% (w/v) BSA) for 30 min. The primary antibody was diluted 1:3000 in 
TBST and the antigen-antibody interaction was carried out at room temperature for 30 
min. The membrane was washed (3 × 10 min) with TBST before probing with 
secondary antibody diluted 1:2000 in TBST (30 min). After washing (3 × 10 min) with 
TBST the immunoblot was developed using nitroblue tetrazolium (NBT)/5-bromo-4-
chloro-3-indolyl phosphate (BCIP) colorimetric method (100 mM Tris-HCl pH 9.5, 100 
mM NaCl, 5 mM MgCl2, 0.33 mg/mL NBT, 0.17 mg/mL BCIP) and the reaction was 
stopped by change to Milli-Q water. LD from barley malt served as positive and P. 
pastoris strain GS115 transformed with the empty vector pPIC9K as negative control. 
 
2.1.1.5 Pilot Scale Expression and High Cell-Density Fermentation of P. pastoris 
Twelve His+ transformants selected by colony immunoblotting were tested for 
expression in 50 mL culture using buffered complex medium following the supplier’s 
guidelines for Mut+ phenotype (71). LD activity was monitored after 96 h using the 
Limit-Dextrizyme assay (see section 2.2.1; Megazyme, Bray, Ireland). The culture 
medium was changed by adding 60 volumes of 100 mM Na acetate pH 5.5 followed by 
10-fold concentration (Centricon, 30 kDa cut-off; Millipore, Cork, Ireland) prior to 
testing. Due to low LD activity in shake flask cultures, a 5 h assay reaction time was 
applied to ensure detection of secretory expression of active LD. The effect of induction 
temperature was analyzed by comparing LD activity in cell-free extract of cultures 
grown in minimal medium at either 30 or 22 °C for 72 h. The transformant selected for 
large scale bioreactor production was shown to secrete LD activity in minimal medium 
after induction at 22 °C for 72 h.  
The bioreactor fermentation has three stages; i) a glycerol batch phase generating 
biomass; ii) a glycerol feed phase, with glycerol being delivered at growth limiting rate 
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for continued biomass generation and derepression of the alcohol oxidase promoter 
AOX1; and iii) a methanol feed phase for induction of expression with increasing 
methanol feed to a maximum level at 11 g/(L·h). Methanol induction was maintained 
for 89 h. The fermentation procedure guidelines for methanol feeding of the Mut+ 
phenotype (73) were optimized and the fermentation was carried out in a 5-L Biostat B 
(B. Braun Biotech International, Melsungen, Germany) bioreactor equipped with an 
additional feed pump, gas mixer, dissolved oxygen tension polarographic electrode, and 
water cooler (73, 74). The 2 L starting basal salt medium containing PMT1 (74) trace 
salts was inoculated with 150 mL culture (OD600 = 16) propagated overnight at 30 °C in 
buffered complex medium (BMGY: 1% (w/v) yeast extract, 2% (w/v) peptone, 0.1 M 
KH2PO4 pH 6.0, 1.34% (w/v) YNB, 1.64 µM biotin, 1% (v/v) glycerol) (71). The 
temperature was maintained at 29 °C by water cooling during glycerol batch and fed-
batch phases. Prior to induction, the temperature was decreased to 22 °C and kept 
throughout the methanol feed phase. Solutions of 50% (w/v) glycerol and 100% 
methanol both containing PTM1 trace salts were used as carbon source during glycerol 
feed phase and methanol feed phase, respectively.  Continuous addition of 28% aqueous 
ammonia served to maintain the pH at 5.5 and as a nitrogen source.  
 
2.1.1.6 Purification of LD 
Cells were harvested after five days of fermentation (centrifugation, 12,000g, 4 °C, 
30 min), and the supernatant (2.5 L) was kept at 4 °C after adding sodium azide (final 
concentration 0.02% (w/v)). LD was purified by a two-step procedure involving affinity 
chromatography using β-cyclodextrin (β-CD) conjugated to Sepharose followed by gel 
filtration (Hiload Superdex 200 26/60, GE Healthcare, Uppsala, Sweden). The culture 
supernatant was split in two and ammonium sulphate was added to a final concentration 
of 1 M to secure binding of LD to β-CD-Sepharose (72), followed by centrifugation 
(12,000g, 4°C, 30 min) and filtration (0.45 µm, GE Water & Process Technologies, 
Trevose, PA), and pumped (30 mL/h) onto β-CD-Sepharose (20 mL bed volume in XK 
16/10 column; GE Healthcare) equilibrated in 10 mM Na acetate pH 5.5, 500 mM 
NaCl, 5 mM CaCl2. After wash with equilibration buffer (four column volumes; 60 
mL/h), bound LD was eluted with 10 mM Na acetate pH 5.5, 5 mM CaCl2, 7 mM β-CD 
at the same flow rate. Fractions (960 µL) were collected in tubes containing 40 µL 1 M 
Hepes/NaOH pH 7.0, 125 mM CaCl2, 0.125% Triton X-100 and aliquots were analyzed 
by SDS-PAGE. Fractions with LD activity (see section 2.2.1 for assay) were pooled and 
concentrated to 18 mL (Centricon; 30 kDa cut-off, Millipore) after 2 mL were removed 
and dialyzed (Spectra/por dialysis membrane cut-off 12−14 kDa; Spectrum 
Laboratories, Rancho Dominguez, CA) 2 × 12 h against 2 × 3 L 50 mM Mes/NaOH pH 
6.6, 250 mM NaCl and assayed for activity. Subsequently 4 × 4 mL portions from the 
concentrated β-CD pool (approximately 2.5 mg/mL LD) were applied on a Hiload 
Superdex 200 26/60 column (GE Healthcare) equilibrated with 50 mM Mes/NaOH pH 
6.6, 250 mM NaCl and eluted (30 mL/h) with the same buffer. Collected fractions (4 
mL) were analyzed by SDS-PAGE and LD containing fractions were pooled, 
concentrated (Centricon, 30 kDa cut-off; Millipore), assayed for activity, and stored at 4 
°C. An ÄKTAexplorer (GE Healthcare) interfaced by UNICORN 5.0 control software 
(GE Healthcare) was used for both chromatographic procedures. 
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2.1.2 Limit Dextrinase Inhibitor 
 
2.1.2.1 Cloning of LDI   
A cDNA clone of LDI was provided by Birgit Bønsager, who had performed the 
cloning as follows. Husk from frozen barley seeds (cultivar Morex) was removed and 
milling of the seed was carried out in a mortar cooled in liquid nitrogen. RNA was 
extracted using RNeasy Plant Mini kit (Qiagen, Düsseldorf, Germany) and RT-PCR 
was carried out using One-Step RT-PCR Kit (Qiagen) and the primers LDI F and LDI R 
(Table 2.3). The cDNA was subsequently cloned in to the pCR 2.1-TOPO vector 
(Invitrogen) using the NdeI and BamHI sites (in bold) and the construct (pCR 2.1-
TOPO /LDI) was transformed into E. coli TOP10 competent cells (Invitrogen).  
 
Table 2.3. Primers used for cloning and mutagenesis of LDI and construction of LDI expression 
plasmids. Restriction sites are marked as bold in the primer 
Primers for cloning of LDI 
Name Sequence 
LDI F (forw.) 5’-GAGAGACATATGACCCTGGAGAGCGTCAAGGACG-3’ 
LDI R (rev.) 5’-GGATCCCCTTATCCCGGCTCCTGGACGGACGA-3’ 
Primers for Intein-LDI construct 
Name  Sequence 
MVC11 (forw.) 5’-AAAAAAAGCTCTTCTAACACCCTGGAGAGCGTCAAGGAC-3’ 
MVC12 (rev.) 5’-AAGGATCCTCATCCCGGCTCCTGAACGGA-3’ 
Primers for His-LDI 
Name Sequence 
MVC21 (forw.) 5’-AAAAAAAAAGAATTCCATCATCATCATCATCATCTTGTTCCACGTGG 
TTCTACCCTGGA-3’ 
MVC22 (rev.) 5’-TGATTAACTGGTACCTTATCCCGGCTCCTG-3’ 
Primers for P. Pastoris construct (EF-LDI-His) 
Name Sequence 
MVC23 (forw.) 5’-AAAAAAAAAGAATTCACCCTGGAGAGCG-3’ 
MVC20 (rev.) 5’-TGATTAACTGGTACCTTAATGATGATGATGATGATGTCCCGGCTCCTG-3’ 
Primers for deletion of EF (wt-LDI-His) 
Name Sequence 
MVC24 (forw.) 5’-GAGAAAAGAGAGGCTGAAGCTACCCTGGAGAGCGTCAAGGACGA-3’ 
MVC25 (rev.) 5’- TCGTCCTTGACGCTCTCCAGGGTAGCTTCAGCCTCTCTTTTCTC-3’ 
Primers for deletion of TLESV (∆V5LDI-His) 
Name Sequence  
MVC28 (forw.) 5’-GAGAAAAGAGAGGCTGAAGCTAAGGACGAGTGCCAACCAGGGGT-3’ 
MVC29 (rev.) 5’-ACCCCTGGTTGGCACTCGTCCTTAGCTTCAGCCTCTCTTTTCTC-3’ 
 
 
The cDNA corresponding to amino acid residues 25−138 (accession No, 
ABB88573, NCBI Protein database), encoding a protein sequence identical to the 
previously published (61, 75), was used as template for PCR amplification with the 
appropriate primer pairs (Table 2.3).  
 
2.1.2.2 Cloning, Expression and Purification of the Intein-LDI Construct  
The intein-LDI construct was amplified using the primer pair MVC11 and MVC12 
(Table 2.3). The restriction sites SapI and BamHI were used for cloning the fragment 
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in-frame with the chitin binding domain (CBD) from Bacillus circulans and the Ssp 
DnaB intein from the cyanobacterium Synecchocystis sp PCC6803 of the E. coli 
expression plasmid, pTWIN1 (New England Biolabs, Ipswich, MA). Purification of the 
expressed gene product by auto cleavage on a chitin bead column by decreasing the pH 
and increasing the temperature will result in wild-type N-terminal sequence of LDI. The 
ligated plasmid pTWIN/LDI was subsequently transformed into the E. coli cloning 
strain DH5α, before transformation into the expression strain Rosetta-gami™2(DE3) 
(Novagen). This strain contains an extra plasmid harbouring the genes encoding the 
tRNA for the seven rare codons (AUA, AGG, AGA, CUA, CCC, CGG, and GGA) as 
well as mutations in both the thioredoxin reductase (trxB) and glutathione reductase 
(gor) genes, resulting in enhanced disulfide bond formation in the cytoplasm and 
improved protein folding in vivo. Small scale plasmid preparation, restriction enzyme 
digestion, ligation, and transformation followed standard molecular biology protocols 
(69). 
A preculture of LB containing 100 µg/mL ampicillin, 34 µg/mL chloramphenicol, 
12.5 µg/mL tetracycline was inoculated with a single colony and propagated at 37 °C 
overnight. Fresh LB medium (400 mL) including 100 µg/mL ampicillin, 34 µg/mL 
chloramphenicol, 12.5 µg/mL tetracycline was inoculated with the overnight culture to a 
start OD600 of approximate 0.08 and grown at 37 °C until mid log phase (OD600 ~ 0.5). 
The cells were divided into two flasks (200 mL) and induced by addition of IPTG (final 
concentration 0.3 mM). The two cultures were incubated at 15 °C and 37 °C for 19 h 
and 2h, respectively. The cells were harvested by centrifugation (5,000g, 4 °C, 10 min) 
and the pellets were stored at –20 °C until use. The cells were resuspended in buffer B1 
(100 mM Tris pH 8.5, 0.5 M NaCl, 1 mM EDTA), lysed by sonication followed by 
centrifugation (19,000g, 4 °C, 30 min). The clarified cell extract was loaded (30 mL/h) 
on a chitin bead column (column volume = 4 mL) (New England Biolabs) equilibrated 
with 40 mL B1 (60 mL/h) and subsequently washed with 48 mL B1 (120 mL/h). The 
auto cleavage of the intein was facilitated by washing the column with 48 mL B2 (20 
mM Hepes/NaOH pH 7.0, 0.5 M NaCl, 1 mM EDTA) until pH of the eluate was ~ 7.0. 
The column flow was stopped and the cleavage reaction was left overnight at 23 °C. 
The cleavage protein (LDI) was eluted with 12 mL B2 (60 mL/h) in 0.5 mL fractions, 
which were analysed by SDS. Fractions were pooled three and three and concentrated 
20-fold before analysing for LD inhibition activity. An ÄKTAexplorer (GE Healthcare) 
interfaced by UNICORN 5.0 control software (GE Healthcare) was used for the 
chromatographic procedures. 
 
2.1.2.3 Cloning, Expression and Purification of P. pastoris His-LDI Construct  
The pCR 2.1-TOPO/LDI construct (section 2.1.2.1) was used as template for PCR 
amplification of a P. pastoris His-LDI expression construct with forward primer 
MVC21 and reverse primer MVC22 (Table 2.3.) A thrombin (underlined in primer) 
cleavable N-terminal hexa-histidine tag (in italic) was introduced with the forward 
primer MVC21. Cleavage of the expressed gene product with thrombin will result in an 
N-terminal addition of two extra amino acids, glycine and serine (in bold) 
(GSTLESVKDECQ). The amplified product was cloned in-frame with the 
Saccharomyces cerevisiae α-factor secretion signal of the P. pastoris vector pPICZα A 
using the EcoRI and KpnI sites (marked in bold in the primer). The plasmids harbouring 
the above constructs were linearized with PmeI and transformed into P. pastoris strain 
                 Experimental Procedure 
______________________________________________________________________ 
 
 
______________________________________________________________________ 
17 
 
X33 by electroporation and selected on YPDS plates supplemented with 100 µg/mL 
zeocin (Invitrogen). Small scale plasmid preparation, restriction enzyme digestion, 
ligation, and transformation followed standard molecular biology protocols (69). Five 
selected clones were tested for heterologous expression of LDI in 50 mL culture flasks 
according to the EasySelectTM Pichia Expression Kit (Invitrogen) (71). Precultures of 
YPD (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose) of the selected 
clones were inoculated with a single colony and incubated overnight at 30 °C. 1 mL of 
the precultures were used for inoculating 50 mL of freshly prepared BMGY (1% (w/v) 
yeast extract, 2% (w/v) peptone, 0.1 M KH2PO4 pH 6.0, 1.34% (w/v) YNB, 1.64 µM 
biotin, 1% (v/v) glycerol), which were incubated overnight at 30 °C. The cells were 
induced by changing the growth medium to buffered methanol-complex medium 
(BMMY: 1% (w/v) yeast extract, 2% (w/v) peptone, 0.1 M KH2PO4 pH 6.0, 1.34% 
(w/v) YNB, 1.64 µM biotin, 0.5% (v/v) methanol). The cells were harvested by 
centrifugation (1,500g, 20 °C, 5 min) and resuspended in BMMY (50 mL) to give an 
OD600 ~ 5. The cultures were incubated at 17 °C for 72 h. Methanol (final concentration 
0.5 % (v/v)) was added every 24 h for continous induction and supply of carbon source. 
1 mL samples were taken every 24 h and analysed by SDS-PAGE for LDI expression 
and secretion. Cells were harvested by centrifugation (12,000g, 4 °C, 30 min). Based on 
the SDS-PAGE result two clones were selected for purification. Imidazole and NaCl 
were added to the culture supernatant to 10 mM and 500 mM, respectively, and pH was 
adjusted to 7.4 by addition of K2HPO4(s), followed by centrifugation (12,000g, 4 °C, 30 
min) and filtration (0.45 µm) before application onto the 1 mL HisTrap HP column (GE 
Healthcare) (40 mL/h) equilibrated with 20 mM Na phosphate, pH 7.4, 10 mM 
imidazole, 500 mM NaCl. The column was washed with equilibration buffer (60 mL/h) 
until a stable A280 signal was reached, and a linear imidazole gradient by mixing the 
equilibration buffer with 20 mM Na phosphate pH 7.4, 500 mM imidazole, 500 mM 
NaCl (0–100%, 20 mL, 60 mL/h) was applied. Fractions (1 mL) were collected and 
analyzed by SDS-PAGE. An ÄKTAexplorer (GE Healthcare) interfaced by UNICORN 
5.0 control software (GE Healthcare) was used for the chromatographic procedures. 
LD inhibition was assayed by measuring residual LD activity after LDI addition 
(20 µL of culture supernatant concentrated 10-fold) using Limit-Dextrizyme tablets as 
substrate in 0.1 M sodium acetate buffer pH 5.5, 0.005% Triton X-100 (see section 
2.2.1. for detailed assay description). The concentration of LDI was estimated from the 
band on a SDS-PAGE gel, resulting in an estimated ratio of LDI:LD in the reaction 
mixture to 1000:1. 
 
2.1.2.4 Cloning and Site-Directed Mutagenesis of LDI-His  
The pCR 2.1-TOPO/LDI construct (section 2.1.2.1) was used as template for PCR 
amplification of a P. pastoris LDI-His expression construct with forward primer 
MVC23 and reverse primer MVC20 (Table 2.3.) A hot start PCR protocol at 94 °C (3 
min), 3 cycles at 94 °C (30 s), 50 °C (30 s), and 72 °C (45 s), followed by 22 cycles at 
94 °C (30 s), 58 °C (30 s), and 72 °C (45 s) and a final elongation (7 min) was used. The 
resulting PCR product comprising the LDI gene and nucleotides encoding a C-terminal 
hexa-histidine tag (in italic, Table 2.3) was cloned in-frame with the Saccharomyces 
cerevisiae α-factor secretion signal of the P. pastoris vector pPICZα A using the EcoRI 
and KpnI sites (in bold, Table 2.3). This cloning procedure results in the additional 
amino acids glutamate and phenylalanine at the N-terminus (EFTLESVKDECQ) of the 
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gene product denoted as EF-LDI. The addition of EF was a consequence of using the 
EcoRI restriction site. Deletion of these two amino acid residues was done by site-
directed mutagenesis using QuikChange® Lightning Site-Directed Mutagenesis Kit 
(Stratagene) and forward primer MVC24 and reverse primer MVC25 (Table 2.3). 
Expression of this clone results in a native N-terminus (TLESVKDECQ) denoted as wt-
LDI.  An N-terminal deletion of the TLESV was also constructed using QuikChange® 
Lightning Site-Directed Mutagenesis Kit and the following primer pair MVC28 and 
MVC29 (Table 2.3). This N-terminally truncated mutant, with the expected N-terminal 
sequence KDECQ, was denoted ∆V5LDI (Figure 2.2). All the above mentioned N-
terminal sequences assume correct processing at the second Ste13 protease cleavage site 
of the Saccharomyces cerevisiae α-factor secretion signal of the P. pastoris vector 
pPICZαA expression vector (71). Small scale plasmid preparation, restriction enzyme 
digestion, ligation, and transformation followed standard molecular biology protocols 
(69). 
 
 
Figure 2.2. N-terminal sequence of wild-type and mutant LDI. The actual sequence of mutant ∆V5LDI 
differed for the expected due to the addition of four amino acid residues originating from the expression 
plasmid (see Result, section 3.2.3 for further description). 
 
2.1.2.5 Expression and Purification of LDI-His and LDI-His-mutants  
The plasmids harbouring the above constructs were linearized with PmeI and 
transformed into P. pastoris strain X33 by electroporation and selected on YPDS plates 
supplemented with 100 µg/mL zeocin (Invitrogen). Six selected clones from each 
construct transformation were tested for heterologous expression of LDI in 100 mL 
culture flasks according to the EasySelectTM Pichia Expression Kit (Invitrogen) (71). 
The cultures were induced after 24 h growth in BMGY (71) at 30 °C by transferring to 
BMMY (71) at 17 °C. Cells were harvested by centrifugation (12,000g, 4 °C, 30 min) 
after 72 h methanol induction. The production of active recombinant LDI was verified 
by SDS-PAGE and LD inhibition ([LD]=10 nM) was assayed by measuring residual LD 
activity after LDI addition (30 µL of culture supernatant) using Limit-Dextrizyme 
tablets as substrate in 0.1 M sodium acetate buffer pH 5.5, 0.005% Triton X-100  (see 
section 2.2.1 for detailed assay description). To achieve a high level of active LDI, 
selected clones (EF-LDI and wt-LDI) were cultured in a 5-L Biostat B (B. Braun 
Biotech International) (see section 2.1.1.5). Cells (OD600 = 22) from a shake flask 
culture (300 mL) grown overnight at 30 °C in BMGY were harvested by centrifugation 
(1,500g, 20 °C, 5 min), resuspended in fresh BMGY (80 mL) and used for inoculation 
of the starting basal salt medium (3 L) containing PMT1 trace salts (74). The 
temperature was maintained at 28 °C by water cooling during the glycerol batch (~20 h) 
and fed-batch (30 mL/h 50% (w/v) glycerol; ~7 h) phases. Prior to induction, the 
temperature was decreased to 17 °C, and kept throughout the methanol feed phase (22–
28 h). The methanol flow was successively increased from 1 g/(L·h) to reach the 
maximum of 11 g/(L·h) after 8 h. Addition of 28% aqueous ammonia served to 
maintain pH 5.5 and as a nitrogen source.  
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Cells were harvested by centrifugation (12,000g, 4 °C, 30 min); the supernatant 
(3.2 L) was supplemented with sodium azide to 0.02% (w/v) and kept at 4 °C. EF-LDI 
and wt-LDI were purified by a two-step procedure involving of affinity chromatography 
(5 mL HisTrap HP column; GE Healthcare) followed by anion exchange 
chromatography (MonoQ (10/100 GL) column; GE Healthcare). An ÄKTAexplorer 
chromatograph (GE Healthcare) interfaced by UNICORN 5.0 control software was used 
for the chromatographic purifications. Imidazole and NaCl were added to the culture 
supernatant to 10 mM and 500 mM, respectively, and pH was adjusted to 7.4 by 
addition of K2HPO4(s), followed by centrifugation (12,000g, 4 °C, 30 min) and 
filtration (0.45 µm) before application (120 mL/h) onto the HisTrap HP column  
equilibrated with 20 mM Na phosphate, pH 7.4, 10 mM imidazole, 500 mM NaCl. After 
washing with equilibration buffer (60 mL/h) until a stable A280 signal was reached, 
bound LDI was eluted (60 mL/h) by a two-step linear imidazole gradient by mixing the 
equilibration buffer with 20 mM Na phosphate pH 7.4, 500 mM imidazole, 500 mM 
NaCl (0–10%, 10 mL; 10–100%, 300 mL). Fractions (5 mL) were collected and 
analyzed by SDS-PAGE. LDI containing fractions were collected in two pools (2 × 50 
mL), concentrated (Centricon; 3 kDa cut-off, Millipore) to 2 × 15 mL, and each was 
dialyzed (Spectra/por dialysis membrane (cut-off 6–8 kDa; Spectrum Laboratories) 
against 2 × 5 L 5 mM Bicine/NaOH pH 8.5 and 1 × 5 L 10 mM Bicine/NaOH pH 8.5. 
The dialyzed samples were centrifuged (12,000g, 4 °C, 30 min) and the supernatants (2 
× 15 mL) were loaded onto a MonoQ 10/100 GL column and washed (150 mL/h; 150 
mL) with the above buffer. Protein was eluted by a five-step linear salt and pH gradient 
with the elution buffers A: 10 mM Bicine/NaOH pH 8.5 and B: 10 mM Hepes/NaOH, 
pH 7.0, 250 mM NaCl (0–12.5%, 24 mL; 12.5–25%, 160 mL; 25–30%, 8 mL; 30–38%, 
15 mL; 38–100%, 80 mL). Collected fractions (4 mL) were analyzed by SDS-PAGE 
and LDI containing fractions eluted in one peak were pooled, concentrated and buffer-
changed to 10 mM Bicine/NaOH pH 8.5, 100 mM NaCl (Centricon, 3 kDa cut-off; 
Millipore).  
The ∆V5LDI mutant was produced as described above for the clone selection in a 
500 mL shake flask culture with 48 h induction. Adjusted culture supernatant (pH 7.4, 
10 mM imidazole, 500 mM NaCl) was loaded onto a 1 mL HisTrap HP column and 
eluted as above. The buffer was exchanged (10 mM Bicine/NaOH pH 8.5) using 
Microcon (3 kDa cut-off; Millipore) and the SDS-PAGE electrophoretically 
homogenous ∆V5LDI (770 µg/mL) pool was used for SPR analysis. 
 
 
2.2 Enzyme Activity and Inhibition 
2.2.1 LD Hydrolytic Activity  
 
LD activity during pilot expression, fermentation, and purification was assayed 
with Limit-Dextrizyme tablets (Megazyme) in 0.1 M Na acetate pH 5.5, 0.005% Triton 
X-100. LD (5–10 nM) diluted in assay buffer (0.5 mL) was preheated (5 min) on a 40 
°C water bath before adding the Azurine-crosslinked-pullulan substrate tablet. The 
reaction was stopped after 10 min by adding 5 mL 1% (w/v) Tris and vigorously whirl-
mixing. After 10 min incubation at R.T., the tubes were whirl-mixed and 2 mL were 
transferred to eppendorf tubes and centrifuged (14,000g, 10 min). The absorbance of the 
supernatant was measured at 590 nm. One activity unit is defined as the amount of 
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enzyme that releases one micromole of glucose reducing-sugar equivalents per min 
from pullulan under the defined assay conditions (76).  
Kinetic constants of LD were determined from initial rates of hydrolysis at 12 
different concentrations (0.02−1 mg/mL) of pullulan (Megazyme) by 3.6 nM LD in 20 
mM Na acetate pH 5.5, 5 mM CaCl2, 0.005% Triton X-100 (starting assay volume: 1.1 
mL) at 37 °C. Aliquots (200 µL) were removed at 3 min intervals during 0–15 min, 
stopped by mixing with 500 µL freshly prepared developing buffer (0.4 M Na carbonate 
pH 10.7, 2.5 mM CuSO4, 2.5 mM 4,4’-dicarboxy-1,2’-biquinoline, 6 mM L-serine) and 
300 µL Milli-Q water (77) and the absorbance was measured after 30 min at 80 °C in 
microtiter plates (300 µL, in duplicates) at A540. The release of reducing sugar was 
quantified using a maltose standard curve. Vmax and Km were determined by fitting 
either the Michaelis-Menten equation (eq. 2.1) or the equation for uncompetitive 
substrate inhibition (eq. 2.2) to the initial rates. Ki,s is the dissociation constant for the 
inhibitory [substrate-enzyme]-substrate ternary complex.  
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 The fitting and plotting were performed using the Enzyme Kinetics Module 1.0 of the 
program Sigmaplot 9.01 (Systat Software, Chicago, IL ). 
 
2.2.2 LD Inhibition 
 
wt-LDI (0.1–0.2 µM, 300 µL; 10 mM Bicine/NaOH pH 8.5, 0.1 M NaCl) was 
preincubated with LD (52 nM, 1200 µL; 100 mM Na acetate buffer pH 5.5, 5 mM 
CaCl2, 0.005% Triton X-100) for 15 min at 25 °C. From the preincubation mixture 110 
µL was added to 990 µL pullulan (Megazyme) at 8 different concentrations (0.025−0.3 
mg/mL) in 100 mM Na acetate buffer pH 5.5, 5 mM CaCl2, 0.005% Triton X-100 at 37 
°C. The final concentrations of LDI and LD in the reaction mixture were 2 or 4 nM and 
4.2 nM, respectively. The assay and detection of the hydrolysis product were performed 
as described in section 2.2.1. The LDI inhibition constant, Ki of LD was determined 
from initial rates of pullulan hydrolysis with or without the inhibitor present. Ki was 
determined by fitting the model for tight competitive inhibition (eq. 2.3) to the data 
using the Enzyme Kinetics Module 1.0 of the program Sigmaplot 9.01 (Systat 
Software). Kapp is the apparent inhibition constant when dissociation of the enzyme-
inhibitor complex is affected by substrate addition. 
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To determine the molar ratio for 100% inhibition, pullulan and LD concentrations 
were kept constant in the assay at 0.17 mg/mL and 4 nM, respectively, and the final LDI 
concentrations were varied between zero and 20 nM in the assay corresponding to 
LDI:LD molar ratios between zero and 5. The assay was carried out as above.  
 
 
2.3 Transglycosylation 
 
The transglycosylation catalysed by LD (18–38 nM) was analysed by using 20–40 
mM α-maltosyl fluoride (G2F) or α-maltotriosyl fluoride (G3F) (a gift from Rob Field, 
Norwich, UK) as donors and 8–200 mM of different linear (maltose, maltotriose, 
maltotetraose, and maltohexaose) and cyclic oligosaccharides (α-cyclodextrin, β-
cyclodextrin, and 6-O-α-maltosyl β-cyclodextrin) as acceptors. In addition to the linear 
and cyclic oligosaccharides, the known glycoside hydrolase inhibitors, 4-O-α-D-
glucopyranosylmoranoline (G1M) (78) and acarbose (79) were also used as acceptors. 
The reaction was carried out in 50 mM Na acetate pH 5.5 at 40 °C. Samples were taken 
at different time points (0–240 min) and the reaction was terminated by addition of 1/10 
volume of 1 M NaOH. The reaction was followed by thin-layer chromatography (TLC) 
by spotting diluted (1–4 times) samples onto a 8×12 cm TLC plate (TLC silica gel 60 
F254; Merck, Germany) and the plate was repeatedly irrigated (2–3 times) with a solvent 
mixture of acetonitrile: ethyl acetate: iso-propanol: water (85:20:50:70, by volume) at 
25 °C. The carbohydrates on the TLC were detected by dipping the dried plate into a 
solution containing 2% (w/v) orcinol, 83% (v/v) ethanol and 11% (v/v) sulphuric acid 
followed by heating with a heat gun until the sugars appeared as pink-violet spots. 
Selected samples were also analysed by mass spectrometry (MS) to verify the correct 
mass of the transglycosylation products formed. The MS analysis was carried out by Dr. 
Gerhard Saalbach, JIC Proteomics Facility, Department of Biological Chemistry, John 
Innes Centre, UK. Samples were diluted in TFA before spotted on a prespotted 
anchorchip (PAC) plate (Bruker Daltonics, Bremen, Germany) containing pre-spotted 
matrix CHCA (α-cyano-4-hydroxycinnamic acid). 
 
2.4 Surface Plasmon Resonance 
2.4.1 Cyclodextrin Affinity 
 
Affinity of LD for α-, β- and γ-cyclodextrin (CD) was determined using surface 
plasmon resonance (SPR) (BIAcore® T100; GE Healthcare). LD was immobilized 
using 100 µg/mL LD in 5 mM Na acetate buffer pH 4, 1 mM β-CD on a CM5 sensor 
chip (GE Healthcare) using random amine coupling (2800−3200 response units, RU). 
Sensorgrams (RU vs. time) of the binding of α-, β- and γ-CD in the range of 2.5−160 
µM (17 concentrations), 0.125−40 µM (14 concentrations), and 4−160 µM (16 
concentrations), respectively, were obtained at 25 °C using 3 min association and 2 min 
dissociation. CDs were dissolved in 20 mM Na acetate pH 5.5, 100 mM NaCl, 0.005% 
surfactant P-20, which was also used as running buffer. Kd was calculated by steady-
state affinity fitting (BIAcore evaluation software 1.1, GE Healthcare) to the 
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equilibrium response R of CD at a given concentration after subtracting the reference 
flow cell signal; Rmax is the response at saturation of the ligand on the chip.  
 
(eq. 2.4)  
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2.4.2 LD/LDI Interaction 
 
The LD/LDI interaction was analyzed by SPR using a BIAcore® T100 instrument 
(GE Healthcare). Immobilization of the different LDI forms on the sensor surface of a 
BIAcore CM5 sensor chip was performed following a standard amine coupling 
procedure according to the manufacturer’s protocol using 10 µg/mL LDI in 5 mM Na 
acetate buffer pH 4 resulting in immobilization levels of 200–400 response units (RU) 
in sample cells, while reference cells were first activated, and then inactivated in the 
same procedure to be used as reference.  Sensorgrams (RU vs. time) of LD (0.1–80 nM) 
binding using 4 and 15 min association and dissociation times, respectively, were 
recorded. Regeneration was performed by 2 injections of 10 mM glycine/HCl pH 1.5 
for 60 s at 30 µL/min. The standard condition for determining binding kinetics was at 
25 °C at a flow rate of 30 µL/min using seven LD concentrations (0.1–4 nM) in the 
running buffer 10 mM Mes/NaOH pH 6.0, 150 mM NaCl, 0.005% P-20 surfactant: Two 
to three start-up cycles were used before the first analysis cycle to ensure a stable 
response in the analysis. In order to evaluate possible contribution of mass transfer 
limitations, binding kinetics of the LD/LDI interaction at 25 °C were analyzed at two 
different flow rates, 30 µL/min 60 µL/min. 
The effect of ionic strength on the binding kinetics was probed using an identical 
set up as above, but varying the NaCl concentration (0 mM, 75 mM, 150 mM, 300 mM, 
and 1000 mM) in the running buffer and similarly the effect of pH was assessed by 
varying the pH of the running buffer (pH 5.0–5.5, 10 mM Na acetate buffer; pH 6.0–
6.5, 10 mM Mes/NaOH; pH 7.0–7.5 10 mM Hepes/NaOH; pH 8.0–9.0, 10 mM 
Bicine/NaOH; pH 9.5–10.0, glycine/NaOH). Temperature dependence was determined 
at nine temperatures in the range 10–45 °C with standard running buffer (10 mM 
Mes/NaOH pH 6.0, 150 mM NaCl, 0.005% P-20 surfactant) and five LD concentrations 
(0.4–8 nM). Two independent sets of data were collected for all conditions, and all 
concentrations were analyzed in duplicates within each data set, except for 0.4 nM LD, 
which was run four times and functioned as a control for evaluating the effect of time 
on the response level during the time course of the experiment. Sensorgrams collected 
from sample cells were subtracted from reference cell sensorgrams (no ligand 
immobilized) to account for refractive index changes due to minor solvent differences 
and for possible nonspecific LD binding to the reference cell surface. In addition, the 
reference cell subtracted sensorgrams were corrected by subtraction of averaged blank 
sensograms (buffer injected) to account for drift specific for the sample cell. Double 
corrected sensorgrams from the different binding experiments were analyzed using 
BIAcore T100 Evaluation Software version 1.1. A 1:1 binding model (eq. 2.5) (80) 
which also accounts for possible mass-transport limitations was fitted globally using 
non-linear regression to sensorgrams generated for each set of ligand concentrations to 
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determine the association rate constant, kon (L/(mol·s)), the dissociation rate constant, 
koff (s-1).  
 
 
(eq. 2.5)  LD

→LD + LDI
	

⇌
	
LD/LDI    
 
  
Where LD0 and LD are the concentrations of LD in the bulk and at the chip surface, 
respectively, and kt is the mass transfer rate constant (RU M-1 m s-1). The quality of the 
fits was judged by the residuals plots.  
The equilibrium dissociation constant KD (M) is also determined in this procedure 
from the ratio of the rate constants (eq. 2.6). 
 
(eq. 2.6)   KD = koff/kon 
 
The van't Hoff thermodynamic parameters at 25 °C and standard conditions were 
calculated from both non-linear (eq. 2.7) and linear van’t Hoff (eq. 2.8) equations using 
kinetic data of the temperature dependence between 10–35 °C. 
(eq. 2.7)  





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0
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(eq. 2.8)  DRTlnKG =∆ o , ooo STHG ∆−∆=∆  
    
Where ∆G° is the standard free energy change, ∆H° and ∆S° are the standard enthalpy 
and entropy change, respectively. T is the absolute temperature (K), T0 is the reference 
temperature (298.15 K for standard conditions), ∆Cp° is heat capacity change under 
standard conditions, R = 8.314 j/(K·mol) is the gas constant and KD is the equilibrium 
dissociation constant (eq. 2.6). 
  
2.5 Protein Characterization 
2.5.1 Protein Assays  
 
LD and LDI concentration was either quantified by Bradford Coomassie Plus kit 
(Pierce, Rockford, IL) with BSA as standard or spectrophotometrically at 280 nm using 
a molar extinction coefficient of 1.52 ×105 M-1·cm-1 and 3.9 × 103 M-1 cm-1, for LD and 
LDI, respectively, as determined on the basis of LD or LDI concentration calculated by 
aid of amino acid analysis.  
 
2.5.2 SDS-PAGE, Isoelectric Focusing, and Immunoblotting 
 
Protein purity was assessed by SDS-PAGE using NuPAGE® Novex Bis-Tris 
4−12% gels (Invitrogen) in 1% Mes buffered polyacrylamide minigel Novex system 
with reducing agent added in the sample preparation and anti-oxidant in the buffer 
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system according to the manufacturers’ recommendations and Coomassie Brilliant Blue 
G-250 staining (81).  
Isoelectric focusing (IEF) was performed using the PhastSystem (Pharmacia, 
Sweden), pH 4–6 PhastGels (GE Healthcare) with low pI calibration kit (GE 
Healthcare, Buckinghamshire, UK) and Silver Kit staining (Pharmacia, Uppsala, 
Sweden).  
Western blotting on polyvinylidene fluoride (PVDF) membranes (0.22 µm pore 
size) for N-terminal sequencing of impure samples was carried out using the Novex gel 
system with the XCell SureLock Mini-Cell according to the supplier’s manual 
(Invitrogen). The Coomassie stained proteins of interest were excised from the 
membranes and the N-terminal sequence was determined using N-terminal Edman 
degradation (section 2.5.3). 
Immunoblotting was carried out using the Novex gel system with the XCell 
SureLock Mini-Cell according to the supplier’s manual (Invitrogen). LD was detected 
using polyclonal rabbit antibody raised against LD purified from barley malt (72) in 
combination with goat anti-rabbit alkaline phosphatase conjugated antibody (Dako). 
Unspecific binding of the antibodies to the membrane was prevented by blocking in 
TBST with BSA (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.2% (v/v) Tween 20, 1% 
BSA) for 30 min. The primary antibody was diluted 1:3000 in TBST and the antigen-
antibody interaction was carried out at room temperature for 30 min. The membrane 
was washed (3 × 10 min) with TBST before probing with secondary antibody diluted 
1:2000 in TBST (30 min). After washing (3 × 10 min) with TBST the immunoblot was 
developed using NBT/BCIP colorimetric method (100 mM Tris-HCl pH 9.5, 100 mM 
NaCl, 5 mM MgCl2, 0.33 mg/mL NBT, 0.17 mg/mL BCIP) and the reaction was 
stopped by change to Milli-Q water. LD purified from barley malt served as positive 
control. 
 
 
2.5.3 Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Amino 
Acid Analysis, and N-Terminal Protein Sequencing  
 
In-gel trypsin digestion of spots cut out from protein bands of SDS-PAGE gels and 
micropurification on Poros 20 R2 home-made nanocolumns (Perseptive Biosystems, 
Framingham, MA) were done as described (82). Peptides were eluted with 1 µL matrix 
solution (5 g/L α-cyano-hydroxycinnamic acid in 70% (v/v) CH3CN and 0.1% (w/v) 
trifluoroacetate) directly onto the MALDI target and analyzed using an Ultraflex II 
MALDI-TOF-TOF mass spectrometer (Bruker-Daltonics) in positive ion reflector 
mode. Spectra were analyzed using FlexAnalysis software (Bruker-Daltonics) and 
calibrated by trypsin autolysis products (m/z 842.51 and m/z 2211.10). Peptide mass 
data were searched against the NCBI non-redundant database using Biotools software 
(Bruker Daltonics) and the Mascot server (http://www.matrixscience.com). 
Full length mass spectrometry analysis of LDI using liquid chromatography-mass 
spectrometry (LC-MS) was performed as by Dr. Martin Zehls and Dr. Sabina Amon, 
Department of Biochemistry and Molecular Biology, University of Southern Denmark, 
Denmark as follows. Aliquots of the samples were diluted to 100 µL (final 
concentration 2.5 µM) with either 0.1% trifluoroacetic acid (TFA) (1st runs) or 5% 
formic acid (2nd runs). The proteins were desalted on-line to electrospray ionization-
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mass spectrometry (ESI-MS) as described earlier (83). Briefly, the proteins were loaded 
onto a custom-made small-scale reversed-phase trap column and desalted for 3 min with 
0.05% TFA at a flow rate of 200 µL/min. Elution and ESI were performed with 70% 
acetonitrile containing 0.05% TFA at a flow rate of 50 µL/min. Mass spectra were 
recorded with an ESI-Q-TOF mass spectrometer (Synapt HDMS, Waters, Milford, MA) 
in positive ion mode. Source parameters were as follows: capillary voltage: 3500 V, 
sample cone voltage: 50 V (1st runs) or 40 V (2nd runs), source temperature: 80 °C (1st 
runs) or 100 °C (2nd runs), desolvation gas temperature: 150 °C (1st runs) or 300 °C (2nd 
runs), and desolvation gas flow: 300-500 L/h (N2). The mass spectrometer was operated 
in V-mode and calibrated with sodium iodide cluster ions. The mass spectra were 
processed with the MassLynx V4.0 SP2 software (Waters, Milford, MA). The 
accumulated mass spectra of the proteins were smoothed using the Savitzky-Golay 
algorithm and deconvoluted using the MaxEnt 1 algorithm. The deconvolution 
parameters were adjusted to yield optimal matching of the synthesized m/z spectrum 
(the mock spectrum) and the experimental m/z spectrum. 
Amino acid analysis was performed after 24 h hydrolysis as described (84). Protein 
sequencing was carried out by automated N-terminal Edman degradation in a Procise 
494 sequenator according to the manufacturer’s recommendations (Applied Biosystems 
Foster City, CA). Highly pure Milli-Q water (18 MΩ) was used throughout.  
 
 
2.6 Sequence Alignment and LDI Model Prediction  
 
Multiple sequence alignment of plant limit dextrinase from barley, acc.# 
AAD04189, wheat, acc.# ABL84490, rice, acc.#  H0806H05, maize, acc.# AAD11599, 
spinach, acc.# CAA58803 and Arabidopsis acc.# Q8GTR4was carried out using 
ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html) with default settings, gap 
opening and extension penalties of 10 and 0.2, respectively. 
Multiple sequence alignment of the five most studied inhibitors LDI, RATI, CHFI 
(bifunctional corn Hageman factor inhibitor), the dimeric and the monomeric wheat 
inhibitors 0.19 and 0.28, respectively, was carried out using the ClustalW2 server. The 
pairwise alignment algorithms EMBOSS Needle was used for global alignment of LDI 
with RATI, CHFI, 0.19 and 0.28. RATI, was used as template for LDI homology 
modelling using the default parameters of the HHpred server (Homology detection & 
structure prediction by HMM-HMM comparison, 
http://toolkit.tuebingen.mpg.de/hhpred#) and the RATI structure (PDB code: 1B1U) as 
template. Structural visualization and comparison were made in PyMOL1.1 (85). The 
quality of the obtained LDI model was analyzed using the ProQ - protein quality 
prediction server (http://www.sbc.su.se/~bjornw/ProQ/ProQ.cgi) (86). 
 
 
2.7 Crystallization and 3D Structure Determination 
 
2.7.1 LD/LDI Complex Formation and Crystallization 
 
LD (1.7 mL, 4.2 mg/mL) was mixed with LDI (0.8 mL, 6.4 mg/mL) resulting in a 
2:1 molar ratio of LD:LDI. The purity of the LDI solution was only 95% as judged by 
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SDS-PAGE due to a smear at higher molecular mass. The protein mixture was 
incubated at room temperature for 30 min, centrifuged (12,000g, 4 °C, 15 min), loaded 
onto on a Hiload Superdex 200 26/60 column (GE Healthcare) equilibrated with 50 mM 
Mes/NaOH pH 6.6, 250 mM NaCl and eluted (60 mL/h) with the same buffer. Collected 
fractions (2 mL) corresponding to the peak on the chromatogram were pooled (total of 
22 mL) and concentrated (Centricon, 30 kDa cut-off; Millipore) to 1 mL, which 
corresponded to 7 mg/mL of LD loaded on the column. Purified LD/LDI complex (600 
µL) was send to the Centre for high-throughput structural biology, Hauptman 
Woodward Medical Research Institute, Buffalo, USA, for crystal-growth screening 
experiments in 1536-well microassay plates by mixing 0.2 µL protein solution with 0.2 
µL crystallization agent. The crystallization method used in the high-throughput 
screening (HTS) system was microbatch-under-oil. In addition crystallization using 
hanging-drop, vapor-diffusion method was explored with Crystal Screen™ and Crystal 
Screen™ 2, and PEG/Ion™ Screen (Hampton Research, Aliso Viejo, CA) at 22 °C. The 
solution of crystallization drop was prepared on coverslips by mixing 2 µL LD/LDI 
solution with 2 µL of reservoir solution. The droplets were equilibrated against 0.5 mL 
of reservoir solution. Based on the result from the HTS of the crystallization condition, 
microbatch-under-oil screens were set up at 22 °C around the condition identified in the 
HTS by mixing 1 µL LD/LDI solution with 1 µL crystallization agent under 300 µL 
mineral oil (Sigma-Aldrich, Seelze, Germany) in a microtiter plate. Crystallization at 
the same condition was also investigated using the hanging-drop, vapor-diffusion 
method by mixing 1 µL LD/LDI solution with 2 µL of reservoir solution. The droplets 
were equilibrated against 1 mL of reservoir solution at 22 °C. 
 
2.7.2 Crystallization and Data Collection of LD 
 
LD was produced and purified as described in section 2.1.1.5. and 2.1.1.6 and 
concentrated to a final concentration of 9 mg/mL for the initial crystallization screens 
(70). Initially, crystallization using the hanging-drop, vapor-diffusion method was 
explored with Crystal Screen™, Crystal Screen™ 2, and PEG/Ion™ Screen (Hampton 
Research) at 22 °C. The LD solution contained β-CD, mixed in a 1:10 molar ratio. 
Crystals obtained from different condition in the PEG/Ion Screen all showed the same 
crystal morphology, i.e., bundles of very thin needles. These were used for micro-
seeding in later screens.  
Prior to crystallization, LD (20 mg/mL; 50 mM MES, pH 6.6, 250 mM NaCl) was 
incubated on ice with α- or β-CD in 6-fold molar excess giving a final LD concentration 
of 13.3 mg/mL. The crystallization drop was placed on cover slips by mixing 1.5 µL 
LD-CD solution with 1 or 2 µL of reservoir solution. Additive Screen I–III (Hampton 
Research) was used to optimize crystallization conditions. Based on the additive screen 
cysteine (0.2 µL, 0.1 M) was added to the drop to a final concentration of 5–7 mM. 
LD:β-CD co-crystals were obtained by either using a reservoir solution containing 22%  
(w/v) PEG 3350, 5% (v/v) glycerol, 0.3 M NaI and streak seeding the drops, or by using 
a reservoir solution of 30% (w/v) PEG 3350, 10% (v/v) glycerol, 0.3 M NaI without 
seeding. LD:α-CD co-crystals were obtained using a reservoir solution of 30% (w/v) 
PEG 3350, 0.3 M NaI without seeding. In all cases, crystals appeared within one week. 
LD:β-CD crystals grown in 22% (w/v) PEG, 0.3 M NaI and 5% (v/v) glycerol were 
cryo-protected using a 1:1 mix of reservoir solution and PEG 400. LD:α-CD crystals 
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were cryo-protected using a 1:1 mix of reservoir solution and 30% (w/v) PEG 3350, 
10% (v/v) glycerol, 0.3 M NaI. All crystals used for data collection were mounted on 
Mesh Litholoops (loop size 0.2 mm and mesh size 40 µm; Molecular Dimensions, 
Newmarket, UK) and flash-frozen in a steam of nitrogen. Crystal mounting in 
conventional cryo-loops gave rise to excessive mosaicity in the diffraction data. 
X-ray diffraction data of LD:β-CD crystals were collected at the ESRF, Grenoble, 
France, on the micro focus beamline ID23-2 at a wavelength of 0.873 Å. X-ray 
diffraction data of LD:α-CD were collected at MAX-lab II, Lund University, Sweden at 
beamline I911-5 at a wavelength 0.910 Å. 
 
2.7.3 Phasing, Model Building, Refinement and Structual Analysis 
 
The data were integrated in Mosflm (87) scaled using the program Scala from the 
CCP4i Suite (88, 89), and the resultant structure factors were used for molecular 
replacement using Phaser (90) based on residues 177–1070 of KpPUL (PDB code: 
2FGZ). The initial LD:β-CD model was build using Phenix.autobuild (91) from the 
molecular replacement (MR) phases and included 95% of the LD amino acid residues. 
Several rounds of model building and refinement were needed for both LD:β-CD and 
LD:α-CD using Phenix.refine (91) with simulated annealing and 
translation/libration/screw (TLS) refinement (15 segments) activated (92) and COOT 0.5.2 
(93) for molecular visualization, validation and rebuilding. The LD:β-CD structure was 
used as model for MR to solve the structure of LD:α-CD. In addition to the COOT 
validation functions, final analysis of model geometry optimization were done in 
PROCHECK (94) and Molprobity (95). The structure of LD was compared with 
KpPUL, (apo, PDB code: 2FGZ; G4, 2FHF), BsPUL (2E8Y) and BaPUL (2WAN), as 
well as isoamylase from Pseudomonas amyloderamosa (PaISO) (1BF2) and E. coli 
glycogen branching enzyme (1M7X) using the program Pymol 1.1 (85) which was also 
used for generating the structural figures. The protein secondary structure motifs were 
obtained from PDBsum which are computed using PROMOTIF v.3.0 (96). The final 
round of phenix.refine included all reflections, while all other refinement rounds had 
5% randomly chosen reflections kept aside as test set.  
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3 Results 
3.1 Production, Purification and Characterization of Recombinant 
LD 
3.1.1 Pilot Scale Expression in E. coli  
Expression of the LD using the intracellular expression system E. coli 
Rosetta(DE3) and the pET11a/LD construct was analysed by SDS-PAGE. The 
Coomassie stained gel showed no significant difference in expression pattern between 
the induced untransformed strain and that harbouring the pET11a/LD plasmid during 
the three hours of induction. Furthermore, immunoblotting of the same samples did not 
reveal any bands at the expected size confirming that the expression of full-length LD in 
E. coli was unsuccessful. However, bands with lower molecular size were detected, 
which may be either degradation products or results of premature termination of the 
translation (data not shown). 
 
3.1.2 Cloning and Selection of LD Secreting P. pastoris Transformants 
 
The gene fragment encoding LD without the previously proposed putative transit 
peptide (12) was cloned downstream of the P. pastoris AOX1 promoter in pPIC9K in-
frame with the N-terminal α-factor secretion signal to achieve secretion of recombinant 
LD by P. pastoris. The cloning resulted in an N-terminal tripeptide (ATQ) deletion of 
mature LD compared to the earlier published gene sequence (97). The same triptide 
sequence was lacking in approximately 50% of the LD molecules purified from 
germinating seeds (72) and in the gene sequence determined by others (9). The 
linearized construct (Figure 2.1B) was inserted into the genome by homologous 
recombination resulting in stable integration as judged from the maintained P. pastoris 
GS115 Mut+ His+ phenotype. Successful secretory expression was documented by 
strong colony immunoblotting response for 20 transformants out of 50 randomly 
selected and significant variation in production level was judged from intensity 
differences (data not shown). This corroborated the variations in LD activity (2.4–36.8 
mU/mL) observed in a pilot scale secretory expression of the selected transformants. No 
LD activity was produced by strain GS115 transformed with empty pPIC9K and based 
on the results one transformant, LD26, was selected for further analysis. Remarkably, 
after 72 h induction no measurable LD activity was detected in minimal medium at 30 
°C from LD26, whereas induction at 22°C for 72 h gave a 10-fold activity increase 
compared to the highest activity measured after 96 h induction at 30 °C. 
 
3.1.3 Fermentation and Secretory Expression in 5-L Bioreactor 
 
Very low LD yields in shake flask cultures motivated implementation of fed-batch 
high cell-density fermentation. Cell wet weight (CWW) and LD activity were 
monitored throughout the different stages of this fermentation. The initial batch phase 
(30 h) resulted in CWW of 114 mg/mL. The culture was then switched to fed-batch 
mode with 15 g/(L·h) glycerol feed for 6 h leading to CWW of 164 mg/mL. This was 
followed by initiation of induction by a methanol feed of 1 g/(L·h) for 2 h to allow 
adaptation to methanol metabolism. The methanol flow was successively increased to 
  Results 
______________________________________________________________________ 
 
 
______________________________________________________________________ 
29 
 
reach the maximum of 11 g/(L·h) after 12 h. LD activity in the medium and CWW 
increased with time (Figure 3.1). The culture was terminated at 125 h (89 h induction) 
as the reactor headspace became limiting. The CWW was 315 g/L and the 2.5 L cell-
free supernatant contained about 16 mg/L active LD as calculated from the specific 
activity of purified recombinant LD. 
 
Figure 3.1. Progress of secreted LD activity (●) and CWW (cell wet weight) (■) during fermentation 
from the start of the methanol induction (70). 
 
3.1.4 Purification and Characterization 
 
LD purification was monitored by activity assay and SDS-PAGE (Table 3.1; Figure 
3.2A). Less than 1% of the total activity in the culture supernatant appeared in the flow-
through after application to β-CD-Sepharose in 1 M ammonium sulphate and the 
affinity chromatography resulted in high yield of very pure LD (Figure 3.2A, lane 2). 
Precipitation of eluted LD observed in preliminary experiments was prevented by 
immediate adjustment of the eluate to pH 6.7 (see section 2.1.1.6). Gel filtration further 
increased the LD purity and removed β-CD (Table 3.1; Figure 3.2A, lane 3). A minor 
peak eluted prior the main LD peak with an elution time (in column volumes) 
corresponding to dimerized LD.  SDS-PAGE analysis showed that the peak indeed 
contained LD as the sole protein. Immunoblotting of pooled LD-containing fractions 
showed a predominant band corresponding to an apparent molecular weight of 98 kDa 
(Figure 3.2B, lane 2) in excellent agreement with both the theoretical value of 97419 Da 
and the migration of barley malt LD (Figure 3.2B, lane 1). A trace component of 
slightly lower molecular weight visible in SDS-PAGE possibly represented a cleavage 
product of secreted LD. The purification procedure resulted in 34 mg recombinant LD 
with specific activity of 14.2 U/mg corresponding to 11-fold purification and 84% 
recovery from the culture supernatant (Table 3.1).  
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Table 3.1. Purification of LD from 2.5 L P. pastoris culture supernatant (70) 
 Total protein 
(mg) 
Total activity 
(U) 
Recovery 
(%) 
Specific 
activity 
(U/mg) 
Purification 
(fold) 
Supernatant 456.9 573.3 100.0  1.3 1.0 
β-CD-Sepharose  82.7 551.7   96.2 6.7 5.2 
Sephadex G200 33.6 477.3 83.3 14.2 11.0 
 
 
 
Figure 3.2. (A) Coomassie stained SDS-PAGE. Lane 1, culture supernatant (~3.5 µg total protein); lane 
2, pool of β-CD-Sepharose eluate (~2.5 µg total protein); lane 3, pool of Hiload Superdex 200 eluate 
(~0.8 µg total protein). (B) Immunoblotting using barley LD specific antibody. Lane 1, LD purified from 
barley malt (~70 ng); lane 2, purified recombinant LD (~40 ng). (C) Coomassie stained SDS-PAGE. Lane 
1, LD purified from barley malt (~1 µg); lane 2, purified recombinant LD (~1 µg). (D) Isoelectric 
focusing of LD (pH 4−6 PhastGels). Lane 1, LD purified from barley malt (~0.8 µg); lane 2, purified 
recombinant LD (~0.8 µg) (70). 
The identity of recombinant LD was verified by peptide mapping using MALDI-TOF-
MS (data not shown). A search against the NCBI non-redundant database resulted in 
mono-isotopic mass peaks with 27% sequence coverage of the LD protein sequence. 
Tryptic peptides comprising the four putative N-glycosylated positions were not 
identified, owing to size incompatibility with the present mass spectrometric analysis 
for two of them. However, the migration of LD in SDS-PAGE analysis as a single sharp 
band corresponding to the expected molecular mass is not supportive of significant 
glycosylation. Three different processed forms of LD can be predicted depending on the 
protease cleavage site, Kex2 or any of the two Ste13 sites, used (Figure 2.1A). Using 
the NotI site for the cloning will therefore normally, in the processed protein, result in a 
9–13 amino acids N-terminal extension that originates from the expression plasmid 
(Figure 2.1A). N-terminal sequencing of LD revealed an alternative processed form of 
the secreted enzyme (AAFMPDAR, Figure 2.1A) presumably due to cleavage by one or 
more proteases produced by P. pastoris.  
Isoelectric focusing of the recombinant LD and LD purified from barley malt 
showed a similar migration pattern with pI of ≈ 4.1 (Figure 3.2D). A number of closely 
migrating bands appear in a broader smeared zone indicating slight charge 
heterogeneity in both enzyme preparations, which was not further investigated. 
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3.1.5 LD Activity 
 
Fitting the Michaelis-Menten equation (eq. 2.1) to initial rates of LD catalysed 
hydrolysis of pullulan revealed deviation of the hyperbolic fit from experimental data, 
in particular at substrate concentrations above 0.2 mg/mL (Figure 3.3, dashed line). 
Noticeably, however, fitting the Michaelis-Menten expression for uncompetitive 
substrate inhibition (eq. 2.2) matched the data very clearly (Figure 3.3, solid line). This 
is supported using standard statistical tools for model selection such as the corrected 
Akaike information criterion (AICc) (98) and the sum of squared residuals (SS) (tools 
included in the Sigmaplot 9.01 software). The Michaelis-Menten expression for 
uncompetitive substrate inhibition yields an AICc = −43.4 and SS = 8.3, while the 
regular Michaelis-Menten equation has values of AICc = −14.3 and SS = 20.1. Such 
deviation from the Michaelis-Menten model observed for other glycoside hydrolases, 
has previously been attributed to an increased transglycosylation rate at higher substrate 
concentrations rather than to substrate inhibition (99, 100). For LD this is in agreement 
with the Km value for pullulan being significantly higher when fitting the equation for 
uncompetitive substrate inhibition as compared to fitting the regular Michaelis-Menten 
equation (Table 3.2). 
 
 
Figure 3.3. Apparent initial rate of release of reducing sugar as a function of pullulan concentration. Solid 
line, fit of Michaelis-Menten expression with uncompetitive substrate inhibition. Dashed line, classical 
Michaelis-Menten plot. Error bars indicate SD for triplicate measurements (70). 
 
Table 3.2. Apparent kinetic constants of LD on pullulan obtained by nonlinear least-squares curve fittinga 
Classical Michaelis-Menten Uncompetitive substrate inhibition 
Km,app 
mg/mL 
kcat,app 
s-1 
(kcat/Km),app 
mL/(mg·s) 
Km,app 
mg/mL 
kcat,app 
s-1 
Ki,s,app 
mg/mL 
(kcat/Km),app 
mL/(mg·s) 
0.081 ± 0.003 61 ± 13 753 0.16 ± 0.02 78 ± 10 1.5 ± 0.4 488 
aValues are based on independent triplicate measurements (70) 
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3.1.6 Transglycosylation 
3.1.6.1 Linear Acceptors 
α-Maltosyl fluoride (G2F) was used as donor in the initial reactions and a range of 
oligosaccharides from maltose to maltohexaose (G2–G6) were used as acceptors. Using 
maltose as acceptor the conversion rate of the maltosyl fluoride to the acceptor was high 
indicated by a fast decrease in the amount of G2F. The subsequent hydrolysis of the 
formed product seems to be relatively slower indicated by the accumulation of product 
(data not shown). Furthermore, the products formed from the initial transglycosylation 
also act as acceptors resulting in a polymerization of maltose with up to eight maltose α-
1,6 repeats, which were identified by MALDI-tof MS (Appendix 7.1.1). The conversion 
rate of maltosyl fluoride to longer linear oligosaccharide (G3–G6) showed to be slower 
(data not shown) and the subsequent hydrolysis of the formed product relatively faster 
resulting in only minor product accumulation and an increase in maltose concentration. 
The relative hydrolysis and transglycosylation rates using maltotetraose as acceptor and 
maltotriosyl fluoride (G3F) and G2F, respectively, as donors were compared by TLC 
analysis (ratio donor:acceptor, 1:2, 20 mM:40 mM). The conversion rate of G3F was 
slower compared with G2F and the subsequent hydrolysis much faster (Figure 3.4).  
 
 
Figure 3.4. Comparison of the transglycosylation reaction using either maltosyl fluoride (A) or 
maltotriosyl fluoride (B) as donor and maltotetraose as acceptor. Donor:acceptor ratio 1:2 (20 mM: 40 
mM). Transglycosylation products are indicated encircled. 
 
Acarbose, a known α-amylase inhibitor (79) and 4-O-α-D-
glucopyranosylmoranoline (G1M) (78), which has been shown to inhibit both barley α-
glucosidase and β-amylase in vitro in the micro molar range (Martin Rejzek, personal 
communication) were used as acceptors in initial transglycosylation reaction with α-
maltosyl fluoride as donor in order to produce new inhibitors. G1M has also been 
shown in preliminary inhibition studies of small synthetic and natural products to have 
inhibitory activity towards LD in the mM range (data not shown), which may indicate 
binding in the active site. Approximately 40% inhibition of LD (7.5 nM) in the presence 
of G1M (1 mM) was measured (data not shown). By comparison, more than 90% 
inhibition of LD by β-CD (100 µM) was observed under the same reaction conditions. 
The ratio donor to acceptor was 2:1 (20 mM:10 mM) for G2F:acarbose and 2.6:1 (20 
mM: 7.7 mM) for G2F:G1M, which resulted primarily in polymerisation of maltose. 
MS data, however, revealed formation of transglycosylation products with the unique 
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molecular masses of single and double maltose substitutions of both acceptors 
(Appendix 7.1.2 and 7.1.3.). 
 
3.1.6.2 Cyclic Acceptors 
Using α- and β-CD which are known inhibitors of LD as acceptors multiple 
substitutions presumably of the ring were observed both by TLC and MS. These 
experiments were carried out with a large excess of the donor (ratio donor:acceptor, 4:1; 
40 mM:10 mM) in the reaction mixture and additional maltosyl fluoride was added to 
the reaction at different time points. The constant level of maltose, originating from the 
fluoride solution, and the clear decrease in α-CD indicates that the product formed from 
the conversion of maltosyl fluoride to α-CD was not hydrolysed (Figure 3.5A), and 
under these reaction conditions 6 substitution products were detected by MS (Appendix 
7.1.4). 
Despite a 4-fold excess of donor no products from maltose polymerisation were 
observed, indicating that the CD’s are much better acceptors than maltose for the 
transglycosylation. This conforms with the high affinity of LD towards the CD’s (see 
section 3.1.7). The transglycosylation of maltosyl β-CD seems to be slightly faster than 
the α-CD. The subsequent hydrolysis of the product seems to be even faster than the 
transglycosylation resulting in only a minor accumulation of the transglycosylation 
product (Figure 3.5B). The same result was observed when using β-CD as acceptor. 
 
 
 
Figure 3.5. Comparison of the transglycosylation reaction using maltosyl fluoride as donor and either α-
cyclodextrin (A) or (B) maltosyl β-cyclodextrin as acceptor. Donor:acceptor ratio 4:1 (40 mM:10 mM). 
Transglycosylation products are indicated with circles. 
 
3.1.7 Cyclodextrin Affinity 
 
The previously reported binding of cyclodextrins to debranching enzymes (101) is 
here confirmed and analyzed for the recombinant LD by SPR analysis. The 
approximately 100-fold difference in molecular weight between the chip-immobilized 
LD and the three CD analytes poises high demands on sensitivity. The developed 
experimental set up, however, resulted in highly reproducible sensorgrams for all three 
CDs with Rmax values of 16–25 RU. Fitting of a one binding site model to the SPR data 
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of β-CD (Figure 3.6) revealed a submicromolar Kd, whereas α- and γ-CD had 40–50 
times weaker affinity (Table 3.3). 
 
Table 3.3. LD affinity towards cyclodextrins determined by SPRa  
Analyte Kd (µM) Relative Kd* 
α-CD 27.2 ± 0.9 39 
β-CD   0.7 ± 0.1   1 
γ-CD 34.7 ± 0.2 50 
aMeasurements were performed at 25 °C in 20 mM Na acetate pH 5.5, 100 mM NaCl, 
0.005% P-20. Kd is based on independent duplicate runs, each run having three data points 
at each concentration. *Kd values normalized to β-CD. (70) 
 
 
Figure 3.6. Fitting of a one binding site model to the SPR data of β-CD (70). 
 
3.2 Production and Purification of Recombinant LDI  
3.2.1 Expression and Purification of the Intein-LDI Construct  
 
The gene fragment encoding CBD-intein-LDI (37.9 kDa) was expressed at both 15 
°C and 37 °C in Rosetta-gami(DE3), however, the yield at both 37 °C (Figure 3.7) and 
15 °C were very low (data not shown).  
 
 
Figure 3.7. Coomassie stained SDS-PAGE of the CBD-intein-LDI expression in E. coli Rosetta-
gami(DE3) at 37 °C. Lane 1, induction start; lane 2 30 min; lane 3–5, 1, 1.5 and 2 h induction, 
respectively. Expected size of the produced product is 37.9 kDa. 
  Results 
______________________________________________________________________ 
 
 
______________________________________________________________________ 
35 
 
Purification of the fusion protein using the chitin column showed to be very 
efficient, indicated by the absence of the band corresponding to the expressed CBD-
intein-LDI construct in SDS-PAGE analysis of the flow-through. The LDI was cleaved 
efficiently from the CBD-intein part by decreasing the pH and increasing the 
temperature. LDI eluted within the first three fractions and the 20-fold concentrated LDI 
pool was tested for LD inhibition activity. Based on an estimation of the LDI 
concentration from the SDS-PAGE the LDI:LD ratio in the Limit-Dextrizyme assay 
was 30:1.  Despite the large excess of the inhibitor no inhibition of LD was observed.  
 
3.2.2 Expression and Purification of P. pastoris His-LDI Construct  
 
The five selected P. pastoris clones having a chromosomal integrated copy of the 
LDI-gene in-frame with the nucleotide sequence of a thrombin cleavable N-terminal 
His-tag were expressed at 17 °C. All five selected clones expressed and secreted a 
product with approximately the expected size of LDI (14.3 kDa) as judge by SDS-
PAGE (Figure 3.8A). The products from two clones (clone 1 and 4) were selected for 
purification on His-Trap column as previously described (section 2.1.2.3). SDS-PAGE 
analysis of the flow-through from the loading of the samples and the column wash 
revealed that the protein was not binding to the column (Figure 3.8B). A sample from 
the flow-through blotted onto a PVDF membrane and N-terminally sequenced, was 
found to lack the N-terminal His-tag, presumably due to proteolytic activity by 
proteases produced by P. pastoris during fermentation. Two different N-terminal 
sequences were identified in the sample, one identical to the expected sequence 
resulting from cleavage by thrombin (resulting N-terminus; GSTLESVKDECQ)  and 
one identical to the N-terminus of the Ragi α-amylase/trypsin inhibitor, RATI 
(SVKDECQ) (102). The LD inhibitory activity of LDI in the culture supernatant was 
analysed with a 1000-fold excess of LDI resulting in 100% inhibition of LD. 
 
 
Figure 3.8. (A) Coomassie stained SDS-PAGE of the His-LDI expression in P. pastoris at 17 °C. 
Samples from each clone after 48 h and 72 h (harvest) induction. Lane 1–2, clone 1; lane 3–4, clone 4; 
lane 5–6, clone 7; lane 7–8, clone 11; lane 9–10, clone 12. (B) His-Trap purification of clone 1. Lane 1, 
clarified cell extract; lane 2, flow-though; lane 3, column wash. 
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3.2.3 Expression and Purification of LDI-His and LDI-His-mutants 
 
The pilot expression of both EF-LDI and wt-LDI showed only minor variation in 
expression and inhibitory levels of the selected tested clones. Based on these results one 
of each clone (EF-LDI and wt-LDI) was selected for use in fed-batch high cell-density 
fermentation, which ensured reasonably high yields (~ 6 mg LDI pr L cell free extract) 
of inhibitory active LDI visualized by SDS-PAGE. The amount of LDI increased in the 
medium during the methanol phase despite a small decrease in the CWW towards the 
end of the fermentation. The EF-LDI and wt-LDI cultures were terminated after 22 h 
and 28 h induction with a CWW of 170 g/L and 120 g/L, respectively. The 
fermentations resulted in 3.2 L cell-free supernatant containing either EF-LDI or wt-
LDI. Elution of both EF-LDI and wt-LDI from the HisTrap column gave two 
overlapping protein fraction peaks. SDS-PAGE analysis showed that the first eluted 
peak in addition to full-length LDI contained lower molecular mass fragments of LDI. 
Fractions were combined in two pools based on their purity judged from SDS-PAGE 
and purified by anion exchange chromatography. The anion exchange chromatography 
of EF-LDI resulted in several peaks with the EF-LDI eluting in one of them. Proteolytic 
activity in the fermentation medium, resulted in partial formation of a truncated version 
of the EF-LDI that lacks the N-terminal tripeptide (TLE) as compared to the wt-LDI 
sequence (∆E3LDI).  The N-terminus of this construct was identical to the RATI (102). 
Since this truncated version has great relevance in elucidating the role of the N-terminal 
sequence in the LD/LDI interaction it was subjected to further analysis. Anion exchange 
chromatography purification of wt-LDI (pool 2 from HisTrap elution, Figure 3.9B; lane 
1) also resulted in several peaks, however, the purification resulted in highly pure LDI 
with the expected native N-terminus (TLE) (Figure 3.9C, lane 1–5). Pool number 4 
(Figure 3.9C, lane 4) was used for further analysis. Wt-LDI (Figure 3.9C, lane 7) was 
used for crystallization of the LD/LDI complex (section 2.7.1 and 3.4.1). 
 
 
Figure 3.9. Coomassie stained SDS-PAGE of the purification of wt-LDI (A) Lane 1, culture supernatant. 
(B) Concentrated pools from HisTrap elution. Lane 1, pool 2; lane 2 pool 1. (C)  Concentrated pools from 
anion exchange chromatography. Lane 1-6. Fraction from the anion exchange chromatography (of His 
Trap pool 2) of wt-LDI  were pooled according to the peaks of the chromatogram; lane 7, pool from anion 
exchange chromatography of HisTrap pool 1. Expected size of the produced product is 13.5 kDa. 
N-terminal sequencing of the constructed N-terminal truncated ∆V5LDI showed 
that the Kex2 protease cleavage site was used in the processing instead of the Ste13 site 
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yielding an N-terminal sequence of EAEAKDECQ, with EAEA originating from the α-
factor secretion signal (Figure 2.2). 
LC-MS was performed on wt- and ∆E3LDI under nonreducing conditions 
(Appendix 7.2). Unfortunately for unknown reasons the analysis of wt-LDI was 
unsuccessful. LC-MS analysis of ∆E3LDI, however, revealed that the ∆E3LDI pool used 
for SPR analysis was glutathionylated. The presents of several peaks indicated that the 
pool was not entirely pure, however the difference in the major peaks was due to 
cleavage of histidine residues from the hexa-histidine tag which should not affect the 
overall structure or function of LDI. 
 
 
3.3 Characterization of the LD/LDI Interaction 
 
3.3.1 Inhibition Kinetics 
 
LDI inhibition of LD was analysed using pullulan as substrate. A Ki value of 1.7 
nM ± 0.1 was determined by fitting the model for tight competitive inhibition (eq. 2.3) 
to the data (Figure 3.10A). The relatively high standard deviation observed for the 4 nM 
LDI inhibition data, is due to a very low residual LD activity. Fifty percent (50%) 
inhibition was reached at an approximate 1:1 molar ratio (1.1:1, 4.4 nM:4 nM) of 
LDI:LD and more than 90% inhibition was obtained at a 2:1 ratio (Figure 3.10B). At a 
4-fold molar excess of LDI (LDI:LD = 5:1) 100% inhibition of LD was observed.  
 
 
 
Figure 3.10. Inhibition of LD by wt-LDI. (A) Fit of Michaelis-Menten expression for tight competitive 
inhibition. No inhibitor (●), 2 nM LDI (○), 4 nM LDI (▼). Error bars indicate SD for duplicate 
measurements. (B) wt-LDI inhibition level (%) vs. LDI:LD (molar ratio), the curve is drawn though the 
experimental points. Error bars indicate SD for triplicate measurements. 
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3.3.2 Kinetics and Thermodynamics of LD/wt-LDI and LD/LDI Mutant 
Interactions 
 
The set up used offers a two-fold advantage 1) enhanced signal by immobilizing the 
10-fold smaller LDI as compared to LD, 2) signal robustness and longer life of the chip 
as LDI exhibits significantly better thermostability than LD, and thus can withstand 
repeated cycles of relatively harsh regeneration (pH 1.5). Indeed, the signal recovery 
after 27 cycles was 73 %. Relatively low immobilization levels were used to minimize 
possible mass transfer limitation and the essentially the same kinetics rate constants 
were obtained at flow rates of 30 µL/min and 60 µL/min, in addition the mass transfer 
constant, kt in all runs was > 109 indicating that the kinetics of binding are largely 
unaffected by mass-transport from the bulk to the chip surface at these conditions. The 
signal magnitude did not permit injecting much lower LD concentrations than 0.1 nM 
(app. 2.5 KD) which resulted in app. 4–5 RU response, thus determining the lowest 
concentration and an 80 fold higher concentration was the upper limit as using higher 
concentration resulted in significant deviation of the fit quality from the simple 1:1 
model. This was possibly due to chip heterogeneity as less accessible sites or sites with 
decreased affinity due conformational changes that are detected after the saturation of 
natural high affinity sites. Finally the specificity of the binding is also attested with less 
than 5% of non-specific interactions with the reference cell.  
A 1:1 binding model was fitted globally to the sensograms for each set of ligand 
concentrations to determine the rate constants kon and koff. Representative data and fits 
with LD concentration range 0.1–4 nM at standard conditions (Figure 3.11A) and at 
suboptimum conditions (10 mM Bicine/NaOH pH 10.0, 150 mM NaCl, 0.005% 
surfactant P-20, 25 °C) (Figure 3.11C). The figure clearly shows that excellent fits are 
obtained by the 1:1 model at standard conditions with no systematic deviations of the 
residuals which do not exceed 5%. The very high affinity binding evidently derives 
from a very slow koff  and a standard kon value (103, 104). The quality of the fit is 
slightly worse for the pH 10 condition, but it is still very reasonable, and the deviations 
at the transition between the association and the dissociation phases may be caused by 
aggregation of the LD at the surface of the chip at this pH. 
The effect of ionic strength on the LD/LDI-interaction was measured at zero to 1 M 
NaCl (Table 3.4). No binding was detected, however, when omitting salt from the 
running buffer despite an increase in the used LD concentration (1–80 nM) and changes 
in affinity in the concentration range 75 mM –1 M using LD of 0.1–4 nM 
predominantly resulted from increase in the kon, that reached a maximum value at 300 
mM NaCl corresponding also to optimal binding with KD of 27.2 ± 1.3 pM.  
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Figure 3.11. Representative fits of a 1:1 binding model (gray line) to the SPR data (black line) and 
residuals. The LD concentration range is 0.1–4 nM. (A) Binding data at standard conditions, 10 mM 
Mes/NaOH pH 6.0, 150 mM NaCl, 0.005% surfactant P-20, 25 °C and (B) the corresponding residuals. 
(C) Binding data at suboptimum conditions, 10 mM Bicine/NaOH pH 10.0, 150 mM NaCl, 0.005% 
surfactant P-20, 25 °C and (D) the corresponding residuals. 
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Table 3.4. Effect of ionic strength on the kinetics of binding of LD to LDIa 
NaCl 
(mM) 
kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
0 No binding detected 
75 9.0 ± 0.0 3.4 ± 1.5 37.3 ± 17.0 
150 15.4 ± 0.2 6.4 ± 0.2 42.0 ± 2.0 
300 17.3 ± 0.3 4.7 ± 0.1 27.2 ± 1.3 
1000 9.4 ± 0.1 7.0 ± 0.1 74.1 ± 1.0 
aMeasurements were performed at 25 °C in 10 mM Mes/NaOH pH 6.0, 0.005% P-20. Seven LD 
concentrations in the range of 0.1–4 nM and 1–80 nM were used for 75–1000 mM and 0 mM NaCl, 
respectively. KD is based on independent duplicate runs.  
 
The pH dependence of the LD/LDI complex formation was analyzed in the range 
pH 5.0–10.0 (Table 3.5). A three-fold increase in kon was observed from pH 5.0 to pH 
6.5 followed by a slight decrease up to pH 10.0. The effect of pH on koff was much more 
important. koff thus decreased 5-fold from pH 5.0 to reach a minimum at pH 6.5 and 
then increased approximately 10-fold from pH 6.5 to 10.0. The combination of a high 
kon and low koff resulted in lowest KD (highest affinity) of 27.2 ± 0.2 pM at pH 6.5. The 
optimum pH of the interaction is in good agreement with the physiological slightly 
acidic to neutral pH prevalent in the endosperm which is shown to acidify during 
germination (105, 106), and the increase in KD of 12–15 fold at both lower and higher 
pH values showed that KD was dependent on pH.   
 
Table 3.5. pH dependence of the kinetics of binding of LD to LDIa 
pH kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
5.0   6.1 ± 0.6             25.9 ± 3.2   425 ± 119 
5.5   9.7 ± 0.1   8.6 ± 0.1 89.3 ± 0.1 
6.0 14.2 ± 0.4   5.3 ± 0.1 37.3 ± 1.9 
6.5 18.6 ± 0.2   5.1 ± 0.0 27.5 ± 0.2 
7.0 18.1 ± 1.6   6.2 ± 0.2 34.5 ± 1.8 
7.5 16.4 ± 0.0   8.1 ± 0.3 49.3 ± 1.7 
8.0 16.7 ± 0.1 12.3 ± 0.0 73.8 ± 0.4 
8.5 16.0 ± 0.1 21.8 ± 0.1              136.2 ± 2.2 
9.0 12.4 ± 1.1 27.0 ± 0.5 219.2 ± 22.6 
9.5 13.8 ± 0.3 31.3 ± 1.8 227.3 ± 18.0 
10.0 14.5 ± 1.7 49.9 ± 4.4              345.1 ± 9.0 
aMeasurements were performed at 25 °C in appropriate buffers (see Material & Methods), added 150 
mM NaCl and 0.005% P-20. Seven LD concentrations (0.1–4 nM) were used. KD is based on 
independent duplicate runs.  
The temperature dependence of the LD/LDI binding kinetics was determined using 
SPR at 9 different temperatures in the range 10–45 °C and five LD concentrations (0.4–
8 nM) (Table 3.6). The affinity was found to be more favourable at low temperature as 
shown by a 6.5-fold lower KD when the temperature was lowered from 45 to 10 °C 
which stemmed from mainly a 16-fold increase in koff at 45 °C. However, the large 
change in koff at temperatures above 35 °C may not only reflect the real dissociation rate 
of the complex, but could also be influenced by conformational changes of both 
proteins at higher temperature. The approximately 2-fold discrepancy between KD at 
standard conditions (25 °C) determined in the temperature dependency analysis and the 
KD determined in the ionic strength (Table 3.4) and pH dependency analysis (Table 3.5) 
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is primarily due to an approximately 2-fold lower kon. This may be caused by a small 
variation in the LD concentration due to an altered sample preparation procedure.   
Table 3.6. Temperature dependence of LD/LDI interactiona 
Temp. 
(°C) 
kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
10   5.6 ± 0.0   4.9 ± 0.3    88.0 ± 6.0 
15   6.5 ± 0.0   5.7 ± 0.2    88.2 ± 3.1 
20   7.6 ± 0.0   6.6 ± 0.2    86.2 ± 2.1 
25   8.8 ± 0.1   8.3 ± 0.1    94.5 ± 0.5 
30 10.1 ± 0.1 11.5 ± 0.2  114.5 ± 3.0 
35 11.2 ± 0.0 19.7 ± 0.0  176.7 ± 0.4 
37 11.6 ± 0.1 26.1 ± 0.3  225.1 ± 0.2 
40 12.5 ± 0.1 39.6 ± 0.3  317.1 ± 3.6 
45 13.9 ± 1.7 79.9 ± 5.1  580.5 ± 106.8 
aMeasurements were performed at different temperature in 10 mM Mes/NaOH pH 6.0, 150 mM NaCl, 
0.005% P-20. Five LD concentrations (0.4–8 nM) were used. KD is based on independent duplicate 
runs. 
 
Despite the variation in KD the energetics of the interaction at the reference 
temperature T = 298.15 K were extrapolated using the van’t Hoff equation, which 
describes the correlation between temperature and the natural logarithm of the binding 
constant (KD), and thereby allowing calculation of the of the interaction using either the 
non-linear (eq. 2.7) or the linear van’t Hoff equation (eq. 2.8) (BIAcore T100 
Evaluation Software version 1.1). In order to diminish the influence of conformational 
change and/or instability of the proteins at higher temperature the energetic of the 
interaction were calculated based on data measured from 10–35 °C. The standard 
thermodynamic parameters were calculated by applying both the non-linear (eq. 2.7) 
and the linear van’t Hoff equation (eq. 2.8) and using the reference temperature T0 of 25 
°C (298.15 K). The use of the non-linear van’t Hoff equation was justified by the 
curvature of the data over the measured range (Figure 3.12A). Binding of LD to LDI 
was driven by a large favorable free energy change, ∆G° = –57 kJ/mol, and resulted in a 
significant decrease in heat capacity (∆Cp° = –3.2 kJ/(K·mol).  The binding was 
moreover characterized by a substantial favorable change in entropy (T∆S° = 30 kJ/mol) 
mounting to approximately 53% of the total free energy of binding and an enthalpic 
contribution, ∆H° of –27 kJ/mol. Applying the linear van’t Hoff equation changed the 
calculated contribution of the enthalpic and entropic components to the total free energy 
of binding (∆G° = –57 kJ/mol). The calculated contribution from the change in entropy 
was even more favorable (T∆S° = 39 kJ/mol), whereas the enthalpic contribution (∆H° 
= –18 kJ/mol) decreased from 47% to 31% of ∆G° (Figure 3.12B). 
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Figure 3.12. van’t Hoff plots of the fitting of the non-linear (A) or linear (B) function to the data. 
 
Analysis of the N-terminal LDI mutants revealed that the variation in the LDI N-
terminal sequence seemed not to influence the overall interaction between LD and LDI, 
as indicated by similar KD values found for both longer and truncated versions of LDI 
(Table 3.7). kon for the truncated mutants was slightly lower whereas koff for EF-LDI 
was slightly higher. 
 
Table 3.7. Effect of N-terminal sequence on the binding of LDI to LDa 
Inhibitor kon × 105 
(M/s) 
koff ×10-5 
(s-1) 
KD 
(pM) 
wt-LDI        14.8 ± 0.1  5.9 ± 0.7 40 ± 3 
∆V5LDI        10.0 ± 0.0  5.7 ± 0.2 55 ± 2 
∆E3LDI          9.1 ± 0.1  6.6 ± 0.1 72 ± 3 
EF-LDI        13.5 11.3  84* 
aMeasurements were performed at 25 °C in 10 mM Mes/NaOH pH 6.0, 150 mM NaCl, 0.005% P-20. 
Seven LD concentrations in the range 0.1–8 nM were used. KD is based on independent triplicate runs. 
*Based on a single run. 
 
3.3.3 Sequence Alignment and LDI Modelling 
 
Multiple sequence alignment of the five most studied inhibitors of this protein 
family LDI, RATI, CHFI, and the dimeric and monomeric wheat inhibitors 0.19 and 
0.28 (Figure 3.13A) showed that most sequence dissimilarity among these family 
members occurred in the loop regions and in particular in loop 3 (L3) between α-helix 3 
and α-helix 4 and as well as at the C-terminal (see below for further description). 
Pairwise alignment of LDI with RATI, CHFI, 0.19 and 0.28 showed sequence identities 
(similarities) of 48.4% (57.8%), 46.9% (53.1%), 25.8% (37.1%) and 21.7% (34.1%), 
respectively. Based on the high identity and similarity between LDI and RATI, the latter 
was used as template in homology modelling of LDI. 
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Figure 3.13 (A) Result of ClustalW2 multiple sequence alignment of the five most studied inhibitors 
LDI, RATI, CHFI, the dimeric and the monomeric wheat inhibitors 0.19 and 0.28, respectively. The top 
line display the secondary structure of LDI with α-helices shown as dark gray cylinders and β-strands as 
light gray arrows. The secondary structure is also indicated in the alignment for all the proteins; α-helices, 
dark gray shading and β-strands, light gray shading. (B) Homology model of LDI showing a helical 
bundle with a simple up-and-down topology. The α-helices and β-strands are shown in red and blue, 
respectively. The 4 disulfide bonds and Cys59 are shown as yellow sticks and His56 is coloured gray.   
 
The quality of the obtained LDI model was getting a predicted LGscore of 2.035 
placing it in the category of “fairly good models” (107). The structure (Figure 3.13B) 
displays the typical globular four-helix motif in a simple up-and-down manner as well 
as two short anti-parallel β-strands (residues Val69–Thr71 and Gly74–Val79). The four 
helices (α1–α4) are linked by loop segments L1 (residues Gly33–Pro39), L2 (residues 
Val53–Pro54), L3 (residues Gly68–Pro88). The L3 loop between α-helix 3 and α-helix 4, 
may be very flexible thus for 0.19 no electron density was observed for residues Gly69–
Thr77 probably due to high flexibility in this segment (108). The last loop L4 including 
the C-terminus (Thr101–Gly114) follows α-helix 4, and is much shorter (8–13 residues) in 
the LDI structure compared with the structures of RATI, CHFI, and the wheat 0.19 and 
0.28 inhibitors. Eight of the nine cysteine residues in LDI form disulfide bonds 
occurring in the pairs Cys9–Cys57, Cys23–Cys46, Cys32–Cys87, and Cys47–Cys105,  
resulting in a free Cys59, as proposed by others (61).  The N-terminal segment of the 
template structure (RATI) has been shown to be flexible (102) resulting in an 
unstructured N-terminus in the LDI model that lacks residues 1–3 (TLE). The structural 
arrangement surrounding Arg58 is conserved among members of the family. The non-
polar part of the arginine side chain contributes to the hydrophobic core of the protein 
and the guanidinium group makes hydrogen bonds to the main chain carbonyl oxygens 
of Leu50 and Val53 in α-helix 2 and L2, respectively. Furthermore, the hydrogen bonding 
pattern of Arg58 is observed between Nη1 and the main chain carbonyl oxygen of 
Ser108, together with Oδ1 and Oδ2 of Asp55 and finally between Nη2 (Arg58) and the 
main-chain carbonyl oxygen of Val53 and Oδ1 of Asp55. A similar hydrogen pattern is 
present in the crystal structures of RATI, CHFI and 0.19. No density were found in the 
electron density map for the residues Leu118–Glu122 of RATI in complex with TMA (59) 
and residues Tyr120–Val123 of 0.28 in complex with TMA (55), suggesting that the C-
terminus is very flexible. 
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3.4 Crystallization and 3D Structure Determination 
 
3.4.1 LD/LDI Complex Formation and Crystallization 
 
The high affinity of LD towards LDI ensured an efficient purification of the 
LD/LDI complex using gel filtration at the chosen condition, with the complex eluting 
approximately 5% (in column volume) earlier than LD alone (Figure 3.14A). SDS-
PAGE analysis (Appendix 7.2.) of the eluted fraction verified the co-exiting of both LD 
and LDI in the major peak. The symmetric shape of the peak indicates that the majority 
of LD is in complex with LDI. Excess of LDI in the reaction mixture eluted as a single 
peak much later. The minor peak eluting prior the LD/LDI complex has been shown by 
SDS-PAGE analysis to contain LD, which is suggested to have dimerized. The elution 
time for this peak is also approximately 5% (in column volume) earlier indicating that 
LDI interacts with the presumed dimer of LD. 
 
 
Figure 3.14. (A) Overlay of obtained chromatograms from purification of LD (red line) and LD/LDI 
complex (black line) in two separate run on Hiload Superdex 200 26/60 column. Y-axis: A280 (mAU), X-
axis: mL. (B) High-throughput crystallization result one week after setup. Crystallization conditions: Top, 
(NH4)2SO4 1.14 M, CAPS 0.1 M, pH 10; bottom, Na2S2O3 0.94 M, CAPS 0.1 M, pH 10. 
Crystals were obtained from the high-throughput screening of the crystallization 
condition after 1–4 weeks, and nine of these conditions were selected for scale-up 
experiments in both microbatch-under-oil and hanging drops vapour diffusion. Both the 
HTS selected conditions and the commercial available screens failed to produce crystals 
within three month. 
 
3.4.2 Crystallization, Structure Determination and Model Quality of LD 
 
LD expression and purification was according to previously described methods in 
section 2.1.1.5 and 2.1.1.6 (70) and showed a single band in SDS-PAGE. While the 
initial crystallization trials failed to produce crystals within the first three month, the 
PEG/Ion Screen ultimately resulted in protein crystals within a year. LD was found to 
crystallize under several different conditions, which all contained either iodine or 
thiocyanate in the crystallization buffer. The crystal morphology was not dependent on 
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protein or precipitant concentration. Crystals were bundles of very thin needles. 
However, addition of cysteine resulted in thicker separate, single crystal needles. 
Crystals obtained from seeded drops were very homogenous (Figure 3.15A) and 
measured 0.002 × 0.002 × 0.006 mm3. While crystals obtained without seeding were 
slightly bigger and of highly variable crystal quality (Figure 3.15B). The seeded needles 
diffracted to 2.6 Å and belonged to space group P212121, with one molecule in the unit 
cell and cell dimensions of a = 85.0 Å, b = 93.8 Å and c = 114.7 Å. The non-seeded 
crystals of LD:β-CD and LD:α-CD were of space group C2 and diffracted to 2.1 Å and 
2.5 Å, respectively, with one molecule in the unit cell and a solvent contents of 43.7% 
(LD:β-CD) and 47.2% (LD:α-CD). Cell dimensions are included in Table 3.8, which 
summarizes data collection statistics. 
The final structures show overall good electron density. However, the first two 
amino acids and residues 22–28, 40–49, and 102–109 in the N-domain had low level or 
no sigmaA weighted 2Fo-Fc electron density and have not been included in the models. 
In addition to the three loops in the N-domain, the 806–810 loop in the C-domain had 
less than 1σ 2Fo-Fc electron density for both side and main-chain. Two calcium ions, 
iodide (9 in the LD:α-CD structure and 5 in the LD:β-CD structure), glycerol (one in the 
LD:α-CD structure and 7 in the LD:β-CD structure) and water molecules (223 in the 
LD:α-CD structure and 604 in the LD:β-CD structure) are modelled and the resulting 
Rcryst and Rfree  values from the refinement are 16.3 % and 20.0 % for the LD:β-CD 
structure and 17.7 % and 22.6 % for the LD:α-CD structure, respectively. 
 Rcryst values dropped to 15.7% and 17.3%, respectively in the final refinement 
cycle, which included all reflections. The LD moieties of the two cyclodextrin 
complexes are virtually identical with an r.m.s.d. of 0.7 Å for all Cα atoms. Due to the 
higher resolution of the LD:β-CD, this complex is used to describe the overall structure. 
The geometry of the models is good with approximately 89% of the residues in the 
most favoured region of the Ramachandran plot and only one residue (Phe566) in a 
disallowed region.  Phe566 is in a turn in the loop between β-strand 6 and α-helix 6 of the 
(β/α)8-barrel. The unfavourable ϕ and ψ angles in this tight turn could be caused by the 
bi-dentate salt bridge between the adjacent Glu568 and Arg875, and the multiple hydrogen 
bonds emanating from Gln559: Gln559 Nε2 - Glu568 O, Gln559 Nε2 - Thr563 O, Gln559 Oε1 
- Gln574 Nε2 and Gln559 Oε1 - Asn570 N. In addition, the aliphatic part of the Arg581 side-
chain contributes to hydrophobic interactions with the side-chain of Phe566. Three 
residues Ala439, Ala515 and Asn643 were found in the generously allowed region of the 
Ramachandran plot. Ala439 is in the center of a loop located in between two α-helices 
(α-helix 19 and 20, Figure 3.16B) in the B-domain part of the catalytic domain (27). 
The β-turn in the loop is sustained by the hydrogen bond between the main-chain 
nitrogen of Ala439 and the main-chain carbonyl oxygen of Asn436. Ala515 is placed just 
borderline to an additional allowed region in the ϕ/ψ plot. The Ala515 is placed in the 
loop region, which also contains the general acid, Glu510 and Trp512 (subsite +2, see 
below for detailed description). The exact position of this loop exposes Phe514 towards 
subsite +2. It is influenced by hydrogen bonds between Asp513 Oδ1 - Asn525 Nδ2, 
Asp513 Oδ2 - Ala N, Glu516 Oε1 - Ser437 Oγ, Glu516 Oε2 - Asn442 Nδd and the salt bridge 
Glu516 Oε2 - Arg427 Nη1. The strained ϕ and ψ angles of Asn643, which is positioned 
next to the third acid in the catalytic site, is a product of an Asn643 N - Arg697 O 
hydrogen bond but also the direct interactions of the side-chain with the β-CD glucose 
ring in subsite +1 could have an effect. 
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Figure 3.15. Co-crystallization of LD and β-CD. (A) Crystals obtained with seeding diffracted to 2.6 Å 
and belonged to space group P212121. (B) Crystals obtained without seeding diffracted to 2.1 Å and 
belonged to space group C2. For crystallization condition see section 2.7.2. 
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Table 3.8. Data collection and refinement statistics   
 HvLD·β-CD HvLD·α-CD 
Data collection    
  Space group C2 C2                   
  Cell dimensions   
  a, b, c (Å) 175.0, 82.4, 59.4 174.8, 85.6, 61.1    
  α, β, γ (º)  90.0,  96.1,  90.0 90.0, 96.8, 90.0 
  Molecules/asymmetric unit 1 1 
  Wavelength 0.873 0.910 
  Resolution (Å) 41.2–2.10 33.5–2.50 
  Rsym (%) 12.8 (45.8)a 9.3 (42.6) 
  Mean(I)/σ(mean(I)) 11.4 (4.2)a 13.1 (2.3) 
  Completeness (%) 99.6 (99.2)a 97.0 (87)  
  Unique reflections 47764 (7091)a 12135 (3528) 
  Redundancy 4.3 (4.3)a 3.7 (3.1) 
  Wilson B-factorb (Å2) 15.6 50.1 
Refinement   
  Resolution (Å) 41.2–2.10 33.5–2.5 
  Used reflections 48242 30653 
  Rcryst/Rfree (%) 16.4/20.4 17.7/22.6 
  Final Rcryst 15.7 17.3 
  No. protein atoms 6709 6714 
  No. calcium ions 2 2 
  No. iodine  5 9 
  No. of glycerol 7 1 
  No. of cyclodextrin 1 1 
  No. of waters 604 223 
  Mean B-factor (Å2) 12.2 35.1 
R.m.s.d. values from ideal   
  Bond lengths (Å) 0.003 0.003 
  Bond angels (º) 0.742 0.658 
Ramachandran plotc   
  Most favorable (%) 89.0 88.4 
  Additional allowed (%) 10.5 11.2 
  Generously allowed (%) 0.4 0.3 
  Disallowed (%) 0.1 0.1 
aHighest resolution bin. bFrom Truncate (88). cCalculated with Procheck (94). 
 
 
3.4.3 Overall Structure 
 
The final model of HvLD in complex with β-CD is shown in Figure 3.16. The 
domain boarders, indicated by sequence alignment with structurally related proteins 
(27), are slightly displaced relative to those seen from the HvLD structure. The structure 
comprises four structural domains; the N-domain (reidues 3–124) of unknown function, 
a carbohydrate binding module (125–230) assigned to CBM48 of which a few members 
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have been demonstrated to bind to glycogen (30), the catalytic domain (231–774), and 
the C-domain (775–885) of unknown function. The N-domain consists of 8 strands (b1–
b8) arranged primarily in an anti-parallel fashion and 4 α-helices (a1–a4), whereas the 
CBM48 consists of 9 strands (b9–b17) and 2 α-helices (a5–a6) (Figure 3.16B). The 
catalytic domain contains 33 α-helices and 12 β-strands. The core of the domain forms a 
(β/α)8-like barrel (Table 3.9), which resembles the corresponding barrel in α-amylases 
(29, 109) except the LD barrel has no helix α5. Instead, a loop between β5 and β6 holds 
Trp512 and embed subsite +2. As observed in the KpPUL structure (31) and previously 
described as Loop 2 (27, 31, 110), a long loop protrudes from the barrel scaffold 
following the second β-strand. Loop 2 includes Tyr357 and is part of the active site at 
subsite –1 (see below for detailed description of the active site). The B-domain is a part 
of the active site cleft accommodating the side-chain of branched oligosaccharides as 
identified by superimposition of the LD and the KpPUL:maltotetraose (G4) complex. 
Finally, the C-domain comprises a β-sandwich structure, in which each of the two 
sheets in the sandwich contains 4 β-strands flanked by short stretches of α-helices (4 in 
total). 
Two Ca2+ sites were found in the structures of LD in complex with α-CD and β-CD 
(Figure 3.17). The first site is located in Loop 2 close to subsite –1 and Tyr357. This Ca2+ 
site is identical to one of the five Ca2+ binding sites identified in KpPUL (31). The Ca2+ 
site has pentagonal bipyramidal geometry, with Ca2+ ligated by the side-chains oxygen 
atoms of Asp351 (Oδ1) and Asn701 (Oδ1), the main-chain carbonyl oxygens of Gln348 and 
Tyr353 and three, water molecules (Figure 3.17A). The average Ca2+-O distance is 2.6 Å. 
The second LD Ca2+ site has an octahedral geometry. The Ca2+ ligands are the side-
chain oxygen of Ser297 Oγ, the main-chain carbonyl groups of Gly393, Leu301 and Ser297 
and two water molecules. This site is located in the catalytic domain and connects the 
loops extending from the C-terminal ends of β-strand 2 and 3 (Figure 3.17B). The 
average Ca2+-O distance is 2.7 Å. One negatively charged residue contributes to metal 
binding in site 1, while no negative charge contributes to metal binding in site 2. 
 
Table 3.9. Secondary structure elements of the (β/α)8 barrel 
Structure element of the 
(β/α)-barrel 
Sequence 
β1 (b18) 256-TIYEL-259 
α1 (a13) 288-AGMEHLRKLSDA-299 
β2 (b19) 303-HVHL-306 
α2 (a18) 377-SRIIEYRQMVQALNR-391 
β3 (b22) 395-RVVMDV-400 
α3 (a20) 448-FMVDRLIVDDLLNWAVN-464 
β4 (b23) 469-GFRF-472 
α4 (a22) 480-KRTMMRAKSLQ-491 
β5 (b24) 506-YLYG-509 
α5 absent in structure 
β6 (b25) 537-GSFN-540 
α6 (a27) 577-EADTRRSLATYADQIQIGL-595 
β7 (b28) 634-TIN-636 
α7 (a30) 660-VDERCRINHLASMMAL-675 
β8 (b29) 680-IPFFH-684 
α8 (a37) 748-KGHILAALDSFVDILKIR-765 
Numbers in parenthesis refers to the position of the structural elements in 
the topology diagram in Figure 3.16B. 
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Figure 3.16. (A) overall structure of LD:β-CD  and the same structure rotated 90°. N-domain in red, 
CBM48 in yellow, catalytic domain in light gray and C-domain in light cyan. Ca2+ in purple, I+ in orange, 
glycerol in blue and β-CD in green. The catalytic residues, Asp473, Glu510, and Asp642 are shown in dark 
gray. (B) topology diagram of LD. α-helices are shown as cylinders in dark gray and labelled a and β-
strands are shown as arrows in light gray and labelled b. 
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Figure 3.17. The models around the two calcium sites. A, the first Ca2+ site (Ca1) has a pentagonal 
bipyramidal geometry. B, the second LD Ca2+ site (Ca2) displays an octahedral geometry. The calcium 
ion is shown in gray, water molecules in red and ligand side-chains in green with residue numbers in dark 
gray. Polar interactions are shown with dashed lines and the distance between the calcium ion and the 
ligand atom is shown. 
 
3.4.4 Active site of LD and Binding of Cylodextrins 
 
The active site is defined by the positions of the catalytic residues, i.e. the catalytic 
nucleophile Asp473, the general acid/base catalyst Glu510 and the third catalytic site acid, 
Asp642, as determined by sequence alignment (12, 28) (Figure 3.16). The α- and β-CDs 
are bound at this site (Figure 3.18B). Designation of the substrate-binding subsite 
numbering is in accord with previously introduced definitions (31, 111). Subsites at the 
reducing end of the substrate are numbered with positive numbers starting from the 
point of hydrolysis, and  subsites at the non-reducing end have negative numbers (111). 
The active site of LD is composed of two binding sites; the first (the branch binding 
side) being defined by subsites –1 through –2 and the second site (the main-chain site) 
is defined by subsite +2 through 0’ (Figure 3.18A). Due to different structural restraints 
imposed by the ring of α- and β-CD, they bind differently to LD (Figure 3.18B). 
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Figure 3.18. Superimposition of LD:β-CD onto pullulanase:maltotetraose (G4) complex. β-CD is 
coloured in light gray, LD Phe553 in dark gray, glycerol 303 in green, and water molecules in the active 
site of LD in red.  The glycerol and water 2Fo–Fc maps at 1.0σ are shown as gray mesh. The G4 
molecules of the pullulanase:G4 complex are drawn in blue (representing the sugar main-chain) and light 
blue (representing the branched sugar chain). B, Superimposition of LD:β-CD on LD:α-CD complex. β-
CD and α-CD are colored in light gray and cyan, respectively, LD active site residues in dark gray. The 
catalytic residues, Asp473, Glu510, and Asp642 are shown in orange. The subsite numbers and residue 
numbers are black and gray, respectively. 
 
Several amino acid residues of LD are involved in interactions with β-CD (Figure 
3.19 and Figure 3.20), which has the strongest affinity towards LD of the two (β-CD: Kd 
= 0.7 µM, α-CD: Kd = 27.2 µM, section 3.1.7)  (70). The majority of β-CD-protein 
interactions occur at subsite +2. Asp541 Oδ2 is in hydrogen bond contact with Glc O2, 
Arg544 Nη2 interacts with Glc O2, and Nη1 interacts with Glc O3. The position of 
Arg544 is further stabilized by a hydrogen bond between Nη1 of Arg544 and the hydroxyl 
group of Tyr637. Finally, the indole ring of Trp512 stacks with the Glc at subsite +2. The 
Nε1 of Trp512 interacts with the general acid/base Glu510 Oε2, which stabilizes the 
position of this pivotal residue. At subsite +1, Asn643 Nδ2 interacts with O3 of Glc. 
Furthermore, Asn643 Oδ1 interacts via a water molecule with O2 and O3 of Glc at 
subsite 0’ (Fig. 3B; Fig. 4). In addition, van der Waals interactions between Arg697 and 
Glc at subsite 0’ are observed. Binding at this site could be stabilized by water mediated 
contacts to Arg697 O and Asp698 Oδ1. Finally, the aromatic ring of Phe553 is immersed in 
the central cavity of the β-CD molecule with van der Waals interactions or possibly 
weak aromatic hydrogen bonds (C(-H)..O distance = 3.3 Å–3.9 Å) to O4 of several Glc 
subunits of the β-CD molecule (Figure 3.20). The Phe553 Cζ is situated in the plane 
defined by the β-CD Glc residues, with an approximate inclination between this plane 
and the plane of the Phe553 aromatic ring of 20°. Furthermore, the main-chain carbonyl 
oxygen of Phe553 interacts via a water molecule with O3 of Glc of β-CD opposite 
subsite –1. By comparing the α-CD and the β-CD complexes it is suggested that the 40-
fold weaker binding of α-CD to LD (70) may be caused by the lack of interaction 
between Arg697 and two Glc residues both directly or via water mediated contact (Figure 
3.18B), the lack of an interaction between Nδ2 of Asn643 and an O3 as well as the 
missing interaction between Oδ1 and an O3 atom at subsite +1, the absence of the 
hydrogen bond between Asn551 and the glucose residue of β-CD at subsite +4 and a less 
favorable interaction with Phe553. The α-CD plane is ~1 Å below the Phe553 Cζ atom and 
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the inclination between the aromatic ring plane and the α-CD Glc residues is close to 
45°, which might give rise to loss of the hydrogen bond character of the interaction. 
Both CDs have some less well-defined Glc residues (subsites 0’ and –1’) with weighted 
2Fo–Fc less than 1.0σ, and despite the fact that these are within interaction range of LD 
(Fig. 3C) they cannot be major contributors to binding energy. 
 
 
Figure 3.19. Schematic drawing of the LD residues interacting with β-CD. The figure was based on a 
cartoon generated by the program LIGPLOT (112). Both CDs have some less well-defined Glc residues 
(subsites 0’ and –1’) with weighted 2Fo–Fc less than 1.0σ. 
 
Glycerol used in the crystallization buffer (LD:β-CD) and in the cryo-protectant 
was found in the active site of LD:β-CD (Figure 3.20). The binding of glycerol (Gol) in 
the active site of carbohydrate active enzymes during co-crystallization is a well known 
phenomenon (113, 114). Arg471 interacts with Gol302 in the active site of LD. Also the 
three catalytic residues interact with Gol302, while the second glycerol molecule found at 
the active site (Gol303) have hydrogen bonds directly to Asp473 Oδ1/Oδ2 and water 
mediated hydrogen bonds to Glu510 Oε1/Oε2. Moreover, Gol303 is at a distance of 4.2 Å 
of Tyr357. Superimposition of LD:β-CD and the KpPUL:matotetraose (G4) complex 
(31) shows that the two Gol303 primary hydroxyl groups superimpose perfectly with O6 
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and O5 of the Glc residue at subsite −1 and that the secondary alcohol is found in close 
proximity to O4 of the same Glc residue. In addition, three water molecules in the LD 
structure are located at the sites of O1, O2 and O3 of the same glucose residue at subsite 
–1 of KpPUL (Figure 3.18A). Additional five glycerol molecules (Gol301 and Gol304–
Gol307) were found in the LD:β-CD structure (Figure 3.16A). One (Gol306) is buried in a 
part of Loop 2 and the rest were solvent exposed. Two were situated on the surface 
interacting directly or via water molecules with LD, whereas one was found in the 
groove formed at the interface of the CBM48 domain and the catalytic domain. The last 
glycerol molecule was in a solvent channel between the N-domain and the CBM48. 
Possibly because glycerol was not included in the crystallization conditions for LD:α-
CD but only used as cryoprotectant, only one glycerol molecule was found in the LD:α-
CD structure. The Gol molecule was buried in Loop 2 similarly to Gol306 found in the 
LD:β-CD complex. 
 
 
 
Figure 3.20. β-CD and glycerol bound in the active site of LD shown with (A) or without (B) the 2Fo–Fc 
maps. The 2Fo–Fc at 1.0σ and 0.6σ are shown as blue and green mesh, respectively. β-CD is coloured in 
light gray, glycerol in green, LD active site residues in dark gray. The catalytic residues, Asp473, Glu510, 
and Asp642 are shown in orange. The subsite numbers and residue numbers are black and gray, 
respectively. 
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4 Discussion 
 
4.1 Limit Dextrinase 
  
4.1.1 Cloning and Expression of LD 
 
Previous attempts to produce recombinant LDs from plants resulted in extremely 
poor yields (22, 23) and very low specific activity highlighting (24) the difficulties in 
producing large multidomain recombinant plant proteins. Earlier attempts to produce 
barley LD thus resulted in full-length and truncated inactive forms (41). A new attempt 
was made to produce LD in E. coli due to the findings of several mutations in the clone 
used in the previous attempts, which was then corrected to wt-LD sequence. The 
selected production strain for the intracellular production of LD contained an extra 
plasmid harbouring the genes encoding the tRNA for the seven rare codons. However, 
expression of the new LD construct did not lead to the production of active full-length 
LD, which once again emphasises the challenge in producing large multidomain plant 
proteins in a bacterial expression system. The P. pastoris system has been proved to be 
an excellent host for production of plant proteins (26, 99, 115). This system also showed 
to be efficient in the heterologous production of barley LD. Optimization of a fed-batch 
protocol in a 5-L bioreactor thus resulted in 16 mg/L highly active recombinant LD 
secreted to the culture supernatant indicating accumulation of functional and stable 
recombinant LD under the applied culture conditions (Figure 3.1). Lowering the 
induction temperature to 22−25 °C has been reported to increase amounts of secreted 
heterologous protein (116-118). This was confirmed by pilot scale expression of LD at 
22 °C resulting in more than 10 times higher yield than at 30 °C. This is assumed to be 
due to enhanced LD folding and/or reduced protease activity in the medium (116, 119), 
since LD was previously reported to be fully stable at 30 °C (66).  
The functional recombinant barley LD achieved in excellent yields and outstanding 
quality enabled biochemical and structural characterization of this pivotal enzyme in 
cereal starch metabolism and in food processing, in particular in the brewing and 
malting industry (120, 121). 
 
4.1.2 Characterisation of LD 
 
4.1.2.1 Hydrolytic Activity 
As indicated by the purification summary (Table 3.1) a low specific activity was 
observed in the β-CD-Sepharose eluate. The approximately 2-fold increase in activity in 
the gel filtration eluate is not believed to be solely due to removal of contaminant 
species as judged by the SDS-PAGE (Figure 3.2), but was probably due to residual β-
CD, which was efficiently removed by gel filtration, resulting in a final specific activity 
of 14.2 U/mg or approximately twice the value measured for LD purified from barley 
malt (47). The high specific activity was also reflected by the kinetic constants kcat,app= 
78 s–1 and Km,app= 0.16 mg/mL. Previously, Km and kcat values for barley malt LD 
hydrolysing pullulan at pH 5.0 and 40 °C were reported in the ranges 0.16−0.44 mg/mL 
and 33−60 s–1, respectively (37, 122), and giving 2.4−3.5 fold lower catalytic efficiency 
  Discussion 
______________________________________________________________________ 
 
 
______________________________________________________________________ 
55 
 
than the present recombinant LD. In comparison reported Km and kcat values of 
pullulanases from Klebsiella planticola and BaPUL were 0.09 mg/mL and 81 s–1, and 
0.24 mg/mL and 120 s–1, respectively (122).  
The deviation from the hyperbolic fit of the kinetic data at pullulan concentrations 
above 0.2 mg/mL (Figure 3.3) has not previously been described for barley LD. This 
behavior may reflect transglycosylation reactions even though the initial rate kinetics 
towards pullulan models an uncompetitive substrate inhibition. Transfer of fluorescently 
labeled maltotriose onto newly hydrolysed pullulan (42) provides evidence for barley 
LD catalysed transglycosylation and transglycosylation was also reported for rice LD 
using pullulan as substrate (43). Although the in vivo function of LD is mostly 
considered in starch debranching, the present findings motivate further kinetic and 
structural analysis to elucidate features that contribute to the transglycosylation activity 
and the suggested role in starch biosynthesis. 
 
4.1.2.2 Transglycosylation  
The transfer of α-maltosyl fluoride to maltose at lower LD concentrations (25 nM) 
resulted in the formation of only one conformation from α-maltosyl of each substituted 
product, with a specific position of the branch point, indicated by a single uniform spot 
on the TLC (data not shown). Based on previous results (41) it is assumed that the α-
maltosyl fluoride is transferred to the non-reducing end of the acceptor. However, a 
50% increase in LD concentration (37.5 nM) had a significant influence on the 
transglycosylation reaction pattern resulting in transfer of α-maltosyl fluoride to either 
the  reducing or non-reducing end of the of the acceptor maltose. The formation of 
products with different α-1,6 branch points was indicated by the close migration of two 
spots on the TLC. The strong interaction at subsite +2 mediated by hydrophobic 
stacking and hydrogen bonds (see section 3.4.4 and 4.3.4 for detailed description of the 
substrate subsites) presumably contributes to the majority of the branch points being at 
the non-reducing end. Pullulanase from Aerobactor aerogenes has also been shown to 
transfer maltose to the reducing end of a maltose acceptor resulting in 14% of the 
products containing the α-1,6 linkage at the reducing glucose unit which results an 
isomaltose based structure (40). Since isomalto-oligosaccharides are believed to have 
prebiotic affect (123, 124) the oligosaccharide obtained from the LD catalysed 
transglycosylation with an isomaltose-like structure may also be a prebiotic candidate. 
The activated G2F functions as a significantly better glycosyl donor than does the 
transglycosylation product (G2–α-1,6–G4), which allows accumulation of the 
transglycosylation product (Figure 3.4A). However, this was not the case using G3F as 
donor indicated by the much slower conversion to G4 and fast hydrolysis of the 
transglycosylation product (Figure 3.4B), which may be due to the formed 
transglycosylation product being a better glycosyl donor than G3F. This would explain 
the observed difference in the ability to function as an activated substrate donor between 
G2F and G3F. 
Use of maltotetraose as acceptor can lead to four theoretical possible structures 
with one maltose substituted to either one of the four glucose residues. TLC data, 
however, indicates that only one of these products is formed by the appearance of a 
single spot for the G2–α-1,6–G4 product. This may suggest a preferred position of the 
G4 binding at the aglycone site. Structural analyses of this product will help elucidating 
the subsites of the LD active site. However, one might speculate based on the 
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protein:ligand interaction observed in the LD:β-CD and the KpPUL:G4 structures, that 
maltotetraose will bind at subsite +2 to 1’ resulting in the formation of a α-1,6 bond at 
the second glucose residue from the reducing end. Furthermore, the results from the 
transglycosylation with different lengths of donor and acceptor clearly shows that 
longer sugar chains, both side- and main-chain, are preferred for hydrolysis. These 
results are in agreement with previous analysis of the hydrolytic specificity of LD 
towards branched oligosaccharides (11, 41). Based on these preliminary result future 
experiments analysing the initial rate of transglycosylation will reveal more about the 
preferred length of donor and acceptor. 
The inhibition of LD by 4-O-α-D-glucopyranosylmoranoline (G1M) indicates 
binding in the active site. G1M, a disaccharide derivative of the very potent glycosidase 
inhibitor 1-deoxynojirimycin (DNJ) comprises an endocyclic nitrogen insted of the 
oxygen pyranosidic atom (Figure 4.1A). The inhibition ability of G1M and other 
iminosugars is believed to be caused by mimicking both the conformation and the 
charge of the oxocarbonium ion intermediate (125), which involves binding of G1M at 
subsite –1 to –2 of the active site. Barley β-amylase crystals soaked with G1M refined 
to 1.8 Å confirmed the position of G1M (Rejzek & Field, manuscript in prep). 
However, the formation of transglycosylation products from the transfer of G2F to G1M 
suggests that G1M also binds at subsite +1 to +2 of LD. Based on the previous results 
with transfer of G2F to maltose, is most likely that the transfer of G2F to G1M occurs 
on the glucopyranose ring, which is assumed to be positioned at subsite +1.   
The glucosidase inhibitor acarbose (Figure 4.1B) showed also to be an acceptor for 
transglycosylation resulting in both mono- and disubstitution. Crystal structures of 
acarbose in complex with various glycosidases, glycogen debranching enzyme TreX 
from Sulfolobus solfatarius (126), α-amylase from Bacillus halmapalus (127), and β-
amylase from barley (Rejzek & Field, manuscript in prep), show that acarbose binds 
differently to the active site of all enzymes making it impossible to predict the mode of 
binding to LD. Isolation and structural analysis of the product is therefore needed in 
order to determine the position of the newly formed α-1,6 branch point. 
 
Figure 4.1. Structures of the glycoside hydrolases inhibitors G1M (4-O-α-D-glucopyranosylmoranoline 
(A) and acarbose (B). 
The transglycosylation products from the transfer of G2 to G1M and acarbose by 
LD could be potential inhibitors with altered inhibitory activity towards glycoside 
hydrolases compared with the parent inhibitor (G1M or acarbose). Optimization of the 
transglycosylation reactions using G1M and acarbose as acceptors is, however, needed 
in order to increase the yield of the product. Changing the ratio of donor:acceptor may 
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prevent the polymerisation of maltose and thereby increase the yield of the preferred 
product. Doing so, one should be aware of the inhibitory affect of G1M. A solution 
could be to mutate the catalytic nucleophile to e.g. an alanine, which will change the LD 
from being a hydrolase to a potential α-glycosynthase (128). The mutation of the 
catalytic nucleophile is changing the enzyme from being a retaining to an inverting 
enzyme, since the reaction would require the use of β-maltosyl fluoride as donor (128). 
A LD nucleophile mutant would also be useful in increasing the yield of the 
transglycosylation product from the transfer of maltotriosyl to maltotetraose which is 
readily hydrolysed.   
α- and β-CD are extremely good acceptors for transglycosylation reaction catalysed 
by LD presumably owing to the high affinity of α- and β-CD towards LD (Table 3.3). 
Binding of the CD to the active site does not seem to prevent the binding of α-maltosyl 
fluoride at subsite –1 and –2, which would then leave the CD in a favourable position 
for an attack of the glycosyl intermediate. Surprisingly the cleavage of the formed β-CD 
product does not seem to be inhibited by the relatively high β-CD concentration, 
resulting in only a minor product accumulation. However, MS data showed the masses 
corresponding to mono-, di,- tri- and to tetra-substituted β-CD. Structural analysis of the 
formed products will eventually reveal if the G2s are positioned on the CD ring and/or 
if a polymerisation occurs of the maltosyl-β-CD. Synthesis of multiple substituted 
products (dimaltosyl-β-CD and trimaltosyl-β-CD) by KpPUL catalysed 
transglycosylation has previously been shown (44, 129) suggesting that the β-CD ring 
indeed contains multiple substitutions.  
The lower transfer rate as judged by comparison of the developed TLC plates from 
the G2 transglycosylation of α-CD and β-CD (data not shown) and the clear 
accumulation of G2–α-1,6–α-CD substituted products (Figure 3.5) indicates that the 
position of α-CD in the active site is not optimal for synthesis and in particular cleavage 
of the α-1,6 linkage. The restrain of the α-CD ring contribute to a presumed weaker 
binding at subsite 0’-1’ compared with β-CD (see section 3.4.4 and 4.3.4) and an 
unfavourable position of the C6 hydroxyl group, which is essential for the formation of 
the α-1,6 linkage. It is believed as with β-CD that the LD catalysed transglycosylation 
of α-CD results in multiple substitutions of the ring (44). 
The ability of cyclodextrins to form inclusion complexes in the cavities is well 
known (130). Furthermore, branched CDs which have a water solubility 50–100 times 
greater than that of unsubstituted CDs have also the potential to function as drug 
carriers for target delivery systems (130). Therefore multiple substituted CD obtained 
by LD catalysed transglycosylation reaction will not only have great potential in the 
application as drug carrier, but also as food ingredients (131).  
 
4.1.2.3 Cyclodextrin Affinity 
Comparison of the affinity of α-, β- and γ-CD to KpPUL showed strong binding of 
β-CD driven both by hydrogen bond formation and by hydrophobic contacts as 
indicated by a favourable entropic change upon β-CD binding (101). The affinity of β-
CD for LD and the bacterial pullulanase is in the same range. Remarkably, however 
affinity of the KpPUL for α- and γ-CD (Kd = 100 and 102 µM, respectively) was 4 and 3 
times lower than of the barley enzyme (Table 3.3), suggesting that the LD binding site 
differs significantly from the KpPUL active site, which allows optimized interaction 
with the ligands.  The strong binding of α- and β-CD to LD is in part caused by 
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aromatic stacking in the active site cleft as described in section 3.4.4 and discussed 
further in section 4.3.4. β-CD is by far the preferred ligand, thus underscoring the 
resemblance between the conformations of β-CD and α-glucan helices present in starch 
(7). 
 
 
4.2 Limit Dextrinase Inhibitor 
 
Proteinaceous inhibitors of α-amylases are known to play an important role in plant 
defense against pathogens and pests and in the control of endogenous α-amylase activity 
(50, 58, 132-134). LDI is the sole example of an endogenous inhibitor of a debranching 
enzyme, which is believed to be relevant both for starch biosynthesis and degradation, 
and in brewing technology (48, 66, 75). Despite this importance the LD/LDI interaction, 
however, remains to be described in details. The established expression system for LDI, 
and expression of the target enzyme LD together forms the basis for thorough 
investigations of the LD/LDI complex formation. 
 
4.2.1 Cloning and Expression of LDI 
 
Several different LDI constructs has been expressed in different host systems such 
as Lactococuccus lactis, E. coli, and P. pastoris in previous attempts to produces LDI 
recombinantly (135). These, however, resulted in either no expression of LDI or more 
than 50-fold reduction in inhibitory activity compared with LDI isolated from barley 
kernels (135). The unsuccessful expression of active LDI using the intein based 
construct in E coli once again emphasises the challenge in producing LDI 
recombinantly. However, the use of P. pastoris resulted in the production of 
recombinant LDI with high inhibitory activity. The decrease in cell wet-weight during 
the methanol phase suggests that over-expression of LDI is toxic for the host which 
might be due to inhibition of yeast glycoside hydrolase(s). A well known disadvantage 
in the use of P. pastoris as host for heterologous expression of proteins is the presents of 
secreted proteases in the expression media (136). The activity of P. pastoris produced 
proteases is believed to cause the heterogeneous population of LDI, which lowers the 
yield of purified homogeneous LDI. 
 
4.2.2 LD Inhibition by wt-LDI  
 
Since it was shown previously that the cereal-type α-amylase inhibitors (CM-
proteins) inhibit their target enzyme by binding to the catalytic site competitive 
inhibition was also assumed for LD by LDI (51, 54, 55, 59, 60). However, this was not 
observed for the LDI inhibition of LD (data not shown), as the Hanes-Woolf plot slopes 
obtained at 0 or 2 nM were not parallel. Instead a 33% deviation between the slopes was 
observed indicating that the mode of inhibition is only partially competitive, when using 
pullulan as substrate. This behaviour is in agreement with that of other cereal-type 
inhibitors when using larger and more complex substrates for analysis of enzyme 
activities (56, 58). In the case of RATI, the inhibition mode thus shifted from 
competitive when using p-nitrophenyl α-D-maltoside to complex inhibition, when larger 
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oligosaccharide α-maltosideheptaoside (DP7) or α-maltodextrin of DP27 were used as 
substrates(58). Data obtained for inhibition using these substrates agreed both with a 
partial competitive and a partial mixed type inhibition mechanism. Complete inhibition 
of PPA was also not achieved in the presence of any of the larger substrates (DP7 and 
DP27), even at 50–100-fold molar excess of RATI (58). Furthermore, the extent of 
inhibition changed significantly with substrate concentration (56, 58), which was 
explained by RATI binding to the substrate (56). When correcting the RATI 
concentration by subtracting the estimated amount of inhibitor bound to substrate 
(DP27), the inhibition was found to be competitive with Ki = 0.1 nM (56). It is possible 
the deviation from the 1:1 molar stoichiometry of LDI:LD observed in (Figure 3.10B) is 
due to the binding of LDI to pullulan (DP ~ 300). 
As demonstrated in section 3.1.5 the kinetics of hydrolysis of pullulan by LD is 
modelled by Michaelis-Menten kinetics with substrate inhibition, which may be due to 
genuine substrate inhibition or an intrinsically high transglycosylation activity. Either 
way, it is highly likely that this high substrate affinity exerts a significant influence on 
the binding of LDI to LD. As a consequence the apparent Ki value (1.7 nM) obtained by 
fitting the competitive model to the data is expected to be higher than the actual Ki 
value. Deviation from the 1:1 molar ratio for obtaining complete inhibition seems to be 
shared by several plant inhibitors (58, 60, 137). Barley α-amylase/subtilisin inhibitor 
(BASI), a strong inhibitor of barley α-amylase 2 (Ki = 77 nM, KD = 25 nM) belonging to 
the Kunitz inhibitor type forms 1:1 complex, as shown by the crystal structure of the 
complex (138). Still at a 1:1 molar inhibition was only approximately 60% using Blue 
Starch as substrate (137).  
 
4.2.3 Homology Modelling of LDI 
 
The N-terminal of the LDI model was found to be disordered and assumed to be 
very flexible. In the case of the wheat inhibitor 0.19 no electron density was present for 
residues 1–4 indicating multiple conformations and therefore highly flexible (108) and 
in the native structure of RATI the N-terminal was described as a “wagging tail” (102). 
Upon binding to the target enzyme TMA the N-terminal of the wheat homolog 0.28 
became well defined (55). A similar observation was noted for the five flexible N-
terminal residues of RATI, which in the complex with TMA adopt a 310-helical 
conformation that spans the substrate binding site of TMA (59). Assuming a similar 
mode of binding, the terminal part of LDI may be similarly ordered upon binding to LD. 
Furthermore, the open architecture of the active cleft of LD (139) compared with TMA 
seems to be able to accommodate the three extra N-terminal residues specific for LDI. 
N-terminal elongations or insertions of wheat inhibitor 0.28 either diminished or 
abolished the inhibition (140). For N-terminal 0.28 mutants, which retained inhibitory 
activity though decreased, a four-fold longer preincubation time was required to reach 
the maximum inhibition level, suggesting that the N-terminal might only play a role 
upon binding and is not crucial for stabilizing the inhibitor-enzyme complex (140). This 
is in agreement with the findings for the N-terminal truncated mutants of LDI, where 
the deletion of three and five residues only seems to have a modest effect on the kon, of 
complex formation.  
The interaction with the catalytic residues and the importance of a free N-terminal 
α-amino group was apparent not only from the crystal structure of the TMA/RATI, but 
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also by mutational analysis of catalytic residues of α-amylase from Bacillus subtilis 
(60). Changing the catalytic acids of α-amylase to their corresponding amides resulted 
in a substantial loss in the inhibitor binding (60). One could speculate that the ε-amino 
group of Lys6 in LDI could play a similar role in the interaction with the catalytic 
residues as seen for the α-amino group of Ser1 (RATI) (59).This positively charged 
residue (Lys6) is unique for the LDI inhibitor (Figure 3.13A). 
The conserved structural arrangement surrounding Arg58 seems to be fundamental 
for the change from α-helix 2 to α-helix 3 as well as being important for the exposure of 
residue 56, a histidine in case of LDI, but either a tyrosine or a tryptophan in other 
inhibitors (Figure 3.13A).  In the structure of TMA/RATI, the His56 equivalent, Tyr54 
has hydrophobic interactions with Val2 (RATI), Trp56 and Trp57 in TMA (59). The 
equivalent Tyr53 in wheat inhibitor 0.28 was also seen to interact with residues in TMA 
(55). It is therefore likely that His56 is involved in the interaction between LD and LDI. 
The interaction could be caused by π-stacking of His56 to tyrosine and/or tryptophan 
residues (Tyr352 and Trp354 in LD), which are by superimposition of LD on to TMA 
found in similar positions as Trp56 and Trp57 (TMA). This π-stacking may be disrupted 
by protonation of the His56 side-chain and weaken binding to LD in agreement with 
SPR data at slightly acidic pH (Table 3.5). 
The second binding segment of TMA/RATI comprises two flexible loops, L3 and 
L4, interacting with a protruding loop in TMA (residue 132–149). The lack of this loop 
in the LD results in a groove-like structure of the surface, thereby making the distance 
between LD and LDI too large for direct interaction when superimposing LD and LDI 
onto the TMA/RATI complex. 
 
4.2.4 SPR Analysis of Binding of LDI and LDI Mutants to LD  
 
SPR biosensors, when properly utilized, can be very powerful, sensitive biophysical 
tools for analysing the binding kinetics and energetics of the interaction between 
biomolecules, requiring small amounts of proteins. The experimental set up developed 
in the present study, resulted in high quality data as judged by the signal to noise ration 
and by the residual falling mostly within 5%. This study gives valuable insight on the 
driving force of interaction between LD and LDI. The high affinity of the LD/LDI 
complex was mainly due to a very low off-rate koff = 5 × 10-5 s-1 whereas the kon = 1 × 
106 M-1 s-1 (in 10 mM Mes/NaOH pH 6.0, 150 mM NaCl, 25 °C) was in the standard 
range for a typical protein-protein interaction (103, 104). The general dependency on 
ionic strength was determined at different NaCl concentrations (Table 3.4). An increase 
in ionic strength only affected the affinity to a minor extent primarily due less than 2-
fold change in kon. The koff, however, was virtually insensitive to ionic strength, 
indicating that long-range electrostatic forces only play a minor role in the interaction 
between LD and LDI (141). This suggests that any formed salt bridges are likely to be 
shielded in the formed complex.    
The optimum pH (pH 6.5) of the interaction is in good agreement with the 
physiological slightly acidic to neutral pH prevalent in the endosperm of the mature 
seed, which is shown to acidify during germination (105, 106), and the increase in KD of 
12–15 fold at both lower and higher pH values showed that KD was dependent on pH. 
This is in agreement with the pH optimum for enzyme inhibition found for LDI (62). KD 
of LD/LDI interaction dependency on pH (Table 3.5), may reflect alteration of protein 
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surface charge patterns. Above the role of protonation of His56 was discussed and 
similarly introduction of negative charges or loss of positive charges (perhaps at Lys6) 
can interfere with the hydrophobic interaction and decrease the stability of the complex. 
The binding affinity of the LD and LDI varied with the temperature allowing 
calculation of the van’t Hoff thermodynamic parameters. The favourable entropy 
obtained both in the linear and non-linear van’t Hoff analysis suggests that formation of 
LD/LDI increases the area of buried apolar surface, supported also by lack of detectable 
binding at low ionic strength even when using 20-fold higher LD concentration (Table 
3.4).  Although the size of the determined heat capacity estimated from the non-linear 
van’t Hoff analysis is remarkably large, the significant decrease in heat capacity is 
consistent with an increase in the area of buried hydrophobic surface (142). The 
thermodynamic analysis of the interaction between PPA and the wheat inhibitor 0.19 
showed an increase in entropy, again suggesting that hydrophobic interactions plays a 
significant role in the binding (51). This thermodynamic fingerprint with favourable 
enthalpy and entropy has been reported for several protein-protein interaction (142) and 
resembles that determined for the binding of Streptomyces subtilisin inhibitor to 
subtilisin from Bacillus subtilis with ∆G° = –57,9 kJ/mol, ∆H° of –19,8 kJ/mol and 
T∆S° = 38 kJ/mol) (143). The heat capacity, however, calculated for the 
subtilisin/subtilisin inhibitor interaction is ∆Cp° = –1.02 kJ/(K·mol). Values of ∆Cp° for 
protein-protein interaction has be shown in the range of 0.8 to –3.2 kJ/(K·mol) (142) 
with an average value of –1.4 ± 0.8 kJ/(K·mol) placing the calculated ∆Cp° of the 
LD/LDI  interaction on the borderline.  
The literature reports that N-terminal residues of cereal-type inhibitors interact with 
the active site of target enzymes (56, 59, 60, 140). So far, however, only a few α-
amylases have been investigated as targets and as their active site cleft is narrower than 
of debranching enzymes, their inhibition may be more sensitive to changes in the N-
terminal structure of the inhibitor. Deletion from the LDI specific Thr1–Glu3, i.e. the N-
terminus in other inhibitors, and Ser4–Val5 hardly affected KD. Elongation of the N-
terminal sequence of LDI by a charged and a hydrophobic residue (EF-LDI) had no 
effect on kon, but doubled koff for the LD/LDI complex formation. This is presumably 
due to accommodation of these extra residues including a negative charge in the LD 
active site cleft. The finding suggests that the role of the LDI N-terminal segment in 
both formation and stability of the complex with LD is different from that observed 
previously for cereal type α-amylase inhibitors. Molecular recognition of branched 
substrates by debranching enzymes necessitates a wider active site cleft topology 
opened from both the glycone and aglycone sides of the cleft as compared to the deeper 
and narrower active site clefts of α-amylases. It is proposed that these differences in 
active site topology result in different molecular recognition where the affinity and the 
specificity of the interaction is not optimized to rely strongly on the flexible N-terminal 
part of the inhibitor as in the case of α-amylases as evident from the present data. The 
rationale to this difference will have to await the determination of the complex structure 
between LDI and LD. It is tempting to speculate that minimizing the dependence on this 
loop and increasing the proportion of buried apolar surface in the interaction may be 
thermodynamically sound due to the high entropic penalty of fixing this loop in one 
conformation of several possible which can be accommodated by the open cleft of 
debranching enzymes in contrast to the more deep and narrow clefts of α-amylases, 
where the loop may be evolved for optimal chemical and steric fit in the cleft of the 
target enzyme. 
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4.3 3D structure 
 
4.3.1 The Overall Structure  
 
The closest structural relative to LD is KpPUL (PDB code: 2FGZ). The two 
enzymes both belong to GH13 subfamily 13 (6) and have an overall sequence identity 
of 30.2% and a similarity of 45.6% (144). KpPUL could, despite this relatively large 
difference in primary structure, be used as template for molecular replacement. A 
substantial induced-fit motion was observed by the binding of substrate analogous 
(maltose, maltotriose, and maltotetraose) to KpPUL (31). The differences in geometries 
between β-CD and α-CD are not large enough to cause significant structural changes in 
the active site. Is was however, not possible to obtain crystals of LD in the absence of 
an inhibitor, which might be due to a more flexible and/or differently folded +2 subsite 
in the apo-protein, like it was observed for KpPUL.    
The two LD molecules located around the crystallographic two-fold symmetry axis 
have active sites facing each other in the C2 crystals (Figure 4.2), while this is not the 
case in the P212121 crystals. The N-terminal domain, which appears more flexible and 
has poorly defined loops, makes up one half of the molecular interface of the 
crystallographic dimer. A pore (diameter 51.9 Å) separates the active sites of the 
crystallographic dimer. A similar pore, but with a diameter of 65.6 Å was observed in 
KpPUL and speculated to be relevant for the binding of longer polysaccharide 
substrates (31), even though there has been no evidence of KpPUL forming dimers in 
solution. The presence of the extra N-terminal domain in KpPUL explains the larger 
pore diameter. LD has not been reported to form dimers in solution, however, size 
exclusion chromatography on a Hiload Superdex 200 26/60 column (GE Healthcare) 
results in a small LD fraction (less than 1% as judged from the chromatogram)  eluting 
prior the main fraction at a position corresponding to a LD dimer. A similar dimeric 
arrangement of molecules has not been observed for the phylogenetic more distantly 
related BsPUL (GH13_14) and BaPUL (GH13_14). Both BsPUL and KpPUL have 
been reported to display activity towards glycogen (145, 146), whereas LD is not 
hydrolyzing glycogen and have less than ~1% of the pullulan activity level towards 
amylopectin (11). The molecular interactions of the crystallographic dimers of the 
debranching enzyme PaISO (GH13_11) differ from the ones observed in KpPUL and 
LD.  In contrast to LD, PaISO has a preference for larger and more complex polymers 
such as amylopectin and glycogen and their β-limit dextrins, but has no activity towards 
pullulan and only minor activity towards dextrins (38, 147). 
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Figure 4.2. The crystallographic dimer of the LD:
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4.3.3 Ca2+-Sites  
 
The first Ca2+ site (Ca1, Figure 3.17A) is embedded in the enzyme and only 
accessible for solvent via two of the seven ligand sites (solvent exposed surface area is 
1.1 Å2) The ligands coordinating the Ca2+ are located in the long protruding Loop 2, 
which is an important part of the active site and the catalytic domain. The Asn701 ligand 
is positioned next to Tyr700, which interacts with the glucose residue at subsite –2 
(identified by superimposition of LD:β-CD and KpPUL:G4). By connecting Loop 2 
with the core of the catalytic domain and thereby shaping a part of the active site, the 
Ca2+  site is likely to be functionally relevant despite an average Ca2+-O distances of 2.6 
Å (the mean Ca-O distance in proteins is 2.4 Å (150)).  
The second Ca2+ (Figure 3.17B) is more solvent exposed (the solvent exposed 
surface area is 22 Å2) and interacts with ligands from helices α1 and α2 of the (α/β)8-
barrel. The Ca2+ interacts with the protein through only main-chain atoms and the site 
does not resemble any of the known high affinity sites in α-amylses (151). The site has 
even longer average Ca2+-O distances than site 1 (average length 2.7 Å) and therefore 
may be a crystallization artifact rather than a structural relevant site. 
 
4.3.4 (β/α)8-Barrel and Substrate Subsites   
 
The (β/α)8-like barrel of LD has no α-helix 5. This  is also observed in several other 
α-1,6 acting enzymes, e.g. KpPUL (31), PaISO (152) and neopullulanase from Bacillus 
stearothermophilus (153).  These findings suggest that the lack of α5 contributes to the 
α-1,6 specificity of these enzymes, whereas the more conserved β-strands in particular 
the 3, 4, 5 and 7 strands of the barrel and the loops immediately following these strands 
provides a scaffold for the residues involved in catalysis and substrate binding in both 
α-1,4 and α-1,6 acting enzymes. The lack of a fifth helix in the barrel result in a more 
spacious pocket at the reducing end of the substrate binding site, thus it becomes less 
discriminating towards branching in general, but even more important, it positions 
Trp512 for a perfect stacking with Glc at subsite +2 (see below). Despite a high structural 
similarity around the active site there are significant differences between LD and 
KpPUL especially in the loop replacing the fifth helix between β5 and β6. This loop, 
which contains residues Asp513–Asn520 in LD corresponding to residues Asp709–Ser713 in 
KpPUL, differs both in amino acid sequence and in structure. The longer loop in LD 
includes Phe514. This residue seems to narrow the active site cleft around subsites +1 
and +2 by 1–3 Å. The prolonged loop in LD may therefore contribute to the difference 
observed in substrate specificity between the two enzymes (11, 40, 145). 
Met440, which is positioned in a β-turn of the B-domain and is specific for LD 
seems to be essential for the substrate specificity. Superimposition of LD:β-CD onto 
KpPUL:G4 complex shows that Met440 clashes with the Glc residue at subsite –4 and 
that steric hindrance will reduce binding of substrates with a branched chain of G4 or 
longer. It is therefore reasonable to believe that the LDs preferred length of the 
branched-chains is no longer than three glucose units. In the KpPUL structure, this 
particular β-turn is stabilized by a disulfide bridge between Cys643 and Cys644 and by 
interaction between the main-chain carbonyl group of Cys643 and O4 of the Glc residue 
at subsite –3. The position of the main-chain carbonyl group of LD Ala439 is identical to 
that of the KpPUL Cys643 carbonyl, which suggests that Ala439 can be involved in 
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substrate interaction in LD. That interactions at subsite –3 is of importance for substrate 
chain-length preference is in agreement with the observed relative rate of hydrolysis by 
LD of 63-α-maltotriosylmaltotetraose, which is 2-fold higher than that of 63-α-
maltosylmaltotetraose (11). At subsite –2, the sugar-aromatic stacking between Tyr700 
and a Glc residue causes very well-defined binding. Furthermore, the distance between 
Oδ1 and Oδ2 of Asp698 and O2 and O3 of the Glc residue at this subsite is believed to 
be within 3–3.5 Å by superimposing KpPUL:G4 and LD and thereby likely to further 
improve binding at subsite –2. 
The loop between β4 and α4 contains the presumed catalytic nucleophile, Asp473 
and contributes together with Tyr357, His404, Arg471, Glu510, Asp642 and the main-chain 
carbonyl oxygen of Ala438 to the structure of subsite –1. The position of Gol303 and three 
water molecules (w68, w115, w224) are mimicking a Glc residue at subsite –1 and gives 
credibility to the position of the proposed α-1,6 linkage cleavage site. 
A conserved Leu found in the solely α-1,6 acting enzymes, Leu474 in LD, Leu 678 in 
KpPUL, Leu 376 in PaISO Leu 623 in BaPUL and  Leu 407 in BsPUL, is positioned next to 
the catalytic nucleophile, where it obstructs the formation of a subsite +1’ for α-1,4 
linked glucose residues corresponding to subsite +1 in α-1,4 active enzymes and it 
neighbor upon Trp512 thereby aid defining subsite +2. This Leu is therefore believed to 
be a key residue in discriminating between α-1,4 and α-1,6 acting enzymes. The 
neopullulanases and amylopullulanases that both display dual (α-1,4 and α-1,6) activity 
have the shorter Val replacing the Leu in this position, thereby allow binding at subsite 
+1 (α-1,4 substrate binding).  
Among the most striking differences found by comparison of the structures of LD 
and PaISO is the absent of Loop 2 and the difference in length of the loop between β8 
and α8, which is 33 residues longer in LD as well as the significantly longer loop in 
PaISO between β7 and α7. Loop 2 and in particular the prolonged β8-α8 loop in LD 
makes the cleft around subsite –2 through –4 and 0’ through –1’ narrower, which may 
in part inhibit the binding of additional branched chains as found in glycogen and 
glycogen β-limit dextrins. However, the observed difference in activity towards 
amylopectin β-limit dextrins and amylopectin (11) is probably caused by the difference 
in the length of the sugar side-chain extending from subsite –2/–3, where  Met440 
prevents optimum binding due to steric hindrance (as described above). The side-chain 
of the solvent exposed Phe620 had no significant electron density, which indicates a high 
flexibility. Phe620 will, however, irrespective of flexibility narrow the cleft extending 
from subsite +2. This residue may play a role for the substrate specificity by limiting the 
binding of longer substrates. 
 
4.3.5 Mechanism 
  
As described in section 1.21 LD catalysed hydrolysis/transglycosylation takes place 
via a double displacement mechanism involving a oxocarbonium ion-like transition 
state.  The interaction between Gol303 and His404 indicates that His404 can stabilize the 
charged oxocarbonium ion-like transition state as proposed. The position of His641 in a 
superimposition of LD:β-CD and the KpPUL:G4 complex indicate that the distances 
from ε2 of the imidazol side-chain to O2 and O3 of a glucose residue at subsite –1 are 
~2.9 Å and thereby supports the proposed role of His641. 
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LD is known to act as transferases at higher substrate concentration despite a highly 
solvent accessible active site (11, 70). A similar open active cleft is also observed in the 
E. coli glycogen branching enzyme (154). One explanation for the transferase activity, 
however, could be that at high substrate concentration simultaneous binding of sugar 
chains at subsite –1 though –2/–3 and at subsite 1’ throgh +2 would preclude water from 
the active site prior to the nucleophilic attack and the formation of the covalent 
intermediate thereby preferentially allowing the transfer of one sugar chain to the other 
by a α-1,6-glucosidic linkage. This assumes that the affinity at the aglycone subsites is 
high enough to maintain high carbohydrate ligand occupancy. It is tempting to speculate 
that the affinities of these sites are crucial in modulating the transglycosylation versus 
hydrolysis. 
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5 Concluding Remarks and Perspectives 
 
The present Ph.D. project has provided the first report on the successful production 
of functional and stable recombinant barley LD and its endogenous proteinaceous 
inhibitor, LDI. This enables studies of the molecular basis for the substrate specificity 
and transglycosylation activity of LD as well as the regulation of LD activity by LDI. 
The detailed SPR analysis of binding kinetics and energetics of the LD/LDI complex 
reveals binding in the subnanomolar range which was due to very slow dissociation. 
The van’t Hoff parameters indicates that the binding was driven by both enthalpic and 
entropic contributions. Furthermore, electrostatic interactions seemed not to play a role 
as salt screening had essentially no effect. KD, however, depended on pH, possibly due 
to charge disruption of hydrophobic interactions. Analysis of LDI variants suggests that 
the N-terminal segment has a different role compared with other cereal-type inhibitor 
enzyme complex formation (61). In addition, the preliminary results obtained in this 
Ph.D. project on the crystallization of the LD/LDI complex may contribute to the 
establishment of optimal crystallization conditions and eventually lead to determination 
the tertiary structure of the complex. The tertiary structure can be used to identify 
residues involved in the specificity and affinity of the complex formation, and based on 
these directions rational mutational analysis altering the sensitivity of LD to LDI can be 
made. Furthermore, the access to recombinant LDI also makes it possible for the first 
time to investigated the proposed role of barley thioredoxin in the regulation LDI 
inhibitor activity . 
Moreover, the achieved efficient production of fully functional recombinant LD in 
excellent yield also enabled structural determination of LD in complex with the 
inhibitors α- and β-CD. This first structure of a plant limit dextrinase is used for gaining 
insight into the specificity determinants and the possible role in starch biosynthesis. 
It is unknown if the proposed role of plant LD in the starch biosynthesis only 
involves the trimming of the newly synthesized branch points or if LD is also involved 
in the formation of new α-1,6 branch points. However, independent of the specific 
action of LD all evidence suggest that the morphology of the starch granular is highly 
dependent on the LD activity (21, 155). The access to recombinant LD makes it 
possible to gain new insights into starch metabolism in cereals and other plants.  
Based on the data indicating that LD is involved both in starch biosynthesis and 
degradation it suggests here that LD is one of the key enzymes in production of tailor 
made starch for application in both the food biotechnology and in bioethanol 
production. Rational mutational analysis based on the 3D structure presented here can 
be made in order to alter the substrate specificity and thereby produce novel products to 
use in e.g. the food industry.  
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7 Appendix 
 
7.1 Mass Spectra from Transglycosylation 
7.1.1 Donor: α-Maltosyl Fluoride, Acceptor: Maltose 
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7.1.2 Donor: α-Maltosyl Fluoride, Acceptor: 4-O-α-D-glucopyranosylmoranoline 
 
 
7.1.3 Donor: α-Maltosyl Fluoride, Acceptor: Acarbose 
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7.1.4 Donor: α-Maltosyl Fluoride, Acceptor: α-CD 
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7.2 LC-MS of E3LDI 
 
 
Figure 7.1. Deconvoluted ESI-QTOF Mass Spectrum of ∆E3LDI. The data was obtained from 25 µl 
purified ∆E3LDI. 
 
  
7.3 Purification of LD/LDI Complex 
 
 
 
 
Figure 7.2. (A)  Coomassie stained isoelectric focusing gel (pH 3–10). Lane 1, purified LD/LDI 
complex; lane 2, purified LD. (B) Coomassis stained SDS-PAGE gel from gel filtration purification of 
LD/LDI complex. Lane 1, middle fraction from first peak eluted which is believed to be dimerized LD; 
lane 2, middle fraction from LD/LDI peak; lane 3, middle fraction from LDI peak.  
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7.4 Oral Presentations 
 
RSC Carbohydrate Group Meeting 2009, Norwich, UK. 15th to 16th of September 2009. 
“Production and purification of recombinant barley limit dextrinase and its endogenous 
inhibitor and characterization of the protein-protein interaction” (selected from 
abstract). 
 
Invited speaker at the COST 928 2nd Annual Meeting. Istanbul, Turkey. 15th to 17th of 
October 2008. 
“Investigation of the interaction between recombinant barley limit dextrinase and its 
endogenous inhibitor.” 
 
2008 Plant Polysaccharide Workshop, Sigtuna, Sweden, 3rd to 5th of August 2008. 
“Production and purification of recombinant barley limit dextrinase and its endogenous 
inhibitor” (selected from abstract). 
 
 
7.5 Poster Presentations 
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13th of May 2009. 
 
“Production in Pichia pastoris and characterization of recombinant barley limit 
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“Production in Pichia pastoris and characterization of recombinant barley limit 
dextrinase.” Vester-Christensen, M. B.; Næsted, H.; Abou Hachem, M. & Svensson, 
B. Annual Plant Biotech Denmark Meeting 29th to 30th of January 2008. 
 
“Production of recombinant barley limit dextrinase.” Vester-Christensen, M. B.; 
Naested, H.; Abou Hachem, M. & Svensson, B.  3th Symposium on the Alpha-Amylase 
Family, Smolenice Castle, Slovakia, 23rd to 27th of September 2007. 
 
“Physico-chemical characterization of limit dextrinase from barley.” Vester-
Christensen, M. B.; Næsted, H. & Svensson, B. 7th Carbohydrate Bioengineering 
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“Production of recombinant barley limit dextrinase.” Vester-Christensen, M. B.; 
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7.6 Publications 
 
The following publications are enclosed. 
 
Vester-Christensen, M. B., Abou Hachem, M., Naested, H., and Svensson, B. (2009) 
Secretory expression of functional barley limit dextrinase by Pichia pastoris using high 
cell-density fermentation, Protein Expr. Purif., doi: 10.1016/j.pep.2009.08.016. In press. 
 
Vester-Christensen, M. B., Abou Hachem, M., Svensson, B., and Henriksen, A. (2009)  
Crystal structure of barley limit dextrinase. A debranching enzyme involved in starch 
synthesis and breakdown, to be submitted to J. Biol. Chem. 
 
Vester-Christensen, M. B., Jensen, J. M. Abou Hachem, M., Svensson, B., N-terminal 
mutations of the high-affinity barley limit dextrinase inhibitor suggests a mode of action 
different from that of α-amylase inhibitors from the same family, to be submitted to 
Biochemistry. 
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a b s t r a c t
Heterologous production of large multidomain proteins from higher plants is often cumbersome. Barley
limit dextrinase (LD), a 98 kDa multidomain starch and a-limit dextrin debranching enzyme, plays a
major role in starch mobilization during seed germination and is possibly involved in starch biosynthesis
by trimming of intermediate branched a-glucan structures. Highly active barley LD is obtained by secre-
tory expression during high cell-density fermentation of Pichia pastoris. The LD encoding gene fragment
without signal peptide was subcloned in-frame with the Saccharomyces cerevisiae a-factor secretion sig-
nal of the P. pastoris vector pPIC9K under control of the alcohol oxidase 1 promoter. Optimization of a fed-
batch fermentation procedure enabled efﬁcient production of LD in a 5-L bioreactor, which combined
with afﬁnity chromatography on b-cyclodextrin–Sepharose followed by Hiload Superdex 200 gel ﬁltra-
tion yielded 34 mg homogenous LD (84% recovery). The identity of the recombinant LD was veriﬁed by
N-terminal sequencing and by mass spectrometric peptide mapping. A molecular mass of 98 kDa was
estimated by SDS–PAGE in excellent agreement with the theoretical value of 97419 Da. Kinetic constants
of LD catalyzed pullulan hydrolysis were found to Km,app = 0.16 ± 0.02 mg/mL and kcat,app = 79 ± 10 s1 by
ﬁtting the uncompetitive substrate inhibition Michaelis–Menten equation, which reﬂects signiﬁcant sub-
strate inhibition and/or transglycosylation. The resulting catalytic coefﬁcient, kcat,app/Km,app = 488 ±
23 mL/(mg s) is 3.5-fold higher than for barley malt LD. Surface plasmon resonance analysis showed
a-, b-, and c-cyclodextrin binding to LD with Kd of 27.2, 0.70, and 34.7 lM, respectively.
 2009 Elsevier Inc. All rights reserved.
Introduction
Limit dextrinase (LD)1 is a plant enzyme that is essential for
starch debranching, e.g. during cereal seed germination. Starch is
the major energy reserve in seeds and tubers and occurs as compact
supramolecular granules composed of the polysaccharides amylose
and amylopectin. Amylose is a linear a-1,4-glucan, whereas the
more abundant amylopectin contains frequent a-1,6-glucosidic
bonds connecting shorter linear a-1,4-linked branch chains of vary-
ing length to the a-1,4-glucan main chain [1]. In barley, starch gran-
ules are stored in the seed endosperm that consists of dead tissue
and the concerted action of different amylolytic enzymes is required
for its breakdown to metabolisable oligosaccharides, maltose, and
glucose [1]. LD thus hydrolyzes a-1,6-glucosidic bonds in a-limit
dextrins derived from amylopectin, but has low activity towards
amylopectin itself [2]; a-amylase hydrolyzes a-1,4 glucans in an
endo-fashion; b-amylase catalyzes release of maltose from non-
reducing ends of the substrates and is unable to pass a-1,6-branch
points; and the a-glucosidase primarily hydrolyzes maltooligosac-
charides to glucose [3]. LD (EC. 3.2.1.41, pullulanase) is indeed the
sole debranching enzyme in both seed and tuber starch mobilization
[3,4]. LD shows high activity towards pullulan, a linear polysaccha-
ride composed of a-1,6-linked maltotrioside repeats [2,3]. It is a
large multidomain enzyme belonging to subfamily 13 of glycoside
hydrolase family 13 (GH13_13) [5,6].
In barley a single gene encodes LD, which is induced in the ger-
minating seed by the phytohormone gibberellic acid (GA3) [4,7].
Transcripts of the LD gene can be detected in the aleurone layer al-
ready 12 h after the onset of germination, but LD activity does not
increase until 2 days later and reaches a maximum at day 5 after
onset of germination [7,8]. The level of LD activity in the starchy
endosperm is low compared with the a-amylase activity. Further-
more, the release of LD from the aleurone to the endosperm ap-
pears to be slower than of a-amylase [8] and it was suggested
therefore to occur as a consequence of cell wall degradation and
1046-5928/$ - see front matter  2009 Elsevier Inc. All rights reserved.
doi:10.1016/j.pep.2009.08.016
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tance; AOX, alcohol oxidase; CD, cyclodextrin; CWW, cell wet weight; GA3, gibberellic
acid; GH13, glycoside hydrolase family 13; HIS4, histidinol dehydrogenase; KanR,
kanamycin resistance; LD, limit dextrinase; LDI, limit dextrinase inhibitor; MALDI-
TOF-MS, matrix assisted laser desorption ionization time-of-ﬂight mass spectrome-
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dodecyl sulfate; SPR, surface plasmon resonance; SS, sum of squared residuals.
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not via a secretory pathway. The secretion of LD, however, has been
a matter of debate since a putative leader sequence has been iden-
tiﬁed upstream the mature peptide, but was not predicted to be a
signal peptide targeting to the ER [4,7].
In addition to an important role in starch degradation in ger-
minating seeds, LD is shown in maize [9] and Arabidopsis [10] to
participate in the breakdown of transitory starch in leaves. Fur-
thermore, LD is present in developing grains and suggested to
play a role in starch biosynthesis [7,8,11]. The hypothesis that
the structure of amylopectin is the outcome of a balance be-
tween debranching and branching enzyme activities [12,13] gets
support both from maize deﬁcient in pullulanase-type debran-
ching enzyme (i.e. LD), having affected starch granule morphol-
ogy [9] and from a quadruple debranching enzyme deﬁcient
Arabidopsis mutant with abolished starch granule biosynthesis
[14].
LD puriﬁed after extraction from germinating barley seeds oc-
curs in a ‘‘bound”, apparently inactive form, and in a free enzymat-
ically active form. The ratio of bound to free form changed with
time after the onset of germination [15]. The inactive LD form
was proposed to consist of a complex with the endogenous limit
dextrinase inhibitor (LDI) [16]. Extraction under reducing condi-
tions led to fully active LD [15,17]. Whether the disappearance of
LDI at germination is due to reduction by thioredoxin h [18] or deg-
radation by a cysteine protease [15] remains to be uncovered.
In addition to the roles in starch biosynthesis and degradation
LD is central in beer production by catalyzing oligosaccharide
debranching during malting and mashing [19]. However, even
though barley malt LD has been known since the ﬁfties [20] insight
is lacking on the precise role of LD and its interplay with LDI in bio-
logical and industrial processes as well as on the structure/function
relationships and the molecular basis for substrate speciﬁcity and
formation of the LDI-LD complex. In the past recombinant produc-
tion of LD frommaize [21], spinach [22], and wheat [23] resulted in
very poor yields, which emphasized the challenge of producing
plant proteins in Escherichia coli. A similar situation was found
for barley a-glucosidase [24], in which case, however, a break-
through was obtained by high cell-density fermentation of the host
Pichia pastoris resulting in good yields of very pure and ﬁve times
more catalytically efﬁcient a-glucosidase than the enzyme puriﬁed
from malt [25].
The aim of the present work is to produce functional, recombi-
nant LD in amounts sufﬁcient for thorough analysis of stability,
enzymatic properties including LDI interaction, and structure
determination by X-ray crystallography. To this end an expression
system was developed using P. pastoris as host and high cell-den-
sity fermentation in a bioreactor, which resulted in excellent yield
of homogenous recombinant LD with higher activity than the en-
zyme puriﬁed from barley malt [26,27].
Materials and methods
Construction of LD expression plasmid
LD cDNA (GenBank Accession No. AF022725) [4] was used as
template in PCR with forward primer 50-AAGCGGCCGCTGCGTTCA
TGCCGGA-30 and reverse primer 50-AAGCGGCCGCTTAACACCGAG
GTTCGACAAAGACT-30 involving preheating at 94 C (2 min), 30 cy-
cles at 94 C (15 s), 55 C (30 s), and 72 C (3 min), followed by a ﬁ-
nal elongation (7 min). The resulting PCR product (2678 bp)
encoding the mature LD lacking the putative leader sequence (ami-
no acid residues 22–905 according to Accession No. AAD04189,
NCBI Protein database) with ﬂanking NotI restriction sites intro-
duced by the primers (in bold) was digested, gel-puriﬁed and
cloned into the NotI site of the pPIC9K vector (Invitrogen, USA)
to obtain in-frame cloning with the a-mating-factor secretion sig-
nal from Saccharomyces cerevisiae (Fig. 1A). E. coli, XL10-Gold
(Stratagene, USA) was transformed with the resulting pPICK9/LD
(Fig. 1B) and isolated plasmids from single colony transformants,
selected on LB-agar plates containing 100 lg/mL ampicillin, were
analyzed for correct orientation of the inserted gene using the XbaI
restriction site present in both vector and insert. The sequence of
the ﬁnal construct was veriﬁed by sequencing using forward prim-
ers 50-TACTATTGCCAGCATTGCTGC-30, 50-TGCAATTACCCGGCGTGC
TG-30, 50-GAATATCGTCAGATGGTCCA-30, and 50-TGATGTTATCAG
TGTGAAGA-30; and reverse primers 50-CGGTTTTCCCACTCTCTTG
G-30, 50-TTAACCTATCAACCATGAAA-30, 50-AACACCCCAATTGTTTG
TTT-30, and 50-GCAAATGGCATTCTGACATCC-30 covering the LD ma-
ture protein encoding region. Small scale plasmid preparation,
restriction enzyme digestion, ligation, and transformation followed
standard molecular biology protocols [28].
Fig. 1. Design of pPIC9K/LD plasmid. (A) Schematic representation of the construction of LD gene cloned in-frame with a-factor secretion signal. The linker in between a-
factor and the LD gene is a part of the multiple cloning site. (B) The LD encoding expression plasmid used for P. pastoris transformation.
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Transformation of P. pastoris and selection for expression and LD
secretion
Prior to transformation, pPICK9K/LD (20 lg) was linearized
with PmeI followed by puriﬁcation (Strataclean; Stratagene,
USA), precipitation, and redissolving in sterile Milli-Q water. Elec-
trocompetent P. pastoris strain GS115 (Invitrogen, USA) was trans-
formed with the linearized plasmid by electroporation using a
Micropulser (Bio-Rad, USA). Transformants were isolated by proto-
trophic growth on minimal medium lacking histidine and supple-
mented with 1% sorbitol (RDB plates: 1 M sorbitol, 2% dextrose,
1.34% yeast nitrogen base without amino acids (YNB), 1.64 lM bio-
tin, 270 lM L-glutamic acid, 335 lM L-methionine, 342 lM L-ly-
sine, 381 lM L-leucine, 381 lM L-isoleucine) [29]. Plates were
incubated at 30 C for 2–4 days.
Transformants secreting LD were selected by colony blotting
using antibodies against LD from barley malt [30]. Single colonies
of His+ transformants were picked from the initial RDB plates,
transferred to YPD plates, grown for 2 days and then replicated
to nitrocellulose membranes (Hybond ECL, 0.45 lm, Amersham
Biosciences, Germany) placed on minimal medium plates contain-
ing 0.5% methanol (MM plates: 1.34% YNB, 1.64 lM biotin, 0.5%
methanol) followed by incubation at 30 C for 2 days. Secreted
LD was detected by immunoblotting using anti-LD primary anti-
body [30], and goat anti-rabbit alkaline phosphatase conjugated
secondary antibody (Dako, Denmark). The membrane was rinsed
with Milli-Q water to remove cells before blocking in TBST with
BSA (25 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.2% v/v Tween 20,
1% BSA) for 30 min. The primary antibody was diluted 1:3000 in
TBST and the antigen–antibody interaction was carried out at room
temperature for 30 min. The membrane was washed (3  10 min)
with TBST before probing with secondary antibody diluted
1:2000 in TBST (30 min). After washing (3  10 min) with TBST
the immunoblot was developed using nitroblue tetrazolium
(NBT)/bromo chloro indolyl phosphate (BCIP) colorimetric method
(100 mM Tris–HCl, pH 9.5, 100 mMNaCl, 5 mMMgCl2, 0.33 mg/mL
NBT, 0.17 mg/mL BCIP) and the reaction was stopped by change to
Milli-Q water. LD from barley malt served as positive and P. pasto-
ris strain GS115 transformed with the empty vector pPIC9K as neg-
ative control.
Pilot scale expression
Twelve His+ transformants selected by colony immunoblotting
were tested for expression in 50 mL culture using buffered com-
plex medium following the supplier’s guidelines for Mut+ pheno-
type [29]. LD activity was monitored after 96 h using the Limit-
Dextrizyme assay (see below; Megazyme, Ireland). The culture
mediumwas changed by adding 60 volumes of 100 mMNa acetate,
pH 5.5, followed by 10-fold concentration (Centricon, 30 kDa cut-
off; Millipore, Ireland) prior to testing. Due to low LD activity in
shake ﬂask cultures, a 5 h assay reaction time was applied to en-
sure detection of secretory expression of active LD. The effect of
induction temperature was analyzed by comparing LD activity in
cell-free extract of cultures grown in minimal medium at either
30 or 22 C for 72 h. The transformant selected for large scale bio-
reactor production was shown to release LD activity in minimal
medium after induction at 22 C for 72 h.
High cell-density fermentation
The bioreactor fermentation has three stages; (i) a glycerol
batch phase generating biomass; (ii) a glycerol feed phase, with
glycerol being delivered at growth limiting rate for continued bio-
mass generation and derepression of the alcohol oxidase promoter
AOX1; and (iii) a methanol feed phase for induction of expression
with increasing methanol feed to a maximum level at 11 g/(L h).
Methanol induction was maintained for 89 h.
The fermentation procedure guidelines for methanol feeding of
the Mut+ phenotype [31] were optimized and the fermentation
was carried out in a 5-L Biostat B (B. Braun Biotech International,
Germany) bioreactor equipped with an additional feed pump, gas
mixer, dissolved oxygen tension polarographic electrode, and
water cooler [31,32]. The 2 L starting basal salt medium containing
PMT1 [32] trace salts was inoculated with 150 mL culture
(OD600 = 16) propagated overnight at 30 C in buffered complex
medium (BMGY: 1% w/v yeast extract, 2% w/v peptone, 0.1 M
KH2PO4, pH 6.0, 1.34% w/v YNB, 1.64 lM biotin, 1% v/v glycerol)
[29]. The temperature was maintained at 29 C by water cooling
during glycerol batch and fed-batch phases. Prior to induction,
the temperature was decreased to 22 C and kept throughout the
methanol feed phase. Solutions of 50% glycerol and 100% methanol
both containing PTM1 trace salts were used for as carbon source
during glycerol feed phase and methanol feed phase, respectively.
Continuous addition of 28% aqueous ammonia served to maintain
the pH at 5.5 and as a nitrogen source.
Puriﬁcation of LD
Cells were harvested after 5 days of fermentation (centrifuga-
tion, 12,000g, 4 C, 30 min), and the supernatant (2.5 L) was kept
at 4 C after adding sodium azide (ﬁnal concentration 0.02% w/v).
LD was puriﬁed by a two-step procedure involving afﬁnity chroma-
tography using b-cyclodextrin (b-CD) conjugated to Sepharose fol-
lowed by gel ﬁltration (Hiload Superdex 200 26/60). The culture
supernatant was split in two and ammonium sulfate was added
to a ﬁnal concentration of 1 M to secure binding of LD to b-CD–Se-
pharose [30], followed by centrifugation (12,000g, 4 C, 30 min)
and ﬁltration (0.45 lm, GE Water & Process Technologies, USA),
and pumped (30 mL/h) onto b-CD–Sepharose (20 mL bed volume
in XK 16/10 column; GE Healthcare, Sweden) equilibrated in
10 mM Na acetate, pH 5.5, 500 mM NaCl, 5 mM CaCl2. After wash
with equilibration buffer (four column volumes; 60 mL/h), bound
LD was eluted with 10 mM Na acetate, pH 5.5, 5 mM CaCl2,
7 mM b-CD at the same ﬂow rate. Fractions (960 lL) were collected
in tubes containing 40 lL 1 M HEPES, pH 7.0, 125 mM CaCl2,
0.125% Triton X-100 and aliquots were analyzed by SDS–PAGE.
Fractions with LD activity (see below for assay) were pooled and
concentrated to 18 mL (Centricon; 30 kDa cut-off, Millipore, Ire-
land) after 2 mL were removed and dialyzed (Spectra/por dialysis
membrane MWCO 12–14 kDa; Spectrum Laboratories, USA)
2  12 h against 2  3 L 50 mM MES, pH 6.6, 250 mM NaCl and as-
sayed for activity. Subsequently 4  4 mL portions from the con-
centrated b-CD pool (approximately 2.5 mg/mL LD) were
chromatographed on a Hiload Superdex 200 26/60 column (GE
Healthcare, Sweden) equilibrated with 50 mM MES, pH 6.6,
250 mM NaCl and eluted (30 mL/h) with the same buffer. Collected
fractions (4 mL) were analyzed by SDS–PAGE and LD-containing
fractions were pooled, concentrated (Centricon, 30 kDa cut-off;
Millipore, Ireland), assayed for activity, and stored at 4 C. An ÄK-
TAexplorer (GE Healthcare, Sweden) interfaced by UNICORN 5.0
control software (GE Healthcare, Sweden) was used for both chro-
matographic procedures.
Enzyme activity
LD activity during pilot expression, fermentation, and puriﬁca-
tion was assayed with Limit-Dextrizyme tablets (Megazyme,
Ireland) in 0.1 M Na acetate, pH 5.5, 0.005% Triton X-100. LD (5–
10 nM) diluted in assay buffer (0.5 mL) was preheated (5 min) on
a 40 C water bath before adding the Azurine-crosslinked-pullulan
substrate tablet. The reaction was stopped after 10 min by adding
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5 mL 1% w/v Tris and vigorously whirl-mixing. After 10 min incu-
bation at R.T., the tubes were whirl-mixed and 2 mL were trans-
ferred to Eppendorf tubes and centrifuged (14,000g, 10 min). The
absorbance of the supernatant was measured at 590 nm. One activ-
ity Unit is deﬁned as the amount of enzyme that releases one
micromole of glucose reducing-sugar equivalents per min from
pullulan under the deﬁned assay conditions [33].
Kinetic constants of LD was determined from initial rates of
hydrolysis at 12 different concentrations (0.02–1 mg/mL) of pullu-
lan (Megazyme, Ireland) by 3.6 nM LD in 20 mMNa acetate, pH 5.5,
5 mM CaCl2, 0.005% Triton X-100 (starting assay volume: 1.1 mL)
at 37 C. Aliquots (200 lL) were removed at 3 min intervals during
0–15 min, stopped by mixing with 500 lL freshly prepared devel-
oping buffer (0.4 M Na carbonate, pH 10.7, 2.5 mM CuSO4, 2.5 mM
4,40-dicarboxy-1,20-biquinoline, 6 mM L-serine) and 300 lL Milli-Q
water [34] and the absorbance was measured after 30 min at 80 C
in microtiter plates (300 lL, in duplicates) at A540. The release of
reducing sugar was quantiﬁed using a maltose standard curve.
Vmax and Km were determined by ﬁtting either the Michaelis–Men-
ten equation (Eq. (1)) or the equation for uncompetitive substrate
inhibition (Eq. (2)) to the initial rates. Ki,s is the dissociation con-
stant for the inhibitory substrate–enzyme–substrate ternary
complex.
V ¼ Vmax
1þ Km½S
ð1Þ
V i;sub ¼ Vmax
1þ Km½S þ ½SK i;s
ð2Þ
The ﬁtting and plotting were performed using the Enzyme Kinetics
Module 1.0 of the program Sigmaplot 9.01 (Systat Software,
Germany).
Cyclodextrin afﬁnity
Afﬁnity of LD for a-, b- and c-cyclodextrin (CD) was determined
using surface plasmon resonance (SPR) (BIAcore T100; GE Health-
care, Sweden). LD was immobilized in the presence of 1 mM b-CD
on a CM5 sensor chip (GE Healthcare, Sweden) using random
amine coupling (2800–3200 response units, RU). Sensorgrams
(RU vs. time) of binding of a-, b- and c-CD in the range of 2.5–
160 lM (17 concentrations), 0.125–40 lM (14 concentrations),
and 4–160 lM (16 concentrations), respectively, were obtained
at 25 C using 3 min association and 2 min dissociation. CDs were
dissolved in 20 mM Na acetate, pH 5.5, 100 mM NaCl, 0.005% sur-
factant P-20, which was also used as running buffer. Kd (Eq. (3))
was calculated by steady-state afﬁnity ﬁtting (BIAcore evaluation
software 1.1) to the equilibrium response R of CD at a given con-
centration after subtracting the reference ﬂow cell signal; Rmax is
the response at saturation of the ligand on the chip.
R ¼ Rmax  ½CD½CD þ Kd ð3Þ
Protein assays
LD concentration was either quantiﬁed by Bradford Coomassie
Plus kit (Pierce) with BSA as standard or spectrophotometrically
at 280 nm using a molar extinction coefﬁcient of
1.52  105 M1 cm1 determined experimentally on the basis of
LD concentration calculated by aid of amino acid analysis. A lower
theoretical value of 130,680 M1 cm1 (www.expasy.org/tools/
protparam.html) probably reﬂects inﬂuence of the protein struc-
ture on spectral properties of tyrosine and tryptophan residues.
SDS–PAGE, isoelectric focusing, and immunoblotting
Protein purity was assessed by SDS–PAGE using NuPAGE No-
vex Bis-Tris 4–12% gels (Invitrogen) in 1% MES buffered polyacryl-
amide minigel Novex system with reducing agent added in the
sample preparation and anti-oxidant in the buffer system accord-
ing to the manufacturers’ recommendations and Coomassie Bril-
liant Blue G-250 staining [35].
Isoelectric focusing (IEF) was performed using the PhastSystem
(Pharmacia, Sweden), pH 4–6 PhastGels (GE Healthcare, Sweden)
with low pI calibration kit (GE Healthcare, UK) and Silver Kit stain-
ing (Pharmacia, Sweden). Immunoblotting was carried out using
the Novex gel system with the XCell SureLock Mini-Cell according
to the supplier’s manual (Invitrogen). LD was detected using poly-
clonal rabbit antibody raised against LD puriﬁed from barley malt
[30] in combination with goat anti-rabbit alkaline phosphatase
conjugated antibody (Dako, Denmark).
Mass spectrometry, amino acid analysis, and protein sequencing
In-gel trypsin digestion of spots cut out from protein bands of
SDS–PAGE gels and micropuriﬁcation on Poros 20 R2 home-made
nanocolumns (Perseptive, Biosystems, USA) were done as de-
scribed [36]. Peptides were eluted with 1 lL matrix solution (5 g/
L a-cyano-hydroxycinnamic acid in 70% [v/v] CH3CN and 0.1%
[w/v] triﬂuoroacetate) directly onto the MALDI target and analyzed
using an Ultraﬂex II MALDI-TOF-TOF mass spectrometer (Bruker-
Daltonics, Germany) in positive ion reﬂector mode. Spectra were
analyzed using FlexAnalysis software (Bruker-Daltonics, Germany)
and calibrated by trypsin autolysis products (m/z 842.51 and m/z
2211.10). Peptide mass data were searched against the NCBI non-
redundant database using Biotools software (Bruker-Daltonics)
and the Mascot server (http://www.matrixscience.com).
Amino acid analysis was performed after 24 h hydrolysis as de-
scribed [37]. Protein sequencing was carried out by automated N-
terminal Edman degradation in a Procise 494 sequenator according
to the manufacturer’s recommendations (Applied Biosystems Fos-
ter City, USA). Highly pure Milli-Q water (18 MX) was used
throughout.
Results
Cloning and selection of LD secreting transformants
The gene fragment encoding LD without the previously pro-
posed putative transit peptide [4] was cloned downstream of the
P. pastoris AOX1 promoter in pPIC9K in-frame with the N-terminal
a-factor secretion signal to achieve secretion of recombinant LD by
P. pastoris. The cloning resulted in an N-terminal tripeptide (ATQ)
deletion of mature LD compared to our earlier published gene se-
quence [4]. The same triptide sequence was lacking in approxi-
mately 50% of the LD molecules puriﬁed from germinating seeds
[30] and in the gene sequence determined by others [7]. The line-
arized construct (Fig. 1B) was inserted into the genome by homol-
ogous recombination resulting in stable integration as judged from
the maintained P. pastoris GS115 Mut+ His+ phenotype. Successful
secretory expression was documented by strong colony immuno-
blotting response for 20 transformants out of 50 selected randomly
and signiﬁcant variation in production level was judged from
intensity differences (not shown). This corroborated the variations
in LD activity (2.4–36.8 mU/mL) observed in a pilot scale secretory
expression of the selected transformants. No LD activity was pro-
duced by strain GS115 transformed with empty pPIC9K and based
on the results one transformant, LD26, was selected for further
analysis. Remarkably, after 72 h induction no measurable LD activ-
4 M.B. Vester-Christensen et al. / Protein Expression and Puriﬁcation xxx (2009) xxx–xxx
ARTICLE IN PRESS
Please cite this article in press as: M.B. Vester-Christensen et al., Secretory expression of functional barley limit dextrinase by Pichia pastoris using high cell-
density fermentation, Protein Expr. Purif. (2009), doi:10.1016/j.pep.2009.08.016
ity was detected in minimal medium at 30 C from LD26, whereas
induction at 22 C for 72 h gave a 10-fold activity increase com-
pared to the highest activity measured after 96 h induction at
30 C.
Fermentation and secretory expression in 5-L bioreactor
Very low LD yields in shake ﬂask cultures motivated implemen-
tation of fed-batch high cell-density fermentation. Cell wet weight
(CWW) and LD activity were monitored throughout the different
stages of this fermentation. The initial batch phase (30 h) resulted
in CWW of 114 mg/mL. The culture was then switched to fed-batch
mode with 15 g/(L h) glycerol feed for 6 h leading to CWW of
164 mg/mL. This was followed by initiation of induction by a meth-
anol feed of 1 g/(L h) for 2 h to allow adaptation to methanol
metabolism. The methanol ﬂow was successively increased to
reach the maximum of 11 g/(L h) after 12 h. LD activity in the med-
ium and CWW increased with time (Fig. 2). The culture was termi-
nated at 125 h (89 h induction) as the reactor headspace became
limiting. The CWW was 315 g/L and the 2.5 L cell-free supernatant
contained about 16 mg/L active LD as calculated from the speciﬁc
activity of puriﬁed recombinant LD.
Puriﬁcation and characterization of recombinant LD
LD puriﬁcation was monitored by activity assay and SDS–PAGE
(Table 1 and Fig. 3A). Less than 1% of the total activity in the culture
supernatant appeared in the ﬂow-through after application to b-
CD–Sepharose in 1 M ammonium sulfate and the afﬁnity chroma-
tography resulted in high yield of very pure LD (Fig. 3A, lane 2).
Precipitation of eluted LD observed in preliminary experiments
was prevented by immediate adjustment of the eluate to pH 6.7
(see Materials and methods). Gel ﬁltration further increased the
LD purity and removed b-CD (Table 1 and Fig. 3A, lane 3). Immuno-
blotting of pooled LD-containing fractions showed a predominant
band corresponding to an apparent molecular mass of 98 kDa
(Fig. 3B, lane 2) in excellent agreement with both the theoretical
value of 97,419 Da and the migration of barley malt LD (Fig. 3B,
lane 1). A trace component of slightly lower molecular mass visible
in SDS–PAGE possibly represented a cleavage product of secreted
LD. The puriﬁcation procedure resulted in 34 mg recombinant LD
with speciﬁc activity of 14.2 U/mg corresponding to 11-fold puriﬁ-
cation and 84% recovery from the culture supernatant (Table 1).
The identity of recombinant LD was veriﬁed by peptide map-
ping using MALDI-TOF-MS (data not shown). A search against the
NCBI non-redundant database resulted in mono-isotopic mass
Fig. 2. Progress of secreted LD activity (d) and CWW (cell wet weight) (j) during
fermentation from the start of the methanol induction.
Fig. 3. (A) Coomassie stained SDS–PAGE. Lane 1, culture supernatant (3.5 lg total protein); lane 2, pool of b-CD–Sepharose eluate (2.5 lg total protein); lane 3, pool of
Hiload Superdex 200 eluate (0.8 lg total protein). (B) Immunoblotting using barley LD speciﬁc antibody. Lane 1, LD puriﬁed from barley malt (70 ng); lane 2, puriﬁed
recombinant LD (40 ng). (C) Coomassie stained SDS–PAGE. Lane 1, LD puriﬁed from barley malt (1 lg); lane 2, puriﬁed recombinant LD (1 lg). (D) Isoelectric focusing of
LD (pH 4–6 PhastGels). Lane 1, LD puriﬁed from barley malt (0.8 lg); lane 2, puriﬁed recombinant LD (0.8 lg).
Table 1
Puriﬁcation of LD from 2.5 L P. pastoris culture supernatant.
Total protein (mg) Total activity (U) Recovery (%) Speciﬁc activity (U/mg) Puriﬁcation (fold)
Supernatant 456.9 573.3 100.0 1.3 1.0
b-CD–Sepharose 82.7 551.7 96.2 6.7 5.2
Sephadex G200 33.6 477.3 83.3 14.2 11.0
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peaks with 27% sequence coverage of the LD protein sequence.
Tryptic peptides comprising the four putative N-glycosylated posi-
tions were not identiﬁed, owing to size incompatibility with the
present mass spectrometric analysis for two of them. However,
the migration of LD in SDS–PAGE analysis as a single sharp band
corresponding to the expected molecular mass is not supportive
of signiﬁcant glycosylation. Three different processed forms of LD
can be predicted depending on the protease cleavage site, Kex2
or any of the two Ste13 sites, used (Fig. 1A). Using the NotI site
for the cloning will therefore normally, in the processed protein,
result in a 9–13 amino acids N-terminal extension that originates
from the expression plasmid (Fig. 1A). N-terminal sequencing of
LD revealed an alternative processed form of the secreted enzyme
(AAFMPDAR, Fig. 1A) presumably due to cleavage by one or more
proteases produced by P. pastoris.
Isoelectric focusing of the recombinant LD and LD puriﬁed from
barley malt showed a similar migration pattern with pI of 4.1
(Fig. 3D). A number of closely migrating bands appear in a broader
smeared zone indicating slight charge heterogeneity in both en-
zyme preparations.
Fitting the Michaelis–Menten equation to initial rates of LD cat-
alyzed hydrolysis of pullulan revealed deviation of the hyperbolic
ﬁt from experimental data, in particular at substrate concentra-
tions above 0.2 mg/mL (Fig. 4). Noticeably, however, ﬁtting the
Michaelis–Menten expression for uncompetitive substrate inhibi-
tion matched the data very clearly (Fig. 4). This is supported using
standard statistical tools for model selection such as the corrected
Akaike information criterion (AICc) [38] and the sum of squared
residuals (SS) (tools included in the Sigmaplot 9.01 software).
The Michaelis–Menten expression for uncompetitive substrate
inhibition yields an AICc = 43.4 and SS = 8.3, while the regular
Michaelis–Menten equation has values of AICc = 14.3 and
SS = 20.1. Such deviation from the Michaelis–Menten model ob-
served for other glycoside hydrolases, has previously been attrib-
uted to an increased transglycosylation rate at higher substrate
concentrations rather than to substrate inhibition [39,40]. For LD
this is in agreement with the Km value for pullulan being signiﬁ-
cantly higher when ﬁtting the equation for uncompetitive sub-
strate inhibition as compared to ﬁtting the regular Michaelis–
Menten equation (Table 2).
The previously reported binding of cyclodextrins to debran-
ching enzymes [41] is here conﬁrmed and analyzed for the recom-
binant LD using surface plasmon resonance. The approximately
100-fold difference in molecular mass between the chip-immobi-
lized LD and the three CD analytes poises high demands on sensi-
tivity. The developed experimental set up, however, resulted in
highly reproducible sensorgrams for all three CDs with Rmax values
of 16–25 RU. Fitting of a one binding site model to the SPR data of
b-CD revealed a submicromolar Kd, whereas a- and c-CD had 40–
50 times weaker afﬁnity (Table 3).
Discussion
The functional recombinant barley LD achieved in excellent
yields and outstanding quality enables future biochemical and
structural characterization of this pivotal enzyme in cereal starch
metabolism and in food processing, in particular in the brewing
and malting industry [42,43]. Previous attempts to produce recom-
binant LDs from plants resulted in extremely poor yields [21,22]
and very low speciﬁc activity [23] highlighting the difﬁculties in
producing large multidomain recombinant plant proteins. Earlier
attempts to produce barley LD thus resulted in full-length and
truncated inactive forms [44]. Here heterologous production of
barley LD was successfully conducted in P. pastoris. Optimization
of a fed-batch protocol in a 5-L bioreactor thus resulted in
16 mg/L highly active recombinant LD secreted to the culture
supernatant indicating accumulation of functional and stable re-
combinant LD under the applied culture conditions (Fig. 2). Lower-
ing the induction temperature to 22–25 C has been reported to
increase amounts of secreted heterologous protein [45–47]. This
was conﬁrmed by pilot scale expression of LD at 22 C resulting
in more than 10 times higher yield than at 30 C. We assume this
is due to enhanced LD folding and/or reduced protease activity in
the medium [45,48], since LD was previously reported to be fully
stable at 30 C [49].
Comparison of the afﬁnity of a-, b- and c-CD for pullulanase
from Klebsiella pneumoniae showed strong binding of b-CD driven
both by hydrogen bond formation and by hydrophobic contacts
as indicated by a favorable entropic change upon b-CD binding
Fig. 4. Apparent initial rate of release of reducing sugar as a function of pullulan
concentration. Solid line, ﬁt of Michaelis–Menten expression with uncompetitive
substrate inhibition. Dashed line, classical Michaelis–Menten plot. Error bars
indicate SD for triplicate measurements.
Table 2
Apparent kinetic constants of LD on pullulan obtained by nonlinear least-squares curve ﬁtting.
Classical Michaelis–Menten Uncompetitive substrate inhibition
Km,app (mg/mL) kcat,app (s1) (kcat/Km),app (mL/(mg s)) Km,app (mg/mL) kcat,app (s1) Ki,s,app (mg/mL) (kcat/Km),app (mL/(mg s))
0.081 ± 0.003 61 ± 13 753 0.16 ± 0.02 78 ± 10 1.5 ± 0.4 488
Values are based on independent triplicate measurements.
Table 3
LD afﬁnity towards cyclodextrins determined by SPR.
Analyte Kd (lM) Relative Kda
a-CD 27.2 ± 0.9 39
b-CD 0.7 ± 0.1 1
c-CD 34.7 ± 0.2 50
Measurements were performed at 25 C in 20 mM Na acetate, pH 5.5, 100 mMNaCl,
0.005% P-20. Kd is based on independent duplicate runs, each run having three data
points at each concentration.
a Kd values normalized to b-CD.
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[41]. The afﬁnity of b-CD for LD and the bacterial pullulanase is in
the same range. Remarkably, however afﬁnity of the bacterial pul-
lulanase for a- and c-CD (Kd = 100 and 102 lM, respectively) was
four and three times lower than of the barley enzyme (Table 3),
suggesting that the LD binding site possesses a higher level of plas-
ticity allowing generally optimization of the ligand interactions. b-
CD is by far the preferred ligand, thus underscoring the resem-
blance between the conformations of b-CD and a-glucan helices
present in starch [1]. The strong binding of b-CD to LD is most
likely caused by aromatic stacking in the active site cleft as sup-
ported by the reported Ki value of 40 lM [4]. An enhanced b-CD–
Sepharose binding in 1 M ammonium sulfate, secured very high
recovery of LD from the culture supernatant. A lower speciﬁc activ-
ity of LD in the b-CD–Sepharose eluate was probably due to resid-
ual b-CD, which was efﬁciently removed by gel ﬁltration, resulting
in a ﬁnal speciﬁc activity of 14.2 U/mg or approximately twice the
value measured for LD puriﬁed from barley malt [50]. The high
speciﬁc activity was also reﬂected by the kinetic constants
kcat,app = 78 s1and Km,app = 0.16 mg/mL. Previously, Km and kcat
values for barley malt LD hydrolyzing pullulan at pH 5.0
and 40 C were reported in the ranges 0.16–0.44 mg/mL and
33–60 s1, respectively [26,27], and giving 2.4–3.5-fold lower
catalytic efﬁciency than the present recombinant LD. In compari-
son reported Km and kcat values of pullulanases from Klebsiella
planticola and Bacillus acidopullulyticus were 0.09 mg/mL and
81 s1, and 0.24 mg/mL and 120 s1, respectively [27].
The deviation from the hyperbolic ﬁt of the kinetic data at
pullulan concentrations above 0.2 mg/mL (Fig. 4) has not previ-
ously been described for barley LD. This behavior may reﬂect trans-
glycosylation reactions even though the initial rate kinetics
towards pullulan models an uncompetitive substrate inhibition.
Transfer of ﬂuorescently labeled maltotriose onto newly hydro-
lyzed pullulan [51] provides evidence for barley LD catalyzed
transglycosylation and transglycosylation was also reported for
rice LD using pullulan as substrate [52]. Although the in vivo func-
tion of LD is mostly considered in starch debranching, the present
ﬁndings motivate further kinetic and structural analysis to eluci-
date features that contribute to the transglycosylation activity
and the suggested role in starch biosynthesis.
The successful production of functional and stable recombinant
LD enables studies of the molecular basis for the substrate speciﬁc-
ity and transglycosylation as well as the regulation of LD activity
by the endogenous proteinaceous inhibitor LDI. Overall the access
to recombinant LD makes it possible to gain new insights into
starch metabolism in cereals and other plants.
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Barley limit dextrinase (HvLD)1 catalyses 
hydrolysis of α-1,6-glucosidic linkages from 
the amylopectin component of starch, an 
activity that plays a role in starch 
degradation during germination and 
presumable also in starch biosynthesis 
during grain filling. The crystal structures 
of HvLD in complex with the competitive 
inhibitors α- and β-cyclodextrin (CD) are 
solved and refined to 2.5 Å and 2.1 Å, 
respectively. HvLD belongs to glycoside 
hydrolase family 13 (subfamily 13) and is 
composed of four domains; an eight β-
strand N-terminal domain; a putative 
carbohydrate binding module (CBM48), a 
catalytic (β/α)8-like barrel domain lacking 
α-helix 5; and a C-terminal two-sheet β-
sandwich motif domain. The CDs as 
expected are accommodated at the 
carbohydrate main-chain binding-site 
occupying aglycone subsites +1 and +2. A 
glycerol and three water molecules mimic a 
glucose residue at subsite –1, thereby 
identifying residues involved in substrate 
binding. The spaciousness of Met440, a 
unique residue at its position amongst the α-
1,6 acting enzymes would clash with any 
glucose residue at subsite –4. The observed 
steric hindrance is proposed to affect 
substrate specificity. A part of an extended 
loop (residues Asp513–Asn520) between β5 
and β6 of the catalytic domain differs from 
microbial pullulanases in sequence and 
structure and seems to contribute both to 
the observed substrate specificity and to 
higher affinity of HvLD towards α-CD 
compared to pullulanases. Novel insight into 
specificity determinants and a possible role 
in starch biosynthesis is illuminated by this 
first structure of a plant limit dextrinase. 
  
Starch is the most prominent carbohydrate 
in the human diet and the major carbohydrate 
reserve in cereal seeds where it is found as 
compact supramolecular granules. Starch is 
also a very important industrial raw material. 
Barley seed starch is composed of about 70% 
amylopectin, an α-glucan containing α-1,6 
glucosidally linked branch points, and 30% 
amylose, a linear α-1,4-glucan (reviewed in 
(1)). In addition to starch synthases and 
branching enzymes, successful biosynthesis of 
amylopectin in plants involves two types of α-
1,6 debranching enzymes, the limit dextrinases 
(LDs, EC 3.2.1.41) or pullulanases and the 
isoamylases (EC 3.2.1.68) (2,3).  
LD is found in developing grains in 
accordance with a role in starch biosynthesis 
(4-6). Maize mutants lacking pullulanase-type 
debranching enzyme, i.e. LD, exhibit changes 
in starch granule morphology (7). Moreover, 
starch granule biosynthesis is abolished in 
quadruple Arabidopsis knock-outs deficient in 
three isoamylase isozymes and the single LD 
isozyme (8). This further supports the 
hypothesis that the amylopectin structure is the 
result of the action of debranching and 
branching enzyme activities (9-11). 
Debranching in starch degradation during 
germination, however, depend solely on LD 
that has high activity towards α-1,6 glucosidic 
linkages in limit dextrins derived from 
amylopectin (12), but the enzyme display 
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remarkably low activity on amylopectin itself 
(13).  
LD is highly activity towards pullulan, a 
linear polysaccharide composed of α-1,6-
linked maltotriose repeats (12,13). LD 
therefore has been classified with the 
pullulanases that are large multidomain 
enzymes of either glycoside hydrolase family 
13 subfamily 12 (firmicutes), subfamily 13 
(bacteria and eukaryota) or subfamily 14 
(bacteria) (14,15). Several plant pullulanase – 
also referred to as LD - encoding genes have 
being identified, but the vast majority of 
characterized pullulanases are microbial. The 
lack of an LD structure stems for its low 
natural abundance and lack of efficient 
heterologous expression systems. Previous 
attempts to produce maize (16), spinach (17), 
and wheat (18) LD recombinantly resulted in 
very low yields. However, our recently 
established expression in Pichia pastoris 
provides > 20 mg functional HvLD (19). The 
kinetics of pullulan hydrolysis showed 
deviation from the Michaelis-Menten model at 
relatively low substrate concentrations and 
initial hydrolysis rates were modeled by 
including a substrate inhibition term to give 
Km,app = 0.16 mg/ml and kcat,app = 78 s-1. This 
behaviour may also reflect a high intrinsic 
transglycosylation activity or a combination of 
this and substrate inhibition (19). This kinetic 
seems to be unique for LD and may have 
biologically significance through the proposed 
role of LD in amylopectin biosynthesis. 
Recombinant HvLD has up to 3.5-fold higher 
catalytic efficiency than LD purified from 
germinating barley seeds (12,19,20). Surface 
plasmon resonance (SPR) and activity assays 
(21) showed β-cyclodextrin (CD) to bind 
strongly (Kd of 0.7 µM), while α- and γ-CD 
had 40–50 times weaker affinity for HvLD 
(19). The affinity of β-CD for HvLD and 
Klebsiella pneumoniae pullulanase (KpPUL) 
was in the same range, whereas KpPUL had 4 
and 3 times lower affinity for α- and γ-CD, 
respectively (22) The significantly higher 
affinity with β-CD was suggested to reflect its 
resemblance with the conformation of α-
glucan helices in starch  (1,19).  
Several α-1,6 glucoside hydrolases, i.e. 
pullulanases and LDs (EC 3.2.1.41), 
isoamylases (EC 3.2.1.68), neopullulanases 
(EC 3.2.1.135), the latter having a α-1,4 
activity as the main activity, share a similar 
domain organisation, although the number of 
domains can vary. Hence, pullulanases possess 
an N-terminal part varying in length and which 
can be composed of several structural domains 
including carbohydrate binding modules 
(CBMs) preceding the catalytic (β/α)8-like 
barrel domain. In LDs and pullulanases a loop 
protrudes between β-strand 2 and α-helix 2 and 
is often referred to as Loop 2 (23). 
Furthermore, a long loop connects β-strand 3 
and α-helix 3 (by convention called B-domain 
(23,24)), despite the fact that this is not a truly 
independent domain. The catalytic domain is 
followed by a C-terminal two-sheet β-
sandwich fold described first in TAKA-
amylase A, an α-amylase from Aspergillus 
oryzae (25).  
LDs and isoamylases have one annotated 
CBM namely CBM48 (26), whereas 3D 
structures of KpPUL and Bacillus 
acidopullulyticus pullulanase (BaPUL) (27,28) 
show both CBM41 and CBM48 situated N-
terminally to the catalytic domain. Based on 
multiple sequence alignment of GH13 family 
members and using Pfam domain prediction 
(23,29), the catalytic domain of LD was 
proposed to be preceded by an N-terminal part 
including a sequence of unknown function and 
a CBM48 module (26). 
Besides the biologically important roles in 
starch biosynthesis and degradation, HvLD 
catalyzed hydrolysis of branched 
maltooligosaccharides in malting and mashing 
is central for beer production (30). Although 
HvLD was studied since the fifties (31) insight 
is lacking both on the precise biological role of 
HvLD and on the molecular basis for its 
substrate specificity also in industrial 
processes. 
The crystal structures of HvLD in complex 
with the inhibitors α- and β-CD are described 
and represent the first LD crystal structures. 
The two LD/ligand complexed structures 
provide novel insight on the carbohydrate LD 
interactions at the substrate main-chain 
aglycone binding subsites +1 and +2. The 
protein carbohydrate recognition and residues 
involved in specificity are discussed including 
structures of other α-1,6 acting enzymes. 
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EXPERIMENTAL PROCEDURES 
 
Crystallization and Data Collection. HvLD  
showing Km,app = 0.16 mg/ml and kcat,app = 78 s-1 
toward pullulan and a single band on SDS-
PAGE was obtained using Pichia pastoris as 
host and concentrated to 9 mg/ml for the initial 
crystallization screens (19). Initially, 
crystallization using the hanging-drop, vapor-
diffusion method was explored with Crystal 
Screen™, Crystal Screen™ 2, and PEG/Ion™ 
Screen (Hampton Research, Aliso Viejo, CA 
) at 22 °C. The HvLD solution contained β-CD 
in a 1:10 molar ratio. Crystals obtained from 
different condition in the PEG/Ion Screen all 
showed the same crystal morphology, i.e., 
bundles of very thin needles. These were used 
for micro-seeding in later screens.  
Prior to crystallization, HvLD (20 mg/ml; 
50 mM MES, pH 6.6, 250 mM NaCl) was 
incubated on ice with α- or β-CD in 6-fold 
molar excess and final HvLD concentration of 
13.3 mg/ml. The crystallization drop was 
placed on cover slips mixing 1.5 µl HvLD-CD 
with 1 or 2 µl reservoir solution. Additive 
Screen I–III (Hampton Research) was used to 
optimize crystallization conditions. Based on 
the additive screen cysteine (0.2 µl, 0.1 M) 
was added to the drop to a final concentration 
of 5–7 mM. HvLD:β-CD co-crystals were 
obtained using a reservoir solution of 22% 
(w/v) PEG 3350, 5% (v/v) glycerol, 0.3 M NaI 
and streak seeding the drops, or a reservoir 
solution of 30% (w/v) PEG 3350, 10% (v/v) 
glycerol, 0.3 M NaI without seeding. HvLD:α-
CD co-crystals were obtained using a reservoir 
solution of 30% (w/v) PEG 3350, 0.3 M NaI 
without seeding. In all cases, crystals appeared 
within one week. HvLD:β-CD crystals grown 
in 22% (w/v) PEG and 5% (v/v) glycerol were 
cryo-protected using a 1:1 mix of reservoir 
solution and PEG 400. HvLD:α-CD crystals 
were cryo-protected using a 1:1 mix of 
reservoir solution and 30% (w/v) PEG 3350, 
10% (v/v) glycerol, 0.3 M NaI. All crystals 
used for data collection were mounted on 
Mesh Litholoops (loop size 0.2 mm and mesh 
size 40 µm; Molecular Dimensions, 
Newmarket, UK) and flash-frozen in a steam 
of nitrogen. Crystal mounting in conventional 
cryo-loops gave rise to excessive mosaicity in 
the diffraction data. 
X-ray diffraction data of HvLD:β-CD 
crystals were collected at the ESRF, Grenoble, 
France at the micro focus beamline ID23-2 at a 
wavelength of 0.873 Å. X-ray diffraction data 
of HvLD:α-CD were collected at MAX-lab II, 
Lund University, Sweden at beamline I911-5 
at a wavelength 0.91 Å. 
 
Phasing, Model Building, Refinement and 
Structural Analysis. The data were integrated 
in Mosflm (32) scaled using the program Scala 
from the CCP4i Suite (33,34), and the 
resultant structure factors were used for 
molecular replacement using Phaser (35) 
based on residues 177–1070 from KpPUL 
(PDB code: 2FGZ). The initial HvLD:β-CD 
model was build using Phenix.autobuild from 
the molecular replacement (MR) phases and 
included 95% of the HvLD amino acid 
residues. Several rounds of model building and 
refinement were needed for both HvLD:β-CD 
and HvLD:α-CD using Phenix.refine (36) with 
simulated annealing and 
translation/libration/screw (TLS) refinement 
(15 segments) activated (37) and COOT 0.5.2 
(38) for molecular visualization, validation and 
rebuilding. The HvLD:β-CD structure was 
used as model for MR to solve the structure of 
HvLD:α-CD. In addition to the COOT 
validation functions, final analysis of model 
geometry optimization were done in 
PROCHECK (39) and Molprobity (40). The 
structure of HvLD was compared with 
KpPUL, (apo, PDB code: 2FGZ; G4, 2FHF), 
Bacillus subtilis str. 168 (BsPUL) (2E8Y), and 
BaPUL (2WAN), as well as isoamylase from 
Pseudomonas amyloderamosa (PaISO) (1BF2) 
and E. coli glycogen branching enzyme 
(1M7X) using the program Pymol 1.1 which 
was also used for rendering the structural 
figures (41). The protein secondary structure 
motifs were obtained from PDBsum which are 
computed using PROMOTIF v.3.0 (42). The 
final round of phenix.refine included all 
reflections, while all other refinement rounds 
had 5% randomly chosen reflections kept aside 
as test set. 
 
RESULTS 
 
Crystallization, Structure Determination and 
Model Quality. While initial crystallization 
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trials of HvLD failed to produce crystals 
within three months, the PEG/Ion Screen 
ultimately resulted in protein crystals within a 
year. HvLD was found to crystallize as 
bundles of very thin needles under different 
conditions, which all contained either iodine or 
thiocyanate. The crystal morphology did not 
depend on protein or precipitant concentration, 
but addition of cysteine resulted in thicker 
separate, single crystal needles. Crystals 
obtained from seeded drops were very 
homogenous and measured 0.002 × 0.002 × 
0.006 mm3, while crystals obtained without 
seeding were slightly bigger and of highly 
variable quality. The seeded needles diffracted 
to 2.6 Å and belonged to space group P212121, 
with one molecule in the unit cell and cell 
dimensions of a = 85.0 Å, b = 93.8 Å and c = 
114.7 Å. The non-seeded crystals of HvLD:β-
CD and HvLD:α-CD were of space group C2 
and diffracted to 2.1 Å and 2.5 Å, respectively, 
with one molecule in the unit cell and solvent 
contents of 43.7% (HvLD:β-CD) and 47.2% 
(HvLD:α-CD). Cell dimensions are given in 
Table 1 that summarizes data collection 
statistics. 
The final structures show overall good 
electron density. However, the first two amino 
acids and residues 22–28, 40–49, and 102–109 
in the N-domain had low level or no sigmaA 
weighted 2Fo-Fc electron density and were not 
included in the models. In addition to the three 
loops in the N-domain, loop 806–810 in the C-
domain had less than 1σ 2Fo-Fc electron 
density for both side- and main-chain atoms. 
Two calcium ions, iodide (9 in HvLD:α-CD; 5 
in HvLD:β-CD), glycerol (one in HvLD:α-CD; 
7 in HvLD:β-CD) and water molecules (223 in 
HvLD:α-CD; 604 in HvLD:β-CD) are 
modeled and the resulting Rcryst and Rfree from 
the refinement are 16.3% and 20.0% for the 
HvLD:β-CD and 17.7% and 22.6% for the 
HvLD:α-CD structure, respectively (Table 1). 
Rcryst dropped to 15.7% and 17.3%, 
respectively, in the final refinement cycle that 
included all reflections. The HvLD moieties of 
the two cyclodextrin complexes are virtually 
identical with an r.m.s.d. of 0.7 Å for all Cα 
atoms. Due to the higher resolution of the 
HvLD:β-CD, this complex is used to describe 
the overall structure. 
The geometry of the models is good with 
approximately 89% of the residues in the most 
favored region of the Ramachandran plot and 
only one residue (Phe566) in a disallowed 
region. Phe566 is in a turn in the loop between 
β-strand 6 and α-helix 6 of the (β/α)8-like 
barrel. The unfavorable ϕ and ψ angles in this 
tight turn could be caused by the bi-dentate 
salt bridge between the spatially adjacent 
Glu568 and Arg875, and the multiple hydrogen 
bonds emanating from Gln559: Gln559 Nε2 - 
Glu568 O, Gln559 Nε2 - Thr563 O, Gln559 Oε1 - 
Gln574 Nε2 and Gln559 Oε1 - Asn570 N. In 
addition, the aliphatic part of the Arg581 side-
chain contributes to hydrophobic interactions 
with the side-chain of Phe566. Three residues 
Ala439, Ala515 and Asn643 were found in the 
generously allowed region of the 
Ramachandran plot. Ala439 is in the center of a 
loop located in between two α-helices in the 
B-domain part of the catalytic domain (23). 
The β-turn in the loop is sustained by the 
hydrogen bond between the main-chain Ala439  
N and the main-chain Asn436 O. Ala515 is 
borderline to an additional allowed region in 
the ϕ/ψ plot and placed in the loop region, 
which also contains the general acid, Glu510 
and Trp512 (at subsite +2, see below for 
detailed description). The exact position of this 
loop exposes Phe514 towards subsite +2. It is 
influenced by hydrogen bonds between Asp513 
Oδ1 - Asn525 Nδ2, Asp513 Oδ2 - Ala N, Glu516 
Oε1 - Ser437 Oγ, Glu516 Oε2 -Asn442 Nδd and 
the salt bridge Glu516 Oε2 - Arg427 Nη1. The 
strained ϕ and ψ angles of Asn643, which is 
positioned next to the third acid in the catalytic 
site, is due to the Asn643 N - Arg697 O hydrogen 
bond, but also the direct interactions of the 
side-chain with the β-CD glucose residue at 
subsite +1 could have an effect.  
 
Overall Structure. The final model of HvLD in 
complex with β-CD is shown in Figure 1. The 
domain boarders, indicated by sequence 
alignment with structurally related proteins 
(23), are slightly displaced relative to those 
seen from the HvLD structure. The structure 
comprises four structural domains; the N-
domain (reidues 3–124) of unknown function, 
a carbohydrate binding module (125–230) 
assigned to CBM48 of which a few members 
have been demonstrated to bind to glycogen 
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(26), the catalytic domain (231–774), and the 
C-domain (775–885) of unknown function. 
The N-domain consists of 8 β-strands arranged 
primarily in an anti-parallel fashion and 4 α-
helices: the CBM48 contains 9 strands and 2 
α-helices; while the catalytic domain has 33 α-
helices and 12 β-strands. The core of this 
domain forms a (β/α)8-like barrel (Suppl. 
material Table S2) resembling the 
corresponding domain in α-amylases (25,43) 
except that HvLD has no helix α5, but a loop 
connecting β5 and β6 which carries Trp512 and 
embeds subsite +2. As observed in the KpPUL 
structure (27) and previously described as 
Loop 2 (23,27,44), a long loop protrudes from 
the barrel scaffold following the second β-
strand, which includes Tyr357 and forms part 
substrate binding subsite –1 (see below for 
detailed description of the active site). The 
loop referred to as the B-domain extends from 
β3. It makes part of the active site cleft 
contributing to accommodate the 
oligosaccharide substrate branch chain as 
identified by superimposition of HvLD:β-CD 
with the KpPUL:maltotetraose (G4) complex. 
Finally, the C-domain comprises a β-sandwich 
fold, in which each of the two sheets in the 
sandwich contains 4 β-strands flanked by 4 
short α-helices. 
Two Ca2+ binding sites were found in 
both HvLD:α-CD and HvLD:β-CD (Fig. 2). 
The first site is located in Loop 2 close to 
subsite –1 and Tyr357 and is identical to one of 
the five Ca2+ binding sites identified in KpPUL 
(27). It shows pentagonal bipyramidal 
geometry, with Ca2+ ligated by the side-chain 
oxygen atoms of Asp351 (Oδ1) and Asn701 
(Oδ1), the main-chain carbonyl oxygens of 
Gln348 and Tyr353 and three water molecules 
(Fig. 2A). The average Ca2+-O distance is 2.6 
Å. The second HvLD Ca2+ site has an 
octahedral geometry. The Ca2+ ligands are the 
side-chain oxygen of Ser297 Oγ, main-chain 
carbonyl oxygens of Gly393, Leu301 and Ser297, 
and two water molecules. This site is located 
in the catalytic domain and connects the loops 
extending from the C-terminal ends of β-strand 
2 (Loop 2) and 3 (B-domain) (Fig. 2B). The 
average Ca2+-O distance is 2.7 Å. One 
negatively charged residue contributes to 
metal binding in site 1, while no negative 
charge contributes to metal binding in site 2. 
 
The Active Site of HvLD and Cyclodextrin 
Binding. The active site is defined by the 
positions of the catalytic residues, i.e. the 
catalytic nucleophile Asp473, the general 
acid/base catalyst Glu510 and the third catalytic 
site acid Asp642 (Fig. 1 and Fig. 3B-D) as 
confirmed by sequence alignment (24,44,45). 
The α- and β-CDs are bound at this site (Fig. 
3B). Designation of the substrate-binding 
subsite numbering is in accord with previous 
definitions (27,46). Subsites at the reducing 
end of the substrate are defined by positive 
numbers and subsites at the non-reducing end 
have negative numbers, all starting from the 
point of hydrolysis (46). The active site of 
HvLD is composed of two binding sites; the 
first (the branch binding site) is defined by 
subsites –1 and –2 and the second (the main-
chain site) comprises subsites +2 through 0’ 
(Fig. 3A). Due to different structural restraints 
imposed by the cyclic six- and seven-
membered oligo-glucoside rings, α- and β-CD 
bind differently to HvLD (Fig. 3B) and β-CD 
(Kd = 0.7 µM) has 40-fold higher affinity for 
HvLD than α-CD (Kd = 27.2 µM) (19). 
Several amino acid residues of HvLD are 
involved in binding of β-CD (Fig. 3D and Fig. 
4). The majority of β-CD-protein interactions 
occur at subsite +2. Asp541 Oδ2 is in hydrogen 
bond contact with Glc O2, Arg544 Nη2 interact 
with Glc O2, and Nη1 interacts with Glc O3 
(Fig. 4). The position of Arg544 is further 
stabilized by a hydrogen bond between Arg544 
Nη1 and the hydroxyl group of Tyr637 (Fig. 
3C, D). Finally, the indole ring of Trp512 stacks 
with the Glc at subsite +2 (Fig. 3C, D and Fig. 
4). The Trp512 Nε1 interacts with the general 
acid/base Glu510 Oε2, stabilizing the position 
of this pivotal residue. At subsite +1, Asn643 
Nδ2 interacts with O3 of Glc. Furthermore, 
Asn643 Oδ1 interacts via a water molecule with 
O2 and O3 of Glc at subsite 0’ (Fig. 3B; Fig. 
4). In addition, van der Waals interactions 
between Arg697 and Glc at subsite 0’ are 
observed. Binding at this site could be 
stabilized by water mediated contacts to Arg697 
O and Asp698 Oδ1. Finally, the aromatic ring of 
Phe553 is immersed in the central cavity of the 
β-CD molecule having van der Waals 
interactions or possibly weak aromatic 
hydrogen bonds (C(-H)..O distance = 3.3 Å–
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3.9 Å) to O4 of several Glc units of β-CD (Fig. 
3D). The Phe553 Cζ is situated in the plane 
defined by the β-CD Glc residues, with an 
approximate inclination between this plane 
and the plane of the Phe553 aromatic ring of 
20°. Furthermore, the Phe553 O interacts via a 
water molecule with O3 of Glc of β-CD 
opposite subsite –1 (Fig. 4). This interaction is 
not present in HvLD:α-CD. Comparing the α-
CD and the β-CD HvLD complexes we 
suggest that the 40-fold weaker binding of α-
CD (19) to be due to lack of interaction 
between Arg697 and two Glc residues both 
directly or via water mediated contact (Fig. 
3B), lack of interaction of Asn643 Nδ2 and an 
O3 as well as a missing water mediated 
interaction between Asn643 Oδ1 and O2 and 
O3 atoms at subsite 0’, the absence of a 
hydrogen bond between Asn551 and the Glc 
residue at subsite +4 (Fig. 4) and a less 
favorable interaction with Phe553. The α-CD 
plane is ~1 Å below the Phe553 Cζ atom and 
the inclination between the aromatic ring plane 
and the α-CD Glc residues is close to 45°, 
which might give rise to loss of the hydrogen 
bond character of the interaction. Both CDs 
have some less well-defined Glc residues (at 
subsites 0’ and –1’) with weighted 2Fo–Fc less 
than 1.0σ. Despite the fact that these Glc 
residues are within interaction range of HvLD 
(Fig. 3C) they cannot be major contributors to 
the binding. 
Glycerol from the crystallization buffer 
(HvLD:β-CD) and the cryo-protectant was 
found in the active site of HvLD:β-CD 
(Fig.3D). Co-crystallized glycerol (Gol) bound 
in the active site of carbohydrate active 
enzymes is a well known phenomenon (47,48). 
Arg471 interacts with Gol302 in the active site of 
HvLD as do the three catalytic residues, while 
the second glycerol molecule found at the 
active site (Gol303) are in direct hydrogen bond 
contact with the catalytic nucleophile Asp473 
Oδ1/Oδ2 and via water mediated hydrogen 
bonds with Glu510 Oε1/Oε2. Moreover, Gol303 
is at a distance of 4.2 Å of Tyr357 (Fig. 3C, D). 
Superimposition of HvLD:β-CD and 
KpPUL:G4 (27) shows that the two Gol303 
primary hydroxyl groups superimpose 
perfectly with O6 and O5 of Glc at subsite −1 
and that the secondary alcohol group is in 
close proximity to O4 of the same Glc residue. 
In addition, three water molecules in the 
HvLD structure are located at the positions 
corresponding to O1, O2 and O3 of the same 
Glc residue at subsite –1 of KpPUL (Fig. 3A). 
Additional five glycerol molecules (Gol301, 
Gol304–Gol307) were found in HvLD:β-CD 
(Fig. 1). One (Gol306) is buried in a part of 
Loop 2 while the rest are solvent exposed. 
Two were situated on the surface interacting 
directly or via water molecules with HvLD, 
whereas one was found in the groove formed 
at the interface of the CBM48 domain and the 
catalytic domain. The last glycerol molecule 
was in a solvent channel between the N-
domain and the CBM48. Possibly because 
glycerol was not included in crystallization 
conditions for HvLD:α-CD but only used as 
cryoprotectant only one Gol molecule was 
found in the HvLD:α-CD structure, which was 
buried in Loop 2 similar to Gol306 in HvLD:β-
CD. 
  
DISCUSSION 
 
The Overall Structure. The closest structural 
relative to HvLD is KpPUL (PDB code: 
2FGZ). Both enzymes belong to GH13 
subfamily 13 (15) and have an overall 
sequence identity of 30.2% and a similarity of 
45.6% (49). KpPUL served, despite this large 
difference in primary structure, as template for 
molecular replacement to solve the structure of 
HvLD. Important induced-fit movement was 
observed by binding substrate analogues 
(maltose, maltotriose and  maltotetraose) to 
KpPUL (27). The different geometries 
between β-CD and α-CD were not large 
enough to result in significant conformational 
differences at the active site. However, HvLD 
crystal were not obtained in the absence of 
cyclodextrin inhibitors, possibly due to a more 
flexible and/or differently folded +2 subsite in 
the apo-protein, as observed for KpPUL (27).    
The two HvLD molecules located around 
the crystallographic two-fold symmetry axis 
have active sites facing each other in C2 
(Suppl. material Fig. 1S), while this is not the 
case in P212121 crystals. The N-terminal 
domain that appears flexible and has poorly 
defined loops, makes up one half of the 
molecular interface of the crystallographic 
dimer. A pore (diameter 52 Å) separates the 
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active sites in the crystallographic dimer. A 
similar pore, but with a diameter of 66 Å was 
found in KpPUL and speculated to be relevant 
for the binding of polysaccharide substrates 
(27), even though there is no evidence that 
KpPUL dimerises in solution. The presence of 
an extra N-terminal domain in KpPUL can 
explain the larger pore diameter. The presence 
of similar pores leading to the substrate 
binding site in the crystal structures of KpPUL 
and HvLD may suggest a functional 
importance of the pore. A similar dimeric 
molecular organization, however, was not 
observed for the phylogenetically more distant 
BsPUL and BaPUL both belonging to GH13 
subfamily 14. BsPUL and KpPUL both 
degraded glycogen (50,51), in contrast to 
HvLD that cannot hydrolyze glycogen and has 
less <1% of the activity level towards pullulan 
towards amylopectin (13). The molecular 
interactions of crystallographic dimers for the 
debranching PaISO (GH13 subfamily 11) 
differ from those observed in KpPUL and 
HvLD. PaISO shows a preference for larger 
more complex polymers such as amylopectin 
and glycogen and their β-limit dextrins, but 
has no activity towards pullulan and low 
activity towards dextrins (52,53). 
 
Carbohydrate Binding Module 48. CBM48 
motifs from GH13_12, GH13_13 and 
GH13_14 members are all localized N-
terminal to the catalytic (β/α)8-barrel (26). This 
is also the case in HvLD (Fig. 1). Structure-
based alignment of CBM48 with CBM20, that 
is known to bind onto raw starch (54), shows 
that two tryptophans identified as key residues 
in the interaction with starch or the starch 
mimic β-CD (55), are conserved in CBM48 - 
or the glycogen binding domain (GBD) of 
AMP-activated protein kinase from Rattus 
norvegicus. Furthermore, Trp33 and Trp100 of 
GBD are identified in the structure of the β-
CD complex as critically involved in binding 
β-CD to GBD. These tryptophans, however, 
are both missing in CBM48s of KpPUL (26) 
and HvLD. In HvLD, Tyr212 corresponds to the 
second tryptophan, Trp100 in GBE, and is 
situated in a cleft and is not exposed on the 
surface as is the case of Trp100 in GBD. This 
indicates that if HvLD CBM48 is involved in 
carbohydrate binding, then the binding-mode 
and key residues differ from those interacting 
in GBE CBM48. So far functional roles in 
carbohydrate binding have not yet been 
confirmed experimentally for any pullulanase 
(26). 
Despite the 6-fold molar excess of CDs 
present in the HvLD-CD mix used for 
crystallization, neither α-CD nor β-CD were 
found to be bound to the CBM48 domain in 
the HvLD structure, which is in agreement 
with the observed failure of HvLD to bind 
onto raw barley starch granules (21).  
Ca2+ Binding Sites. The Ca1 site (Fig. 
2A) is buried in the enzyme (solvent exposed 
surface area is 1.1 Å2) and only accessible for 
solvent via two of the seven ligands. All 
protein ligands coordinating the Ca2+ except 
Asp701 are from the long protruding Loop 2 
that is an important part of the catalytic 
domain and contributes to the active site. 
Asn701 however, is situated next to Tyr700 that 
interacts with Glc bound at subsite –2 
(identified by superimposition of HvLD:β-CD 
and KpPUL:G4). By connecting Loop 2 with 
the core of the catalytic domain and thereby 
shaping a part of the active site, Ca1 is likely 
to be functionally relevant despite an average 
Ca2+-O distance of 2.6 Å compared to a mean 
Ca-O distance in proteins of 2.4 Å (56).  
The Ca2 site is more accessible (solvent 
exposed surface area is 22 Å2) and interacts 
with ligands from helices α1 and α2 of the 
(β/α)8-barrel. The Ca2+ interacts with the 
protein through only main-chain atoms and 
this site does not resemble any of the known 
high affinity sites in α-amylases (57). The site 
has even longer average Ca2+-O distances than 
site 1 (average length 2.7 Å) and therefore 
may be a crystallization artifact rather than a 
structural relevant site. 
 
(β/α)8-Barrel and Substrate Binding Subsites. 
The (β/α)8-like barrel of HvLD has no α-helix 
5. This is also observed in several other α-1,6 
acting enzymes, e.g. KpPUL (27), PaISO (58) 
and neopullulanase from Bacillus 
stearothermophilus (59). These findings 
suggest that the lack of α5 contributes to the α-
1,6 specificity, whereas the more conserved 
barrel β-strands 3, 4, 5 and 7 strands and the 
loops immediately following these strands 
provide a scaffold for the residues involved in 
catalysis and substrate binding in both α-1,4 
and α-1,6 acting enzymes. Due to the missing 
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fifth helix the barrel domain has a spacious 
pocket where the reducing end of the substrate 
is accommodated and the enzyme becomes 
less discriminating towards branching in 
general. Even more important, Trp512 gets in 
position for excellent stacking with Glc at 
subsite +2 (see below). Despite high structural 
similarity around the active site there are 
distinct differences between HvLD and 
KpPUL especially in the loop replacing 
between β5 and β6, which is Asp513–Asn520 in 
HvLD and Asp709–Ser713 in KpPUL, which 
differ in both sequence and in conformation. 
The longer loop in HvLD includes Phe514 and 
seems to narrow the active site cleft near 
subsites +1 and +2 by 1–3 Å. This loop may 
therefore contribute to the substrate specificity 
difference observed between HvLD and 
KpPUL (13,50,60). 
In addition Met440 located in a β-turn of 
B-domain is specific for HvLD and seems 
essential for its substrate specificity. 
Superimposition of HvLD:β-CD onto 
KpPUL:G4 thus shows that Met440 clashs with 
Glc at subsite –4 and this steric hindrance may 
prevent binding of substrates with a branch 
chain of four Glc or longer. It is reasonable to 
believe that HvLD has preference for branches 
no longer than three Glc units. In KpPUL this 
particular β-turn is stabilized by a Cys643 − 
Cys644 disulfide and by interaction between 
main-chain Cys643 O and O4 of the Glc residue 
at subsite –3. The position of the main-chain 
carbonyl group of HvLD Ala439 is identical to 
that of the KpPUL Cys643, suggesting that 
Ala439 may interact with substrate in HvLD. 
That subsite –3 is involved in substrate chain-
length preference agrees with the relative rate 
of hydrolysis by HvLD of 63-α-
maltotriosylmaltotetraose, being 2-fold higher 
than of 63-α-maltosylmaltotetraose (13). At 
subsite –2, stacking between Tyr700 and a Glc 
residue results in very well-defined binding. 
Furthermore, the distance from Asp698 Oδ1 and 
Oδ2 to O2 and O3 of the Glc residue at this 
subsite is suggested to be within 3–3.5 Å by 
superimposing KpPUL:G4 and HvLD and 
thereby likely to strengthen binding at subsite 
–2. 
The loop between β4 and α4 contains the 
catalytic nucleophile in GH13 identified as 
Asp473 in HvLD by sequence alignment (24). It 
contributes together with Tyr357, His404, Arg471, 
Glu510, Asp642 and main-chain Ala438 O to form 
subsite –1. The Gol303 and three water 
molecules (w68, w115, w224), mimicking a Glc at 
subsite –1, give credibility to the position of 
the proposed α-1,6 linkage cleavage site. 
A conserved Leu474 in HvLD found in 
strictly α-1,6 specific hydrolases, i.e. Leu 678 in 
KpPUL, Leu 376 in PaISO, Leu 623 in BaPUL 
and Leu 407 in BsPUL, adjacent to the catalytic 
nucleophile, obstructs formation of a subsite 
+1’ for a α-1,4 linked Glc residue, 
corresponding to subsite +1 in α-1,4 active 
enzymes. This leucine neighbors Trp512 
thereby aid defining subsite +2 and is 
proposed to be a key residue in discriminating 
α-1,4 from α-1,6 acting enzymes. 
Neopullulanases and amylopullulanases both 
displaying dual (α-1,4 and α-1,6) activity have 
the shorter Val rather than Leu at this position, 
which allows binding at subsite +1 (α-1,4 
substrate binding).  
Among the most striking differences 
found by comparison of HvLD and PaISO 
structures is the presence of Loop 2 and the  33 
residues longer loop between β8 and α8 in 
HvLD as well as the significantly longer loop 
in PaISO between β7 and α7. Loop 2 and in 
particular the long β8-α8 loop makes the cleft 
around subsites –2 through –4 and 0’ to –1’ 
narrower in HvLD, which may disfavor 
binding of additional branched chains as found 
in glycogen and glycogen β-limit dextrins. 
However, the observed difference in activity 
towards amylopectin β-limit dextrins and 
amylopectin (13) is probably, in part, caused 
by the difference in the length of the branch-
chain extending from subsite –2/–3, where 
Met440 prevents optimum binding due to steric 
hindrance (as described above). Finally, the 
side-chain of the solvent exposed Phe620 
showed no significant electron density, which 
indicates a high flexibility. Phe620 will, 
however, irrespective of this flexibility 
narrows the cleft extending from subsite +2 
and may therefore be important for substrate 
specificity by restricting binding of longer 
substrates. 
 
Mechanism. HvLD catalyzes hydrolysis of α-
1,6 glycosidic bonds via general acid catalysis 
that requires a catalytic nucleophile (Asp473) 
and a catalytic acid/base proton donor (Glu510). 
Cleavage of the α-1,6 linkage results in 
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retention of the anomeric configuration via a 
double displacement mechanism, characteristic 
of the GH13 family (24). The two-step 
reaction involves nucleophilic attack from 
deprotonated Asp473 forming a covalent β-
glycosyl intermediate and simultaneously 
protonation of the leaving aglycone by Glu510. 
The oxocarbonium ion-like transition state is 
believed to be stabilized by side-chains from 
several conserved amino acids in the active 
site, especially His404 and His641 (45,61). The 
deprotonated Glu510 acts as base by activating 
the acceptor being either water or the primary 
alcohol at C6 in the Glc residue in the 
intermediate, which results in overall retention 
of the α configuration in either hydrolysis 
(Fig. 5A) or transglycosylation forming a new 
α-1,6 glycosidic bond (Fig. 5B).  
The interaction between Gol303 and His404 
suggests that His404 stabilizes the charged 
oxocarbonium ion-like transition state. The 
position of His641 in a superimposition of 
HvLD:β-CD and the KpPUL:G4 complex 
indicates that the distances from ε2 of the 
imidazole side-chain to O2 and O3 of a Glc 
unit at subsite –1 are ~2.9 Å which supports 
His641 to play a role in transition state 
stabilization. 
HvLD is known to act as a transferase at 
higher substrate concentration resulting in 
substantial transglycosylation despite a highly 
solvent accessible active site (13,19). A similar 
open active cleft is observed in E. coli 
glycogen branching enzyme (62). One 
explanation for the transferase activity, 
however, could be that at high substrate 
concentration simultaneous binding of 
carbohydrate chains at subsites –1 through –
2/–3 and at subsite 1’ through +2 excludes 
water from the active site prior to the 
nucleophilic attack and formation of the 
covalent intermediate thereby preferentially 
allowing the transfer of a carbohydrate chain 
to the other by formation of an α-1,6-
glucosidic linkage. This assumes that the 
affinity at the aglycone subsites is high enough 
to maintain high carbohydrate ligand 
occupancy. It is tempting to speculate that the 
affinities of these sites are crucial in 
modulating the transglycosylation versus 
hydrolysis. 
It is unknown if the proposed role of plant 
LD in starch biosynthesis only involves 
trimming of newly synthesized branch points, 
or if LD is involved also in the formation of 
new α-1,6 branch points. However, 
independent of the specific action of LD, 
evidence suggests that the morphology of the 
starch granule is highly dependent on the LD 
activity (7,8). This suggests LD as a key 
enzyme in production of tailor made starch for 
applications in food biotechnology and in 
bioethanol production. Rational mutational 
analysis based on the present HvLD 3D 
structure can be made to alter substrate 
specificity enabling formation of novel α-
glucans e.g. for the food industry. 
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FIGURE LEGENDS 
 
Fig. 1. Overall structure of HvLD. A. overall structure of HvLD:β-CD and the same structure rotated 
90°. N-domain in red, CBM48 in yellow, catalytic domain in light gray and C-domain in light cyan. 
Ca2+ in purple, I+ in orange, glycerol in blue and β-CD in green. The catalytic residues, Asp473, Glu510, 
and Asp642 are shown in dark gray. B. topology diagram of LD. α-helices are shown as cylinders in 
dark gray and labeled a, β-strands are shown as arrows in light gray and labeled b. 
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Fig. 2. The two Ca2+ binding sites in HvLD. A. The first Ca2+ binding site (Ca1) has pentagonal 
bipyramidal geometry. B. The second HvLD Ca2+ site (Ca2) displays an octahedral geometry. The 
Ca2+ is shown in gray, water molecules in dark gray and ligand side-chains in light gray with residue 
numbers in black. Polar interactions are shown with dashed lines. Ca2+ The distance between the Ca2+ 
and the ligand atom is shown by a black label. 
 
Fig. 3. Substrate binding site of HvLD. A. Superimposition of HvLD:β-CD on KpPUL:maltotetraose 
(G4) complex. Glycerol 303 is colored green, and water molecules in the active site of HvLD in red 
The glycerol and water 2Fo–Fc maps at 1.0 σ are shown as a grey mesh. The G4 molecules of the 
KpPUL:G4 complex are drawn in blue (representing the carbohydrate main-chain) and light blue 
(representing the carbohydrate branch chain). B. Superimposition of HvLD:β-CD on HvLD:α-CD. β-
CD and α-CD are colored in light gray and cyan, respectively, C. β-CD and glycerol bound in the 
active site of HvLD shown with or D. without the 2Fo–Fc maps. The 2Fo–Fc at 1.0σ and 0.6σ are 
shown as blue and green mesh, respectively. A, B, C and D, β-CD is colored in light gray, glycerol in 
green and HvLD active site residues in dark gray. The catalytic residues, Asp473, Glu510, and Asp642 
are shown in orange. The subsite numbers and residue numbers are black and gray, respectively 
 
Fig. 4. Schematic drawing of the LD residues interacting with β-CD. The figure was based on a 
cartoon generated by the program LIGPLOT (63). Both CDs have some less well-defined Glc 
residues (at subsites 0’ and –1’) with weighted 2Fo–Fc less than 1.0σ. 
 
Fig 5. The mechanism of HvLD catalysed α-1,6 hydrolysis with retention of the α-anomeric 
configuration. A, The reaction can result in hydrolysis or B, in formation of a new glucosidic bond 
(transglycosylation).  
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TABLES 
 
Table 1. Data collection and refinement statistics  
 
HvLD·β-CD HvLD·α-CD 
Protein Data Bank Code   
Data collection    
  Space group C2 C2                   
  Cell dimensions   
  a, b, c (Å) 175.0, 82.4, 59.4 174.8, 85.6, 61.1    
  α, β, γ (º)  90.0,  96.1,  90.0 90.0, 96.8, 90.0 
  Molecules/asymmetric unit 1 1 
  Wavelength 0.873 0.910 
  Resolution (Å) 41.2–2.10 33.5–2.50 
  Rsym (%) 12.8 (45.8)a 9.3 (42.6) 
  Mean(I)/σ(mean(I)) 11.4 (4.2)a 13.1 (2.3) 
  Completeness (%) 99.6 (99.2)a 97.0 (87)  
  Unique reflections 47764 (7091)a 12135 (3528) 
  Redundancy 4.3 (4.3)a 3.7 (3.1) 
Wilson B-factorb (Å2) 15.6 50.1 
Refinement   
  Resolution (Å) 41.2–2.10 33.5–2.5 
  Used reflections 48242 30653 
  Rcryst/Rfree (%) 16.4/20.4 17.7/22.6 
Final Rcryst 15.7 17.3 
  No. protein atoms 6709 6714 
  No. calcium ions 2 2 
  No. iodide atoms 5 9 
  No. of glycerol 7 1 
  No. of cyclodextrin 1 1 
  No. of waters 604 223 
  Mean B-factor (Å2) 12.2 35.1 
R.m.s.d. values from ideal   
  Bond lengths (Å) 0.003 0.003 
  Bond angles (º) 0.742 0.658 
Ramachandran plotc   
  Most favorable (%) 89.0 88.4 
  Additional allowed (%) 10.5 11.2 
  Generously allowed (%) 0.4 0.3 
  Disallowed (%) 0.1 0.1 
aHighest resolution bin. bFrom Truncate (33). cCalculated with Procheck (39). 
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SUPPLEMENTAL DATA 
 
FIGURE LEGENDS 
 
Fig. 1S. The crystallographic dimer of HvLD:β-CD around the crystallographic two-fold axis. The 
HvLD monomers are colored in light gray and cyan. β-CD bound in the active site is shown in red and 
glycerol molecules are colored blue. Ca2+ and I+ ions are shown as spheres and colored purple and 
orange, respectively. 
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TABLES 
 
Table S2. Secondary structure elements of the (β/α)8 barrel 
Structure element of 
the (β/α)-barrel 
Sequence 
β1 (b18) 256-TIYEL-259 
α1 (a13) 288-AGMEHLRKLSDA-299 
β2 (b19) 303-HVHL-306 
α2 (a18) 377-SRIIEYRQMVQALNR-391 
β3 (b22) 395-RVVMDV-400 
α3 (a20) 448-FMVDRLIVDDLLNWAVN-464 
β4 (b23) 469-GFRF-472 
α4 (a22) 480-KRTMMRAKSLQ-491 
β5 (b24) 506-YLYG-509 
α5 absent in structure 
β6 (b25) 537-GSFN-540 
α6 (a27) 577-EADTRRSLATYADQIQIGL-595 
β7 (b28) 634-TIN-636 
α7 (a30) 660-VDERCRINHLASMMAL-675 
β8 (b29) 680-IPFFH-684 
α8 (a37) 748-KGHILAALDSFVDILKIR-765 
Numbers in parenthesis refers to the position of the structural 
elements in the topology diagram in Fig. 1B. 
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N-terminal mutations of the high-affinity barley 
limit dextrinase inhibitor suggests a mode of action 
different from that of α-amylase inhibitors from the 
same family  
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 2
Abbreviations: CFHI, bifunctional corn Hageman factor inhibitor; CWW, cell wet weight; 
GH13_13, glycoside hydrolase family 13 subfamily 13; LD, limit dextrinase; LDI, limit 
dextrinase inhibitor; Ni-NTA, nickel-nitrilotriacetic acid; PAGE, polyacrylamide gel-
electrophoresis; PPA, porcine pancreatic α-amylase; RATI, ragi α-amylase/trypsin inhibitor; RU, 
response unit; SDS, sodium dodecyl sulfate; SPR, surface plasmon resonance; TFA, 
trifluoroacetic acid; TMA, α-amylase from the larvae of Tenebrio molitor  
  
 3
The barley limit dextrinase (LD) hydrolyses α-1,6-glucosidic linkages in limit dextrins and 
amylopectin during starch degradation in germinating seeds. LD forms an inactive complex with 
the endogenous limit dextrinase inhibitor (LDI) belonging to the CM-protein - or cereal-type 
inhibitor – family. Mode of inhibition and a possible role of the LDI N-terminal sequence for 
binding are examined. Recombinant production of LDI was established in Pichia pastoris and 
kinetics and energetics for recombinant wild-type LD binding wild-type and N-terminal 
sequence LDI variants were determined by aid of surface plasmon resonance (SPR). Fitting a 1:1 
binding model to SPR data showed a high-affinity of KD = 40 ± 3 × 10-12 M with association and 
dissociation rate constants kon ~ 1 × 106 M-1 s-1 and koff ~ 5 × 10-5 s-1 at pH 6.0, 150 mM NaCl and 
25 °C. KD depended on pH as koff increased 10-fold with pH being raised from the optimum for 
binding at pH 6.5 to pH 10, while kon was essentially unaffected. koff and kon changed only by 
factor of 2 in the range 75 mM – 1 M NaCl, thus electrostatic forces seemed not important for 
LD/LDI stability. van’t Hoff thermodynamic parameters, ∆H° = −27 kJ mol-1, T∆S° = 30 kJ mol-
1
 yielding a binding free energy ∆G°= −57 kJ mol-1, calculated from KD (10−35 °C) indicated 
that LD/LDI formation was both entropically and enthalpically favorable. N-terminal extended 
or truncated LDI sequence variants had KD marginally altered suggesting that wild-type LDI N-
terminal sequence is not essential for LD binding.  
 
 4
Barley limit dextrinase (LD) is a large multidomain enzyme belonging to subfamily 13 of 
glycoside hydrolase family 13 (GH13_13) (1, 2). LD catalyses hydrolysis of α-1,6-glucosidic 
linkages in limit dextrins, pullulan - a linear polysaccharide composed of α-1,6-linked 
maltotrioside repeats - and amylopectin and the concerted action of LD, α-glucosidase, α- and β-
amylase results in degradation of endosperm starch to maltose and glucose during the seed 
germination (3). The high activity of LD in oligosaccharide debranching in malt and during 
mashing contributes to the yield of fermentable sugars, hence making LD important in beer 
production (4). LD occurs in extracts of germinating barley seeds on a “bound”, inactive and a 
free, enzymatically active form, respectively (5). Inactive LD was proposed to exist in complex 
with an endogenous limit dextrinase inhibitor (LDI); extraction under reducing conditions 
resulted in full LD activity (5, 6). The amount of free LD increases with time after the onset of 
germination, coinciding with disappearance of LDI (5, 7). The important factor behind the loss 
of LDI, remains to be identified, however both LDI disulfide reduction by thioredoxin h (8) and 
proteolytic degradation (5) have been proposed  
LDI belongs to the CM-protein family of small 110–160 amino acid residues long proteins 
found in chloroform/methanol extracts of cereal flour. Inhibitors of this family also referred to as 
cereal-type inhibitors (9) include α-amylase and protease inhibitors primarily acting on different 
exogenous enzymes (9) and they were proposed to be part of the plant defense against pest and 
pathogens (9). CM-proteins occur in different states of oligomerisation (monomer, dimer or 
tetrameri) (10) and the monomer structure has a common four-helical bundle simple up-and-
down topology referred to as the bifunctional inhibitor/lipid-transfer protein/seed storage 2S 
albumin fold (SCOP: Structural Classification of Proteins (11)). Certain family members of high 
sequence identity (up 98%) still have distinct target enzyme specificity (12) and the structural 
variation responsible for this difference residing in a flexible loop connecting α-helices 3 and 4 
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and in the C-terminal region, makes prediction of interactions between inhibitors and enzymes 
challenging in the absence of a three-dimensional structure of the complex (12, 13). Loops near 
the enzyme catalytic site are also important for inhibitor complex formation (12). Cereal-type 
inhibitors formed 1:1 complexes with target enzymes (13-19), and acted as α- competitive 
inhibitors of amylase catalyzed p-nitrophenyl α-D-maltoside hydrolysis with Ki of 11–57 nM, 
depending on inhibitor and enzyme (14, 16, 17).  
 The Ser1 α-amino group of the α-amylase/trypsin bifunctional inhibitor from ragi (RATI) 
interacts via hydrogen bonds and electrostatic interactions directly with carboxyl groups of 
Asp185 and Asp287 from the catalytic site of α-amylase of larvae of Tenebrio molitor (TMA), as 
shown by X-ray crystallography. Furthermore, Val2 (RATI) with Trp56, Trp57 and Tyr60 (TMA) 
had important hydrophobic interactions (18). 
LDI of 114 amino acid residues included four disulfide bonds and one free thiol group - 
possibly  Cys59 (20). Two LDI forms of identical amino acid sequence and inhibitory activity 
were purified in very small amounts from mature barley seeds and showed different pI of 6.7 and 
7.2 due to glutathionylation and cysteinylation, respectively, at Cys59 (20, 21). Although binding 
of LDI to LD was found by mass spectrometric determination result in a 1:1 (15, 20, 21), 
detailed analysis was lacking on affinity and mechanism of binding. Modeling the LDI structure 
using RATI of 46% sequence identity as template proposed the fold to be shared with the CM-
proteins (13, 20, 22, 23). CM-family trypsin inhibitors share a loop sequence assumed to account 
for trypsin inhibition is lacking in LDI (15). LDI was suggested to bind to the active site of LD 
(20) in the same way as RATI interacts with TMA (18). This implies that the N-terminus of LDI 
is critical in complex formation with LD (20). It was suggested that LDI Ser4 and Val5 interact 
with LD and that the LDI tripeptide Thr1–Glu3 determines the specificity for LD and lack of 
inhibitory activity towards α-amylases (20). LDI purified from barley seeds showed some 
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variation in the the C-terminus, that makes it less likely that the C-terminal sequence participates 
in binding to LD (15, 21). LDI is found as highly specific for LD and does not inhibit the 
debranching pullulanase from Aerobacter aerogenes and isoamylase from Pseudomonas 
amyloderamosa (6).  
One reason for detailed insights into the LD/LDI system being missing has been difficulties 
with purification of LD and LDI from their natural sources. Very recently, however, we 
produced fully functional recombinant LD in excellent yields using Pichia pastoris, enabling 
determination of the structure (24, 25). Here is described successful expression also of LDI in P. 
pastoris allowing inhibition of studies of the LD catalyzed hydrolysis of pullulan as well as 
mutational analysis of the impact of the N-terminal sequence on the inhibitory potential using 
surface plasmon resonance (SPR).  
 
MATERIALS AND METHODS 
Materials. Restriction enzymes were from New England Biolabs (Ipswich, MA); T4 ligase 
(The LigaFast Rapid DNA Ligation System) was from Promega (Madison, WI); Expand High 
Fidelity Polymerase was from Roche Applied Science (Mannheim, Germany). Oligonucleotides 
were from Eurofins MWG Operon (Ebersberg, Germany). pPICZαA expression vector and 
Pichia pastoris expression strain X33 were from Invitrogen (Carlsbad, CA). Pullulan and Limit-
Dextrizyme tablets were from Megazyme (Bray, Ireland). Recombinant LD was produced as 
previously described (24). 
Cloning and Site-Directed Mutagenesis of LDI. Frozen barley seeds (cultivar Morex) were 
dehusked and homogenized in a mortar cooled in liquid nitrogen. RNA was extracted (RNeasy 
Plant Mini kit; Qiagen, Düsseldorf, Germany) and RT-PCR was done (One-Step RT-PCR Kit, 
Qiagen) using 5’-GAGAGACATATGACCCTGGAGAGCGTCAAGGACG-3’ (forward) and 
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5’-GGATCCCCTTATCCCGGCTCCTGGACGGACGA-3’ (reverse) primers. The cDNA was 
cloned into pCR 2.1-TOPO (Invitrogen) using the NdeI and BamHI sites (in bold) and the 
resulting plasmid was used for transformation of Escherichia coli TOP10 competent cells 
(Invitrogen). cDNA corresponding to amino acid residues 25−138 (accession No, ABB88573, 
NCBI Protein database) encoding a protein sequence identical to the previously published  (20, 
26), was used as template for PCR amplification of the expression construct using 5’-
AAAAAAAAAGAATTCACCCTGGAGAGCG-3’ (forward) and 5’- 
TGATTAACTGGTACCTTAATGATGATGATGATGATGTCCCGGCTCCTG-3’ (reverse) 
primers in a hot-start PCR at 94 °C (3 min), 3 cycles at 94 °C (30 s), 50 °C (30 s), and 72 °C (45 
s), followed by 22 cycles at 94 °C (30 s), 58 °C (30 s), and 72 °C (45 s) and a final elongation (7 
min). The PCR product encoding the LDI gene and a C-terminal hexa-histidine tag (in italic) was 
cloned in-frame with the Saccharomyces cerevisiae α-factor secretion signal of the pPICZα A P. 
pastoris vector using EcoRI and KpnI sites (in bold). The EcoRI site resulted in a Glu-Phe N-
terminal extension of the wild-type (EFTLESVKDECQ; denoted EF-LDI).) and site-directed 
mutagenesis (QuikChange® Lightning Site-Directed Mutagenesis Kit, Stratagene, La Jolla, CA) 
using 5’-GAGAAAAGAGAGGCTGAAGCTACCCTGGAGAGCGTCAAGGACGA-3’ 
(forward) and 5’-TCGTCCTTGACGCTCTCCAGGGTAGCTTCAGCCTCTCTTTTCTC-3’ 
(reverse) primers resulted in the native N-terminus (TLESVKDECQ; denoted wt-LDI). N-
terminal truncation of TLESV (denoted ∆V5LDI) was obtained (QuikChange® Lightning Site-
Directed Mutagenesis Kit) using 5’- 
GAGAAAAGAGAGGCTGAAGCTAAGGACGAGTGCCAACCAGGGGT-3’ (forward) and  
5’-ACCCCTGGTTGGCACTCGTCCTTAGCTTCAGCCTCTCTTTTCTC-3’ (reverse) primers 
(Figure 1). Correct wt-LDI and the predicted variants assumed processing at the second Ste13 
site of S. cerevisiae α-factor secretion signal in pPICZαA (27). Small scale plasmid preparation, 
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restriction enzyme digestion, ligation, and transformation followed standard molecular biology 
protocols (28). 
Expression and Purification of Wild-Type and Mutant LDI. Expression plasmids were 
linearized by PmeI, transformed into P. pastoris strain X33 by electroporation and selected on 
YPDS plates supplemented with 100 µg/mL zeocin (Invitrogen). Six clones of each construct 
were tested for production of LDI in culture flasks (100 mL BMGY media) (EasySelectTM Pichia 
Expression Kit, Invitrogen (27)). The cultures were induced after 24 h growth in BMGY medium 
at 30 °C by transferring to BMMY medium (27) at 17 °C. After 72 h methanol induction, cells 
were removed by centrifugation (12,000g, 4 ˚C, 30 min) and LDI production was verified by 
SDS-PAGE and LD inhibition  by measuring residual activity of LD (10 nM) after addition of 
culture supernatant (30 µL) using Limit-Dextrizyme tablets in 0.1 M Na acetate pH 5.5, 0.005% 
Triton X-100. To produce high amounts of LDI, selected wt-LDI and EF-LDI clones were 
cultured in a 5-L Biostat B bioreactor (B. Braun Biotech International, Melsungen  Germany) 
equipped with additional feed pump, gas mixer, dissolved oxygen tension polarographic 
electrode, and water cooler according to the guidelines for methanol feeding Mut+ phenotype 
(29, 30). Cells (OD600 = 22) grown in shake flask (300 mL) overnight at 30 °C in BMGY were 
harvested by centrifugation (1,500g, 20 ˚C, 5 min), resuspended in fresh BMGY (80 mL), and 
used for inoculating the starting basal salt medium (3 L) containing PMT1 trace salts (29). 
Temperature was maintained at 28 °C by water cooling during glycerol batch (~20 h) and fed-
batch (30 mL h-1 50% (w/v) glycerol; ~7 h) phases, adjusted to 17 °C prior to induction and 
maintained during the methanol feed (22–28 h). The methanol flow was successively increased 
from 1 g L-1 h-1 to reach the maximum of 11 g L-1 h-1 after 8 h.. Aqueous ammonia (28%) was 
added to maintain pH 5.5 and serve as nitrogen source.  
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The below detailed protocol ensured good yields of LDI. Cells were subsequently removed 
by centrifugation (12,000g, 4 °C, 30 min), the supernatant (3.2 L) was added sodium azide (to 
0.02% (w/v)). Imidazole and NaCl were added to culture supernatants to 10 mM and 500 mM, 
respectively, and pH was adjusted to 7.4 by addition of K2HPO4(s), followed by centrifugation 
(12,000g, 4 °C, 30 min) and filtration (0.45 µm) before application onto the Ni-NTA column (Ge 
Healthcare, Uppsala, Sweden) (120 mL h-1) equilibrated with 20 mM Na phosphate, pH 7.4, 10 
mM imidazole, 500 mM NaCl. After washing with equilibration buffer (60 mL h-1) LDI was 
eluted (60 mL h-1) by a two-step linear imidazole gradient of equilibration buffer mixed with 20 
mM Na phosphate pH 7.4, 500 mM imidazole, 500 mM NaCl (0–10%, 10 mL; 10–100%, 300 
mL). LDI containing fractions (5 mL) were identified by SDS-PAGE, and combined in two 
pools (2 × 50 mL), each concentrated (Centricon; 3 kDa cut-off, Millipore, Cork, Ireland) to 15 
mL and dialyzed (Spectra/por dialysis membrane, cut-off 6–8 kDa; Spectrum Laboratories, 
Rancho Dominguez, CA) against 2 × 5 L 5 mM Bicine/NaOH pH 8.5 and 1 × 5 L 10 mM 
Bicine/NaOH pH 8.5, centrifuged (12,000g, 4 ˚C, 30 min) and for anion exchange 
chromatography loaded (2 × 15 mL) onto a MonoQ 10/100 GL column (GE Healthcare) and 
washed (150 mL h-1; 150 mL) with the above buffer. Protein was eluted by a five-step linear salt 
and pH gradient of buffers A: 10 mM Bicine/NaOH pH 8.5 and B: 10 mM Hepes/NaOH pH 7.0, 
250 mM NaCl (0–12.5%, 24 mL; 12.5–25%, 160 mL; 25–30%, 8 mL; 30–38%, 15 mL; 38–
100%, 80 mL). LDI eluting as a single peak identified by the chromatogram and SDS-PAGE of 
collected fractions (4 mL) were pooled, concentrated and buffer changed to 10 mM 
Bicine/NaOH pH 8.5, 100 mM NaCl (Centricon, 3 kDa cut-off; Millipore).  
The ∆V5LDI variant was produced essentially as described above in shake flask culture (500 
mL) using 48 h induction. The supernatant was adjusted to pH 7.4, 10 mM imidazole, 500 mM 
NaCl and purified on Ni-NTA column (1 mL; as above), and buffer changed to 10 mM 
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Bicine/NaOH pH 8.5 (Microcon, 3 kDa cut-off; Millipore). ∆V5LDI (770 µg mL-1) gave a single 
band in SDS-PAGE as well as a single N-terminal sequence and was used for SPR analysis 
without further purification.  
An ÄKTAexplorer (GE Healtcare) interfaced by UNICORN 5.0 control software (GE 
Healtcare) was used for all chromatographic procedures. 
Protein Characterization. SDS-PAGE (NuPAGE® Novex Bis-Tris 4−12%) was performed as 
recommended by the manufacturer (Invitrogen). Protein concentration was estimated (Bradford 
Coomassie Plus kit; Pierce, Rockford, IL) using BSA as standard and by A280 using ε of 3.9 × 105 
M-1 cm-1, obtained by aid of amino acid analysis of LDI after 24 h acid hydrolysis (31). 
Automated Ν-terminal sequence analysis (Procise 494 sequenator; Applied Biosystems, Foster 
City, CA) was performed according to the manufacturer’s recommendations.  
LD inhibition. wt-LDI (0.1–0.2 µM, 300 µL; 10 mM Bicine/NaOH pH 8.5, 0.1 M NaCl) was 
preincubated with LD (52 nM, 1200 µL; 100 mM Na acetate pH 5.5, 5 mM CaCl2, 0.005% 
Triton X-100) for 15 min at 25 °C and 110 µL was added to 990 µL pullulan (DP ~ 300) at 8 
different concentrations (0.025−0.3 mg mL-1) in 100 mM Na acetate pH 5.5, 5 mM CaCl2, 
0.005% Triton X-100 at 37 ˚C to final concentrations of LDI and LD of 2 or 4 nM and 4.2 nM, 
respectively. Aliquots (200 µL) were removed at 3 min intervals during 0–15 min, stopped by 
mixing with 500 µL freshly prepared developing buffer (0.4 M Na carbonate pH 10.7, 2.5 mM 
CuSO4, 2.5 mM 4,4’-dicarboxy-1,2’-biquinoline, 6 mM L-serine) and 300 µL Milli-Q water (32) 
and the absorbance was measured after 30 min at 80 ºC in microtiter plates (300 µL, in 
duplicates) at A540. The release of reducing sugar was quantified using a maltose standard curve. 
Ki for inhibition of LD was determined from initial rates of pullulan hydrolysis with or without 
LDI added by fitting the model for tight competitive inhibition (eq. 1) to the data (Enzyme 
Kinetics Module 1.0 of Sigmaplot 9.01; Systat Software, Chicago, IL). Kapp is the apparent 
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inhibition constant when dissociation of the enzyme-inhibitor complex is affected by substrate 
addition. 
(eq. 1) [ ] [ ] [ ]( ) [ ] [ ]( ) [ ]  ⋅⋅+−−−−−⋅





⋅
= appappapi KKK
v
v E4IEIE
E2
20
,                                    
where [ ] 





+⋅=
m
iapp K
KK S1  
To determine the molar ratio for 100% inhibition, pullulan and LD concentrations were kept 
constant at 0.17 mg/mL and 4 nM, respectively, and the LDI concentration varied between 0 and 
20 nM in the assay, yielding LDI:LD molar ratios 0−5. The assay was carried out as above.  
Surface Plasmon Resonance. The LD/LDI interaction was analyzed by SPR (BIAcore® T100; 
GE Healthcare). Immobilization of LDI wild-type and variants on BIAcore CM5 sensor chips 
was performed by amine coupling according to the manufacturer’s protocol using 10 µg mL-1 
LDI in 5 mM Na acetate buffer pH 4 resulting in 200−400 response units (RU) bound in sample 
cells. Reference cells were treated by the same procedure without LDI. Sensorgrams (RU vs. 
time) of LD (0.1–80 nM) binding using 4 and 15 min association and dissociation times, 
respectively, were recorded. Regeneration was performed by 2 × 60 s injections of 10 mM 
glycine/HCl pH 1.5 at 30 µL min-1. Standard condition for binding kinetics was 25 °C, flow rate 
30 µL min-1 and seven LD concentrations (0.1–4 nM) in running buffer 10 mM Mes/NaOH pH 
6.0, 150 mM NaCl, 0.005% P-20 surfactant. The mass transfer rate constant, kt was obtained 
from binding kinetics for the LD/LDI interaction at 30 µL min-1 and 60 µL min-1 at 25 °C to 
evaluate possible mass transfer limitations.  
Effects of ionic strength and pH on the kinetics was determined as above at 75 mM – 1 M 
NaCl in the above running buffer and by using different running buffers all containing NaCl (150 
mM),; pH 5.0–5.5, 10 mM Na acetate; pH 6.0–6.5, 10 mM Mes/NaOH; pH 7.0–7.5 10 mM 
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Hepes/NaOH; pH 8.0–9.0, 10 mM Bicine/NaOH; pH 9.5–10.0, glycine/NaOH, respectively. 
Temperature dependence was measured at nine temperatures (10–45 °C) using standard running 
buffer and five LD concentrations (0.4–8 nM). Two independent data sets were collected for all 
conditions. All concentrations were analyzed in duplicates, except for 0.4 nM LD that was 
analyzed in quadruplicates and served as a control to assess the response level changes during 
the course of the experiment. Sensorgrams from reference cells were subtracted from sample cell 
sensorgrams to account for refractive index changes due to minor solvent differences and for 
possible nonspecific LD binding to the cell surface. The reference cell subtracted sensorgrams 
were corrected by subtraction of averaged blank sensorgrams (buffer injected) to account for 
drift specific for the sample cell. Double corrected sensorgrams from the different binding 
experiments were analyzed using BIAcore T100 Evaluation Software version 1.1. A 1:1 binding 
model (eq. 2) (33) also accounting for possible mass-transport limitations was fitted globally 
using non-linear regression to sensorgrams generated for each set of ligand concentrations to 
determine the association rate constant, kon (M-1 s-1) and dissociation rate constant, koff (s-1)  
 
(eq. 2)  LD

→LD + LDI
	

⇌
	
LD/LDI    
where LD0 and LD are the concentrations in the bulk and at the chip surface, respectively, and kt 
is the mass transfer rate constant (RU M-1 m s-1). The quality of the fits was judged by the 
residual plots given by the BIAcore T100 Evaluation Software.  
The equilibrium dissociation constant KD (M) is also determined from eq. 3. 
(eq. 3)   KD = koff/kon  
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The van't Hoff thermodynamic parameters at 25 °C and standard conditions were calculated 
from non-linear (eq. 4) and linear van’t Hoff (eq. 5) (BIAcore T100 Evaluation Software version 
1.1) equations using kinetic data of the temperature dependence between 10–35 °C. 
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Where ∆G°, ∆H° and ∆S° are the standard free energy, enthalpy, and entropy change, 
respectively. T is the absolute temperature (K), T0 is the reference temperature (298.15 K for 
standard conditions), ∆Cp° is heat capacity change under standard conditions, R = 8.314 J K-1 
mol-1 is the gas constant and KD is the equilibrium dissociation constant (3).  
Sequence Alignment and LDI Model Prediction. Multiple sequence alignment included LDI 
with four structure-determined inhibitors LDI, RATI, bifunctional corn Hageman factor inhibitor 
(CHFI), the dimeric and the monomeric wheat inhibitors 0.19 and 0.28 (ClustalW2 server; 
http://www.ebi.ac.uk/Tools/clustalw2/index.html). The pairwise alignment algorithms EMBOSS 
Needle was used for global alignment of LDI with RATI, CHFI, 0.19 and 0.28. LDI has 
previously been modeled (20), however, the homology modeling programs have evolved 
dramatically in the recent years (34), therefore RATI (PDB code: 1B1U) was used as template in 
LDI homology modeling using the default parameters of the HHpred server (Homology 
detection & structure prediction by HMM-HMM comparison, 
http://toolkit.tuebingen.mpg.de/hhpred#). The quality of the obtained LDI model was analyzed 
using the ProQ - protein quality prediction server (http://www.sbc.su.se/~bjornw/ProQ/ProQ.cgi) 
(35). 
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RESULTS 
Expression and Purification of LDI and LDI-mutants. Fed-batch high cell-density fermentation 
resulted in ~ 6 mg/L inhibitory active wt-LDI or EF-LDI in the cell free extract (3.2 L) as 
assessed by SDS-PAGE. The amount of LDI increased in the medium during the methanol phase 
despite a small decrease in CWW towards the end of the fermentation. EF-LDI and wt-LDI 
cultures were terminated after 22 h and 28 h induction at CWW of 170 g L and 120 g L, 
respectively. Both EF-LDI and wt-LDI eluted from Ni-NTA as two overlapping peaks, the first 
of which contained full-length and some lower molecular weight LDI fragments as shown by 
SDS-PAGE. Fractions were combined in two pools based on purity judged from SDS-PAGE and 
purified by anion exchange chromatography (supplemental material Figure 1). N-terminal 
sequencing showed partial truncation of the EF-LDI resulting in protein (∆E3LDI) lacking the N-
terminal pentapeptide, i.e. the N-terminal tripeptide (TLE) compared to wt-LDI, presumably 
caused by proteases present in the culture medium (36). This N-terminus corresponded to that of 
RATI (23) (see Figure 4) and ∆E3LDI is central for elucidating the functional role of the LDI N-
terminal sequence in the interaction with LD. Anion exchange chromatography resulted in highly 
pure wt-LDI with native N-terminus (supplemental material Figure 1).   
The∆V5LDI variant was obtained in a yield of 1.5 mg and N-terminal sequencing showed an 
unexpected EAEAKDECQ sequence in which EAEA (Figure 1) originates from the α-factor 
secretion signal, reflecting that the Kex2 site was used for processing rather than the Ste13 site 
(27). 
Kinetics of LDI Inhibition of LD. Rates of hydrolysis of pullulan by LD at different [LDI] 
enabled calculation of the Ki of LDI to 1.7 nM ± 0.1 by fitting the model for tight competitive 
inhibition (See Methods, eq. 1) (Figure 2A). The high standard deviation at inhibition by 4 nM 
LDI is due to low residual LD activity. Fifty percent inhibition of LD was obtained at a 1.1:1 
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(4.4 nM:4 nM) LDI:LD ratio and >90% inhibition was seen at a molar ratio of 2:1 (8 nM:4nM) 
(Figure 2B). At LDI:LD of 5:1 (20 nM:4nM) 100% inhibition was obtained.  
Validity of the Binding Kinetics Model. SPR analysis of the formation of the LD/LDI complex 
was performed by LD binding to LDI on the sensorchip. This approach has two advantages i) 
enhanced signal by binding the 10-fold larger LD to LDI on the chip and ii) signal robustness 
and longer chip life-time as LDI exhibits superior stability to LD, and tolerates repeated cycles of 
regeneration at pH 1.5. Thus signal recovery after 27 cycles was 73%. Rather low 
immobilization levels were used to minimize possible mass transfer limitation and essentially the 
same rate constants were obtained at flow rates of 30 µL min-1 and 60 µL min-1. Furthermore, a 
mass transfer constant, kt > 109 in all runs indicated the binding kinetics to be largely unaffected 
by mass-transport from bulk to chip. The signal magnitude did not permit [LD] < 0.1 nM (~ 2.5 
× KD) corresponding to 4–5 RU, and 8 nM was the upper limit as higher [LD] significantly 
reduced fit quality from a 1:1 model, probably due to chip heterogeneity implying less accessible 
sites or sites with lower affinity due conformational changes to be occupied after saturation of 
native high affinity LDI sites. The specificity of the binding was attested by < 5% non-specific 
LD binding with the reference cell.  
Determination of Binding Rate Constants. The rate constants kon and koff were determined 
using a 1:1 binding model fitted globally to sensorgrams for each set of ligand concentrations. 
Representative data and excellent fits with 0.1–4 nM LD at standard conditions at pH 6.0 (Figure 
3A) (and the corresponding residuals (Figure 3B)) and suboptimal conditions at pH 10.0 (Figure 
3C) (and the corresponding residuals (Figure 3D)) show no systematic deviations of the residuals 
which are < 5%. The very high affinity in the subnanomolar range (see Tables 1−4 below) 
stemmed from slow koff combined while kon values are typical for protein-protein interactions 
(37, 38). The fit quality was slightly inferior for data at pH 10, but still acceptable. The 
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deviations at the transition between association and dissociation phases may be caused by 
aggregation of LD at the chip surface at this pH.  
Effect of Ionic Strength, pH and Temperature on the Binding Kinetics. No LD/LDI complex 
formation was detected by SPR at low ionic strength even applying 80 nM LD. However, 
addition of 300 NaCl at LD (0.1–4 nM) gave the lowest KD = 27.2 ± 1.3 pM (Table 1), 
corresponded to the highest kon and the lowest koff, that in fact varied only modestly in the 75 
mM – 1 M concentration range of NaCl
.
 
The LD/LDI complex formation showed a noticeable maximum affinity at pH 6.5 with KD = 
27.2 ± 0.2 pM (Table 2), and KD increasing 12–15 fold at lower and higher values, respectively 
in the range pH 5.0−10.0. The effect was most important on koff, which from pH 5.0 decreased 5-
fold to the minimum at pH 6.5 and then increased 10-fold from pH 6.5 to 10.0.  
The rates of formation and dissociation of the LD/LDI complex was determined at 9 
different temperatures in the range 10–45 °C (Table 3) using five LD concentrations (0.4–8 nM). 
The highest affinity was found at low temperatures (10–20 °C), and KD increased 6.5-fold by 
increasing temperature to 45 °C mainly due to 16-fold increase in koff. The remarkable increase 
in koff above 35 °C, however, may reflect conformational changes of one or both proteins at the 
higher temperatures. The ~2 fold discrepancy between KD values obtained at standard conditions 
(25 °C) in the temperature dependence analysis (Table 3) and in the ionic strength and pH studies 
(Table 1 and Table 2) primarily stems from kon being approximately 2-fold lower in the 
temperature study. This may be caused by a small variation in the LD concentration due to an 
altered sample preparation procedure.  
Thermodynamic Analysis of the LD/LDI Complex Formation. Despite the above KD 
variation the energetics of the interaction at the reference temperature T = 298.15 K was 
extrapolated using the van’t Hoff equation that describes the correlation between temperature 
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and the natural logarithm of KD, and which allows calculation of the interaction using either the 
non-linear (eq. 4) or the linear van’t Hoff equation (eq. 5). To diminish possible effects of 
conformational change and/or instability of the proteins at higher temperature the calculations 
included data measured at 10–35 °C. The use of the non-linear van’t Hoff equation was justified 
by the curvature of the data in the measured range (Figure 5A). The LD/LDI complexation was 
driven by a large favorable free energy change ∆G° of –57 kJ mol-1 which resulted in a 
significant decrease in heat capacity (∆Cp° = –3.2 kJ K-1 mol-1. The binding was moreover 
characterized by favorable entropy term and enthalpy contributions of T∆S° = 30 kJ mol-1 
(corresponding to ∼53% of the total free energy) and ∆H° = –27 kJ mol-1, respectively. If the 
linear van’t Hoff equation was applied (Figure 5B) the calculated contribution of the enthalpic 
and entropic components to the total free energy of binding were more and less favorable, 
respectively, with T∆S° = 39 kJ mol-1 and ∆H° = –18 kJ mol-1, the latter thus decreasing from 
47% to 31% of the ∆G° of –57 kJ mol-1. 
Effect of the N-terminal Sequence on Binding Kinetics. Different variants of the LDI N-
terminal sequence disclosed that it did not represent a structural element strictly required for the 
interaction between LD and LDI, as essentially retained KD values were obtained for wt-, and 
truncated or extended LDI variants (Table 4). kon seemed slightly reduced for truncated LDI 
forms whereas koff for the elongated EF-LDI was doubled compared to wt-LDI. 
Sequence Alignment and LDI Modeling. Multiple sequence alignment of LDI and RATI, 
CHFI, wheat inhibitors 0.19 and 0.28 showed largest sequence diversity in loops, in particular 
loop 3 (L3) between α-helices 3 and 4, and at the C-terminal region (Figure 4A). Pairwise 
alignment of LDI with the other inhibitors showed sequence identity/similarity of 48.4%/57.8%, 
46.9%/53.1%, 25.8%/37.1%, and 21.7%/34.1%, respectively, and based on the higher identity 
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(and similarity) as well as the functional similarity to RATI, LDI was homology modeled using 
the RATI structure as template.  
The quality of the obtained LDI model was getting a predicted LGscore of 2.035, i.e. in the 
category of “fairly good models” (39). The LDI model (Figure 4B) folds in a globular simple up-
and-down four-helix motif with two short anti-parallel β-strands (Val69–Thr71 and Gly74–Val79) 
typical of CM-proteins (13, 20, 22, 23). The helices (α1−α4) are linked by loops (LDI 
numbering) L1 (Gly33–Pro39), L2 (Val53–Pro54), and L3 (Gly68–Pro88), of which the latter appeare 
to be very flexible. Thus no electron density was seen in wheat inhibitor 0.19 for Gly69–Thr77 
(40). LDI has a 8–13 residues shorter C-terminal tail (L4, Thr101–Gly114) following α4 compared 
to the other inhibitors (Figure 4A). Eight of the 9 LDI cysteine residues form disulfide bonds; 
Cys9–Cys57, Cys23–Cys46; Cys32–Cys87; and Cys47–Cys105, while Cys59 is free (20). Finally, the 
N-terminus of RATI is flexible (23) causing an unstructured N-terminus of the LDI model, 
where residues 1–3 (TLE) are not defined. 
Noticeably, the structural arrangement around LDI Arg58 is conserved among CM-proteins. 
Non-polar parts of the Arg58 side chain contribute to the hydrophobic core in LDI and the 
guanidinium group hydrogen bonds to main-chain carbonyl oxygens of Leu50 and Val53 in α-
helix 2 and L2, respectively. Furthermore, a hydrogen bonding pattern is observed between Arg58 
Nη1, the Ser108 main chain carbonyl oxygen, and Asp55 Oδ1 and Oδ2 and between Arg58 Nη2 
and the Val53 main-chain carbonyl oxygen and Asp55 Oδ1 resembling hydrogen bond patterns in 
crystal structures of RATI, CHFI and wheat inhibitor 0.19. No electron density was found for 
Leu118–Glu122 in the structure of RATI in complex with TMA (18) and residues Tyr120–Val123 of 
wheat inhibitor 0.28 in complex with TMA (13) suggesting that the C-terminus is very flexible 
also in the enzyme inhibitor complex. 
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DISCUSSION 
Proteinaceous inhibitors of α-amylases are known to play an important role in plant defense 
against pathogens and pests and in the control of endogenous α-amylase activity (9, 16, 41-43). 
LDI is the sole example of an endogenous inhibitor of a debranching amylolytic enzyme, and its 
target enzyme LD plays a pivotal role at the interface of starch biosynthesis and degradation as 
well as in malting and brewing (7, 26, 44). Despite this importance, the LD/LDI interaction 
remains to be described in details. The established expression system for LDI, and newly 
reported expression of LD (24) enable discerning the kinetics and energetics of the LD/LDI 
complex formation. The achievement of the production of recombinant LDI in excellent yield 
and of high functional quality should be recognized in the light of CM-proteins being notoriously 
cumbersome to produce recombinantly. For this large protein family heterologous expression of 
recombinant functional protein is only reported of CFHI (22), wheat inhibitor 0.28 (45) and BIII 
from rye (46).  
LD Inhibition by wt-LDI. Cereal-type α-amylase inhibitors act as competitive inhibitors by 
direct interaction with catalytic residues in target enzymes - all of glycoside hydrolase family 13  
and the same mode of interaction was assumed for LD/LDI (12, 13, 17-19). However, the 
present LDI inhibition data did not confirmed this (data not shown) as the Hanes-Woolf plot 
slopes for LD hydrolysis of pullulan at 0 or 2 nM LDI were not parallel, but deviated by 33% 
indicating a partially competitive inhibition. This behavior resembles that of other cereal-type 
inhibitors when acting on complex, large substrates (14, 16). Thus RATI inhibition of PPA 
shifted from competitive, when using p-nitrophenyl α-D-maltoside to a partial competitive and 
partial mixed type inhibition mode when using either p-nitrophenyl α-D-maltoheptaoside or a 
maltodextrin of DP27 as substrate (16). Moreover, complete inhibition was not achieved using 
these larger substrates even at 50–100-fold molar excess of RATI over PPA (16). RATI was 
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found to bind to the substrate thus the extent of apparent inhibition depended on the substrate 
concentration (14, 16). Correcting [RATI] for the amount bound to the maltodextrin revealed a 
inhibition to be competitive with Ki = 0.1 nM (14). The LD/LDI deviation from 1:1 
stoichiometry observed in Figure 2B may stem from LDI binding to pullulan. Recently, we 
showed that the kinetics of LD catalyzed hydrolysis of pullulan is modeled by Michaelis-Menten 
kinetics with substrate inhibition (24), which may be due to genuine substrate inhibition or to 
high transglycosylation activity or both. As a consequence the apparent Ki of 1.7 nM found in the 
present study by fitting the competitive model to the data is probably higher than the actual Ki 
value.  
Homology Modeling of LDI. The N-terminal segment (Thr1–Glu8) of the modeled LDI was 
disordered and assumed to be very flexible. Similarly, residues 1–4 of wheat inhibitor 0.19 were 
not seen in the electron density (40) and in the native structure of RATI, the N-terminal segment 
was described as a “wagging tail” (23). In both the wheat inhibitor 0.28 and in RATI, this part 
became well defined adopting a 310-helix conformation in complex with TMA (13, 18). 
Compared to TMA LD has an open architecture of the active site cleft (25) that readily 
accommodates the Thr1-Glu3 extension characteristic of wt-LDI (Figure 4) whereas previously 
engineered N-terminal elongations or insertions of wheat inhibitor 0.28 diminished or completely 
abolished its activity (45). For N-terminal 0.28 mutants, which retained inhibitory activity 
though decreased, a four-fold longer preincubation time was required to reach the maximum 
inhibition level, suggesting that the N-terminal might only play a role upon binding and is not 
crucial for stabilizing the inhibitor-enzyme complex (45).  
The structural arrangement surrounding the conserved Arg58 seems to be fundamental for the 
loop connecting α-helix 2 and α-helix 3 as well as being important for the exposure of residue 
56, a histidine in LDI, but tyrosine or tryptophan in the other inhibitors (Figure 4A).  In the 
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structure of TMA/RATI this Tyr54 has hydrophobic interactions with Val2 in RATI, and TMA 
Trp56 and Trp57 (18). Also Tyr53 in wheat inhibitor 0.28 is interacting with residues in TMA (13). 
On this basis His56 of LDI is suggested to be involved in the interaction with LDI, possibly by 
stacking of His56 onto Tyr352 and Trp354 in LD, which superimpose with Trp56 and Trp57 in TMA. 
This π-stacking may be disrupted by protonation of the His56 side-chain and weaken binding to 
LD in agreement with SPR data at slightly acidic pH (Table 2). 
The second binding area in the TMA/RATI complex involves two flexible loops in RATI, L3 
and L4 that interact with a protruding loop (residues 132–149) of TMA. LD lacks this TMA loop 
resulting in a groove on the surface, making the distance between LD and LDI too large for 
direct interaction when superimposing the structure of LD and LDI-model onto the TMA/RATI 
complex. 
SPR Analysis of Binding of LDI and LDI Mutants to LD. SPR is a sensitive and powerful 
biophysical technique for analyzing kinetics and energetics of macromolecular interactions. 
Despite the advantage of high sensitivity and rapid analysis provided by SPR a set off in the 
absolute values of the binding constant, by e.g. mass transport limitation has to be taken into 
consideration (47-49). In the present study SPR provides novel insight into the binding forces 
involved in the LD/LDI interaction and the unusually high affinity was mainly due to a very low 
off-rate, koff = 5 × 10-5 s-1, of the LD/LDI complex, whereas kon = 1 × 106 M-1 s-1 was in the 
typical range for protein-protein interactions (37, 38). 
The stability of the LD/LDI complex was not very sensitive to variation in ionic strength 
affecting affinity < 2-fold due to change in kon, while koff was virtually insensitive to change in 
ionic strength. This indicates that long-range electrostatic forces have a minor role in the LD/LDI 
interaction (50) and any salt bridges formed in the complex are likely to be shielded from 
solvent.   
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The optimum pH of the interaction is in good agreement with the physiological slightly acidic 
to neutral pH prevalent in the endosperm of the mature seed, which is shown to acidify during 
germination (51, 52), and it corresponds also to the pH optimum found for LD inhibition by LDI 
(21). KD of LD/LDI interaction depended on pH, which may reflect alteration of protein surface 
charge patterns. Above the role of protonation of His56 was discussed and similarly introduction 
of negative charges or loss of positive charges (perhaps at Lys6) can interfere with the 
hydrophobic interaction and decrease the stability of the complex.  
The binding affinity of the LD and LDI varied with the temperature allowing calculation of the 
van’t Hoff thermodynamic parameters. The favorable entropy obtained both in the linear and 
non-linear van’t Hoff analysis suggests that formation of LD/LDI increases the area of buried 
apolar surface, supported also by lack of detectable binding at low ionic strength even when 
using 20-fold higher LD concentration (Table 1). Moreover, the significant decrease in heat 
capacity is also consistence with an increase in the burial of hydrophobic surface (53). The 
thermodynamic analysis of the interaction between PPA and the wheat inhibitor 0.19 showed an 
increase in entropy, again suggesting that hydrophobic interactions play a significant role in the 
binding (17). The contribution to the binding free energy of both enthaphic and entropic 
components has also been reported for other protein-protein interaction (53) here just to mention 
one namely the binding of Streptomyces subtilisin inhibitor to subtilisin of Bacillus subtilis with 
thermodynamic values of the change in binding free energy, enthalpy and entropy  (∆G° = –57,9 
kJ mol-1, ∆H° of –19,8 kJ mol-1and T∆S° = 38 kJ mol-1) (54) similar to the one reported for 
LD/LDI in this study. The heat capacity, however, calculated for the subtilisin/subtilisin inhibitor 
interaction is ∆Cp° = –1.02 kJ K-1 mol-1. Values of ∆Cp° for protein-protein interaction has be 
shown in the range of 0.8 to –3.2 kJ K-1 mol-1 (53) with an average value of –1.4 ± 0.8 kJ K-1 
mol-1  placing the calculated ∆Cp° of the LD/LDI  interaction on the borderline.  
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The literature reports that N-terminal residues of cereal-type inhibitors interact with the active 
site of target enzymes (14, 18, 19, 45). So far, however, only a few α-amylases have been 
investigated as targets and as their active site cleft is narrower than of debranching enzymes, 
their inhibition may be more sensitive to changes in the N-terminal structure of the inhibitor. 
Deletion from the LDI specific Thr1–Glu3, i.e. the N-terminus in other inhibitors, and Ser4 and 
Val5 hardly affected KD. Elongation of the N-terminal sequence of LDI by a charged and a 
hydrophobic residue had no effect on kon, but doubled koff, for the LD/LDI complex formation, 
presumably due to accommodation of an extra charge in the LD active site cleft. The finding 
suggests that the role of the LDI N-terminal segment in both formation and stability of the 
complex with LD is different from that observed previously for cereal type α-amylase inhibitors. 
  
CONCLUSION 
Detailed SPR analysis of binding kinetics and energetics of the LD/LDI complex reveals binding 
in the subnanomolar range due to very slow dissociation and that the binding was driven by both 
enthalpic and entropic contributions. Electrostatic interactions seemed not to play a role as salt 
screening had essentially no effect. KD, however, depended on pH, possibly due to charge 
disruption of hydrophobic interactions. Analysis of LDI variants suggests that the N-terminal 
segment has a different role compared with other cereal-type inhibitor enzyme complex 
formation (20). 
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Table 1. Effect of ionic strength on binding and dissociation rates of LD/LDIa 
NaCl 
(mM) 
kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
0 No binding detected 
75   9.0 ± 0.0 3.4 ± 1.5   37.3 ± 17.0 
150 15.4 ± 0.2 6.4 ± 0.2 42.0 ± 2.0 
300 17.3 ± 0.3 4.7 ± 0.1 27.2 ± 1.3 
1 M   9.4 ± 0.1 7.0 ± 0.1 74.1 ± 1.0 
aMeasurements were performed at 25 °C in 10 mM Mes/NaOH pH 6.0, 0.005% P-
20. Seven LD concentrations in the ranges 0.1–4 nM and 1–80 nM were used for 75 
mM – 1 M and 0 mM NaCl, respectively. KD is based on independent duplicate 
experiments.  
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Table 2. pH dependence of binding and dissociation rates of LD/LDIa 
pH kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
5.0   6.1 ± 0.6 25.9 ± 3.2             425 ± 119 
5.5   9.7 ± 0.1   8.6 ± 0.1   89.3 ± 0.1 
6.0 14.2 ± 0.4   5.3 ± 0.1   37.3 ± 1.9 
6.5 18.6 ± 0.2   5.1 ± 0.0   27.5 ± 0.2 
7.0 18.1 ± 1.6   6.2 ± 0.2   34.5 ± 1.8 
7.5 16.4 ± 0.0   8.1 ± 0.3   49.3 ± 1.7 
8.0 16.7 ± 0.1 12.3 ± 0.0   73.8 ± 0.4 
8.5   16.0 ± 0.12 21.8 ± 0.1 136.2 ± 2.2 
9.0 12.4 ± 1.1 27.0 ± 0.5   219.2 ± 22.6 
9.5 13.8 ± 0.3 31.3 ± 1.8   227.3 ± 18.0 
10.0 14.5 ± 1.7 49.9 ± 4.4 345.1 ± 9.0 
aMeasurements were performed at 25 °C in appropriate buffers (see Materials & 
Methods), containing 150 mM NaCl and 0.005% P-20. Seven LD concentrations 
(0.1–4 nM) were used. KD is based on independent duplicate experiments.  
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Table 3. Temperature dependence of binding and dissociation rate constants of the 
LD/LDIa 
Temp. 
(°C) 
kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
10   5.6 ± 0.0   4.9 ± 0.3   88.0 ± 6.0 
15   6.5 ± 0.0   5.7 ± 0.2   88.2 ± 3.1 
20   7.6 ± 0.0   6.6 ± 0.2   86.2 ± 2.1 
25   8.8 ± 0.1   8.3 ± 0.1   94.5 ± 0.5 
30 10.1 ± 0.1 11.5 ± 0.2 114.5 ± 3.0 
35 11.2 ± 0.0 19.7 ± 0.0 176.7 ± 0.4 
37 11.6 ± 0.1 26.1 ± 0.3 225.1 ± 0.2 
40 12.5 ± 0.1 39.6 ± 0.3 317.1 ± 3.6 
45 13.9 ± 1.7 79.9 ± 5.1     580.5 ± 106.8 
aMeasurements were performed at different temperatures in 10 mM Mes/NaOH pH 
6.0, 150 mM NaCl, 0.005% P-20. Five LD concentrations (0.4–8 nM) were used. KD is 
based on independent duplicate experiments. 
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Table 4. Effect of the LDI N-terminal sequence on binding and dissociation rate of 
complex formation with LDa 
Inhibitor kon × 105 
(M-1 s-1) 
koff ×10-5 
(s-1) 
KD 
(pM) 
wt-LDI 14.8 ± 0.1 5.9 ± 0.7 40 ± 3 
∆V5LDI 10.0 ± 0.0 5.7 ± 0.2 55 ± 2 
∆E3LDI   9.1 ± 0.1 6.6 ± 0.1 72 ± 3 
EF-LDI             13.5          11.3            84* 
aMeasurements were performed at 25 °C in 10 mM Mes/NaOH pH 6.0, 150 mM 
NaCl, 0.005% P-20. Seven LD concentrations in the range 0.1–8 nM were used. KD is 
based on independent triplicate experiments. * Based on a single experiment. 
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Figure 1. N-terminal sequences of wild-type and LDI variants (see Material & Methods and 
Results sections for further description).  
 
Figure 2. Inhibition of LD by wt-LDI. (A) Fit of Michaelis-Menten equation for tight 
competitive inhibition. No inhibitor (), 2 nM LDI (), 4 nM LDI (). Error bars indicate SD 
for duplicate measurements. (B) wt-LDI inhibition level (%) vs. LDI:LD (molar ratio); the curve 
is drawn though the experimental points. Error bars indicate SD for triplicate measurements. 
 
Figure 3. Representative fits of a 1:1 binding model (gray line) to the SPR data (black line) and 
residuals. The LD concentration range is 0.1–4 nM. (A) Binding data at standard conditions, 10 
mM Mes/NaOH pH 6.0, 150 mM NaCl, 0.005% surfactant P-20, 25 °C and (B) the 
corresponding residuals. (C) Binding data at suboptimum conditions, 10 mM Bicine/NaOH pH 
10.0, 150 mM NaCl, 0.005% surfactant P-20, 25 °C and (D) the corresponding residuals. 
 
Figure 4. (A) Multiple sequence alignment of the five inhibitors LDI, RATI, CHFI, and dimeric  
and monomeric wheat inhibitors, 0.19 and 0.28. Secondary structures of the modeled LDI 
structure is shown above the alignment and also indicated on the sequences by α-helices as dark 
gray and β-strands as light gray shading. (B) Homology model of LDI showing a helical bundle 
with a simple up-and-down topology. The α-helices and β-strands are shown in red and blue, 
respectively. The 4 disulfide bonds and Cys59 are shown as yellow sticks and His56 is colored 
gray.   
 
Figure 5. van’t Hoff plots of the fitting of the non-linear (A) or linear (B) function to the data. 
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SUPPLEMENTAL MATERIAL 
Figure S1.  Coomassie stained SDS-PAGE of the purification of wt-LDI (A) Lane 1, culture 
supernatant. (B) Concentrated pools from Ni-NTA elution. Lane 1, pool 2; lane 2 pool 1. (C)  
Concentrated pools from anion exchange chromatography. Lane 1–6. Fractions from the anion 
exchange chromatography of wt-LDI were pooled according to the peaks of the chromatogram. 
Pool 4 was used for all the analysis; lane 7, pool from anion exchange chromatography of the 
first Ni-NTA pool. Expected size of the produced product is 13.5 kDa.  
 
